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ABSTUACT 
LIPID ALDEHYDES ARE SUBSTRATES AND TRANSCRIPTIONAL 
REGULATORS OF CYTOCHROMES P450 
Immaculate Amunom 
May 10,2008 
4-hydroxy-2-nonenal (4-HNE) and propene-2-al (acrolein) are highly reactive 
a,~-unsaturated aldehydes. 4-HNE and acrolein are generated ill vivo as products oj' lipid 
peroxidation. These aldehydes are implicated in the onset of several diseases including 
atherosclerosis and neurodegenerative disease. They also react with nucleophilic cellular 
macromolecules including proteins, DNA and phospholipids. Some of these reactions in 
l'ivo lead to inhibition of enzyme activities, depletion of glutathione and oxicbti\l' stress. 
Because of their pathophysiological relevance, attention has focused during the last 
decade on the ability of mammals to metabolize these lipid aldehydes. 
The purpose of this study was therefore to determine the rok of cytochro!1l~ 
P450s in the metabolism of lipid aldehydes and how exposure to lipid aldehydes 
influences the regulation of the expression of xenobiotic metabolizing enzymes. 
Cytochrome P450s are a superfamily of heme proteins that catalyze the NADPH and Ch-
dependent monooxygenation of a wide variety of compounds. [n addition. P450s arc 
capable of catalyzing the biosynthesis of several molecules including the synthesis of 
sterols, fatty acids, and eicosanoids. In this study used a fluorescence spectroscopy and 
high performance lipid chromatography technique, coupled with mass spectrometry to 
demonstrate that CYPs metabolize lipid aldehydes. This metabolism invol\'es 
Vl 
monooxygenation by mouse, rat and human P450s, of 4-HNE to 4-hydroxynom:nnic acid 
and the reduction of 4-HNE to 1 ,4-dihydroxynonene by specific P450s. By using general 
and specific P450 inhibitors, we have determined that hepatic P450s differentially 
contribute to 4-HNE metabolism. While Cyp2c29 catalyzes oxidative metabolism. Cyp~,a 
predominantly catalyzes the reduction of 4-HNE. 
We demonstrated by microarray analysis and quantitative real-time peR that 
expression of Cyp2c29, Cyp2c37 and Cyp3a25 is induced by acrolein and hutylatcc! 
hydroxyanisole, both activators of AP-l in mouse liver. These P450s include Cyp2.:29. 
Cyp2a5 and CyplA2. BHA and acrolein also induced other xenobiotic mdabolil'ing 
enzymes such as GSTml, heme oxygenase-l and NADHP quinone oxidoreductase 
Certain transcription factors function to regulate gene expression in response to 
xcnobiotic challenge. Lipid aldehydes in particular regulate gene expression through the 
action of two transcription factors, namely AP-l and Nrf2. We determined that Cyp2L'2(j 
is regulated by activator protein I (AP-I) transcription factor. Nrl2 was nut invohd ill 
the induction of Cyp2c29 expression. The results from this study show that there is lipid 
aldehyde-dependent regulation of P450 gene expression. The induced Cyp2c29 goes Ol1 
to metabolize substrate in a manner reminiscent of a self-regulatory loop nf hiolog:eai 
activity. 
Vll 
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Peroxidation of co-6 polyunsaturated fatty acids proceeds by a free-radical chain 
reaction mechanism that yields lipid hydroperoxides as a major initial product. 
Subsequently, decomposition of the lipid hydroperoxides generates reactive lipid 
aldehydes such as malondialdehyde, glyoxal, propene-2-al, 4-hydrcxy-2-mm.:naL and ,]-
oxo-2-nonenal (Uchida, 2003). Plants also produce lipid aldehydes. Ihms-2-hcxenaJ is a 
plant aldehyde. It occurs in green plants as a product of oxidative degradation of plant 
lipids (Visser et aI., 1979). Studies have shown that trans-2-hexenal and other plant 
alLlchydes can be active as host plant attractants (Visser et 0/., 197R), as enhatlCcrs ,)1' 
other host plant odors (Guerin et 01., 1988), indicators of fruit ripeness (Engel ('/ ui .. 
1(88) llr defensive secretions (Neri el al., 2005). Two very important lipid aldehydes to 
which humans are exposed are propene-2-al (Beauchamp et 01., 1985) and 4-hydroxy-2-
t10nenal. They form the bulk of reactive endogenous lipid aldehydes characterized in l'im 
to date and are implicated in a series of pathological conditions including atherosclcn,sis 
and Parkinson's disease (Pauli and Shaur, 20(0). 
4-IIVDROXY-2- NONENAL (4-HNE) 
4-HNE is a long-chain u, ~-unsaturated aldehyde. It has 9 em-bon atoms. in,,'luTng 
a carbonyl group and a 4-hydroxy group (Figure lA). Initially discovered by Bcnedetti e( 
al. (1980) during the investigation of lipid peroxidation by liver microsomes. 4-H NE has 
subsequently been shown to be formed predominantly from the peroxidation of the (1)-6 
polyunsaturated fatty acids linoleic acid and arachidonic acid (Schneider e/ al .. 2001 ). 4-
HNE is the most abundant and cytotoxic lipid aldehyde described to date (Esterbauer c/ 
aI., 1991 and Uchida, 2003). Lipid peroxidation resulting in the production of'l-IINF IS 
a direct consequence of oxidative stress. Sies (1991) described oxidative stress as an 
imbalance between oxidants and antioxidants, potentially leading to damage. Unde,' 
physiological conditions, the cellular concentration of 4-HNE ranges 6'0111 0.1 plVl I,) :1 
~lM. However, under oxidative stress conditions in vitro, 4-HNE may aCCllll111btc to 
higher concentrations from 10 11M to 5 mM (Esterbaucr et 01., 1991: Uchida. 2()Ol). 
Several mechanisms have been put forward to explain the mechanism 0 r :l-IIN I·. 
formation. The most recent mechanism established by Schneider (20() 1) uti li;/ed the ()-
~nd 13-hydroperoxides oflinoleic acid as starting material. Following two distinct 
pathways (Figure 1 B), 4-hydroperoxy-2E-nonenal is generated and subsequently 
converted to 4-HNE. 
PROPENE-2-AL (ACROLEIN) 
Acrolein. ~ike 4-HNE, is an CJ..~-unsaturated aldehyde. It is co~orless. voiatik ,mel 
soluble in water, ethanol and diethyl ether (WHO 1992). Acrolein is a three-carbon 
compound with two reactive sites: a carbon-carbon double bond and a terminal carhollyl 
group (Figure lA). Acrolein was first isolated from dry distillation Ofi~lts ill 1843 by 
Redtenbacher (Beauchamp et aZ., 1985 review). Since then, several other sources have 
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Metal-catalyzed catalyzed oxidation of arachidonic acid (Uchida ct a/., 19(8). I n addition 
to lipid peroxidation. acrolein is a by-product of over-heating organic matter and occurs 
as an ubiquitous pollutant in the environment, for example, incomplete combustion 01" 
plastic materials, cigarette smoke, and over-heating of frying oils (Beauchamp eI 01. 
1(88). 1\ recent study determined the amount of acrolein in a single putT of cigarette 
smoke to range from l.6 - 22 ~lg/cigarette depending on the carbon filter oCthe cigarette 
(Thweatt ct al., 2007). Acrolein is formed in air as a photochemical reaction product. 
during the biotransformation of allyl compounds and the anticancer drug. 
cyclophosphamide (Boor, 1983; Fraiser et af.. 1991). Acrolein is also generated li"11m the 
metabolism of spermine and spermidine by the microsomal enzyme mOl1oLlminl": u"idase 
in liver and heart cells (Timbrell, 1991). It has been estimated to represent 5<% oCthe total 
aldehyde found in polluted air, but is proportionally the most damaging chemical 
contaminant because it is highly irritating, and, as an a,~-unsaturated compound. is \IT)" 
electrophilic (Witz, 1989) allowing it to rapidly react with many nucleophilic sites. 
Levels of acrolein in ambient air are estimated at only 0.04 to 0.08 ppm. although it is 
found at up to 90 ppm in cigarette smoke (Costa and Amdur, 1(96). Subchronic-
inhalation studies have reported physiological effects at 0.4 ppm. The lethal dose 01' 
acrolein in humans is a 10 min exposure of 351 mg/m3 (Stanford Research Institute. 
1(78). 
MOLECULAR EFFECTS OF 4-HNE AND ACROLEIN 
4-HNE and acrolein are diffusible aldehydes. They can act locally or cntcr the 
general circulation. Because these aldehydes are highly reactive elcctrophi!C~. they 
5 
readily react with cellular nucleophilic macromolecules such as proteins and DNA 
(Esterbauer et af., 1991). The use of matrix assisted laser desorption lionization- time oj' 
flight (MALDI-TOF) mass spectrometry and liquid chromatography/mass 
spectrometry/mass spectrometry (LC/MS/MS) has allowed for the identification of points 
of macromolecular modification by 4-HNE and acrolein. 
4-Hydroxy-2-nonenal can form adducts with proteins by reacting with cysteine 
sulfhydryl groups, histidine imidazole groups and lysine £-amino groups (Uchida, 20(3). 
Absorbed acrolein reacts directly with protein and non-protein sulfhydryl groups and 
with primary and secondary amines found in proteins and nucleic acids (Fry e/ a/., 1993). 
Enzymes with sulfhydryl groups in their active site can be inhihited by hoth 4-11NE and 
acrolein. For example, acrolein inhibits rat DNA polymerase (Munsch e/ (fl., 1973). Iligh 
levels of acrolein inhibit GST mu and GST pi (>250 f..tM; Berhane and Mannervik, 1990), 
and aldehyde dehydrogenase (>200 ~lM; Silva and O'Brien, 1989). High levels of 4-HNI': 
differentially inhibit cytoehromes P450 (Kuo et af., 1997). 
4-HNE and acrolein are believed to be involved in aging, chemical-drug toxicity 
and the pathogenesis of a number of human diseases. The concentration of 4-HNE is 
elevated in diseased regions of the brain of patients with Alzheimer's disease 
(l\1arkesbery and Lovell, 1998; Picklo et af., 2(02), in human hippocampus after global 
ischemia (McKracken e/ af., 2001) and in Lewy bodies in neurocortical and hrain stcrn 
neurons in Parkinson's disease (Zarkovic, 2003). Among other effects, recent findings 
suggest that in vivo, covalent modification oflow-density lipoprotein (LDL) by 4- I IN I~ 
and acrolein renders LDL more atherogenic and enhances foam-cell formation 
(Esterbauer 1993; Uchida et al., 1998). Proteins modified by 4-HNE have been detected 
6 
in atherosclerotic lesions. 4-HNE modification of mitochondrial proteins occurs during 
cardiac reperfusion in hearts isolated from senescent rats, thus, establishing a link 
between 4-HNE and cardiac reperfusion injury (Lucas and Szweda. 19(9). Upon 
incubation with low density lipoprotein, acrolein preferentially reacts with lysine residues 
forming N(1-acetyl-N"-(3-formyl-3,4-dehydropiperidino) lysine or FDP-lysine (lichida ,,/ 
aI, 1(98). 4-HNE and acrolein generated during oxidation of low-density lipoprotein 
form covalent adducts with apolipoprotein B (Hubatsch cl al., 1998) and trigger the 
uptake of low density lipoprotein by scavenger receptors located on vascular tissues, 
including vascular smooth muscle cells (Steinbrecher et al., 1990). Thercfore, the 
metabolism of these compounds to less reactive products that can be excreted or 
subjected to further metabolism is of great importance. 
MULTIPLE PATHWAYS ACCOUNT FOR 4-HNE METABOLISM: 
Glutathione S-Transferase, Aldehyde Dehydrogenase And Aldose Reductase 
The ability to withstand toxic chemicals and oxidative stress is esscntial Cor the 
survival of all organisms. Various mechanisms have evolved to protect cells against 
foreign compounds and reactive oxygen species including efflux pumps, anti ox id,mt 
proteins and glutathione COSH), xenobiotic metabolism, sequestration oC toxins and DN.\ 
repair (Hayes and McLellan 1999). When administered in vivo. radiolabelcd "1-) [Nl: is 
rapidly metabolized and excreted into urine as a group of polar products from (n-llxidi/ed 
4-hydroxynonenoic acid (HNA) and their low density lipoprotein conjugatcs, as vvcll as a 
group of less polar mercapturic acid thioesters originating fr0111 the mctabolism or thc 
aldehyde moiety of 4-HNE (Alary ct a11995; De Zwart ct al., 1996). In the study by 
Alary ('/ al. aftcr intravenous administration of 4-HNE into rats, HNJ\ and mercapturic 
7 
acid conjugates accounted for 40%-50% and 30% of the injected dose, respectively. This 
pattern indicates that both oxidation and glutathione (OSH) conjugation arc the main 
metabolic pathways of4-HNE metabolism. Moreover, in vitro studies of4-HNE 
metabolism performed with isolated hepatocytcs (Hartley et aI., 1995; Siems e/ at.. 
1997; Amunom et aI., 2006), enterocytes (Boon et af., 1999), liver slices (Laurent ef ({/, 
2(00), and perfused organs such as liver, kidney, and heart ( Boon et aI., 1999; Grunc ef 
aI., 1997) suggest that HNA and glutathione-conjugated 4-HNE account for the major 
metabolites of 4-HNE. These metabolic studies of the lipid peroxidation-derivcd 
aldehyde 4-HNE suggest that metabolic pathways involving glutathione S-transtCnlse 
(GST), aldehyde dehydrogenase (ALDH) and aldose reductase CAR) arc involved in 
disposition of 4-HNE and related aldehydes. In isolated rat hepatocytes, GST catalyzed 
the Michael addition of 4-HNE to glutathione (GSH), ALDH oxidized 4-HNE to 4-
hydroxynonenoic acid and aldose reductase reduced 4-HNE to 1 A-dihydroxy-2-no;1l~llc 
(Hartley er al., 1995, Srivastava et al., 2001). Figure 2, taken from Alary ef 01. (2003) 
shows the pathways established for 4-HNE metabolism. 
Little is known about the contribution of cytoehromes P450 to the mctc:bolisll1 01' 
lipid aldehydes. There is a single study demonstrating that in PP AR wild-type, but not 
PPAR knockout mice, fibratc treatment resulted in the increase in 4,9-dihydroxy-2-
nonenoic acid, the co-hydroxylated metabolite of 4-HNE and its oxidized form. 4-
hydroxy-2-nonene-l,9-dicarboxylic acid (Oueraud et al., 1999). This suggests a possible 
role of the Cyp4a family in 4-HNE metabolism. There are no other reports of P450s 
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CYTOCHROMES P450 (CYP) 
The history of cytochrome P450 began in 1955 with the first experimenteli 
evidence demonstrating that an enzyme system in the endoplasmic reticulum orthe liver 
was able to oxidize xenobiotic compounds (Axelrod, 1955). Subsequently, Omura and 
Sato (1964) named this enzyme cytochrome P450 because the pigment (P) in liver 
microsomes had a 450-nm spectral peak when reduced and bound to carbon monoxide. In 
the late 1970s, only six P450 enzymes were known to exist. With advances in cloning 
and purification techniques, many other P450s have since been discovcred. As 01'2006. 
there are 57 CYP genes in the human genome 
(http://drnelson.utmem.edu/CytochromeP450.html). 
A basic structural model for P450s has been established based on the structur,d 
comparison of published bacterial P450 crystal structures P450cam. 1>450BM-». 
P';50terp. and P450eryF (Graham-Lorence and Peterson. 1996). P450s are elll1~p()sed or 
t\VO main domains, a predominantly a-helical domain accounting for approximately 70(Yo 
of the protein, and a predominantly ~-sheet domain accounting {(n° 22% of the protein. 
The (X-helices are denoted A-L with the I and L helices contacting the heme. Residues in 
the B, I and F helices contact the substrate. The most conserved region in the P450 is a 
sequence containing a cysteine that acts as the thiolate ligand to the heme iron. This 
sequence is used to identify P450s in gene banks. Along with the cysteille in tbe hCI11l' 
binding region is the highly conserved amino acid sequencc 
F(G/S)XGX(H/R)XCXGX(I/UF)A (Guengerich, 2000; Graham-L and Peterson. 1 ql)()). 
A nomenclature system for the cytochrome P450 gene superfamily exists and is 
continuously updated (http://drnelson.utmem.edu/CytochromeP450.html: Nebert e/ a/.. 
11 
1987). Based on this nomenclature, cytochrome P450 proteins are arranged illto 1~1l~1ilies 
and subfamilies based on their percentage of amino acid identity. P450 enzymes that 
share ~ 40% identity are assigned to a particular family and are designated by an Arabic 
numeral, for example CYPI. Those sharing ~5:5% amino acid identity are grouped into a 
particular subfamily designated by a letter, e.g. CYPIA. 
There are two main types ofP450s. The type I P450s are found in bacteria and in 
mitochondria and receive electrons from NADPH through a flavoprotein (ferreduxin 
reductase) and an iron/sulfur protein (ferredoxin). The type II P450s are found in the 
endoplasmic reticulum and receive electrons from NADPH through a single protein, 
NADPH:cytochrome P450 oxidoreductase or CYPOR (Miller, J98g). CYPOR is a n-
kDa protein that forms a complex with the P450 in the endoplasmic reticulummel1lbrane 
(Hubbard et al., 2001). Of the 57 P450 genes in the human genome. 50 arc type II. 
Among thesc 50, about 15 are involved in drug metabolism, 20 arc invohcd in the 
biosynthcsis of sterols, fatty acids, and eicosanoids, and 15 arc "'orphan" enzymes, \\i10Sl' 
activities remain unknown or ill-defined (Guengerich, 2004). 
The oxidative metabolism of substrates by P450s involves the transfer of two electrons to 
the P450. The first electron transferred to endoplasmic reticulum-localized cytochromes 
P450 is always by CYPOR. The second electron can either come from CYPOR or from 
cytochrome h5 (Porter, 2002). The generally accepted steps for substrate metabolism by 
P450s are summarized in the P450 catalytic cycle (Figure 3). The reactions in this cycle 
include oxygen binding (steps 1-6), followed by the oxidation of substrate (steps 7 and R) 
and the release of product (step 9) (Guengerich, 2(01). 
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Figure 3. Generalized reactions of the cytochrome P450 catalytic cycle. The reactions in 
this cycle include oxygen binding (steps] -6), oxidation of substrate (steps 7 and 8) and 
the release of product (step 9). (Copied from Guengerich, 1001. Current Drug 
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Xenobiotics include drugs, food metabolites and environmental pollutants 
pesticides, herbicides, and industrial combustion wastes. These compounds, as well 
asendogenously generated compounds are substrates for cytochromes P450. 1n humans, 
CYPs that metabolize xenobiotics are in the CYPl, CYP2, CYP3, and, to a lesser extent 
CYP4 families. A list of putative mammalian filll-length P450 isofonns, their suhstrates 
and inducers are shown (Table 1). While humans have only 57 functional CYP genes. the 
mouse has up to 102 (Nelson et aI., 2004). P450s are mostly expressed in the liver: 
however, some are extra-hepatic. Other organs ofP450 gene expression include hrain. 
heart, lungs, kidney, and small intestine. The most abundant mammalian P450, CYP3A4. 
is expressed in adult human liver and intestine (Choudhary e{ at., 2004). Table 2. adapted 
from Hewitt et al., 2007, shows the relative abundance of human hepatic cytoehrollles 
P450. 
NUCLEAR RECEPTORS 
Nuclear receptors comprise a superfamily of proteins which include the lluclear 
hormone receptors, orphan nuclear receptors, the retinoid X receptor (RXR) and its 
beterodimer partners, the thyroid hormone receptor, vitamin D3 receptor (VDR), 
peroxisome proliferator-activated receptor (PPAR), the constitutive androstane receptor 
(CAR), and the pregnane X receptor (Figure 4). Nuclear receptors translocate to the 
nucleus in order to modulate transcription of target genes in response to extracelluar and 
intracellular signals, culminating in an array ofresponses including metabolism, 
differentiation and proliferation which influence physiological processes such as 
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Table 1 
A Summary of CYPs in various species showing the different isoforms, their substrates and inducers 
I Cyp , [J-!Ul~;~l ----~-~-- ---- -, Rat --~--- I Mouse , Dog J 
I ~YP I, I 
3A lsoform 3A4/5 i 3A 1/2 i. 3all ! I -- ---~ - --- --t- -~--- -- - ----- -~ -- --~ ~-- ~--- -~ -- ---
~~~i~~:te J_~~~~ost~rone., Midazola111 ____ - t~::{O;~I~~le,-Mid;i91~~~~-_ i S~jt?ster~I~~'= - _jTeSt~ter~ll~'-=~-_~ 
~-lA -ICYP -\ ~~~pin.~ - - ~- ---~~-TAII2--------~-h~il~~ZOlal!1~_~~-- -[ ~i~;Olan~ __ --~ 
~---- - -- - -- -- ~-~~~~ -~-----+----------~-~-~-~ -------r------- ~-- -~------~~--~---~----~ 
Inducer t- OM, BNF, 3-MC I BNF, 3-\1C, PB I PB 1 0M, BNF, 3-MC i 
2B-~j ~~;trat~j ~~~~;~ti~-,-E~=~ __ ~ __ ~-_=~~_+~~~~I~;~~ti!;~E~--~_-=-~ ~G~~lfgg~~l~R--=~-!- 2B 1-1-~~=~-~ji' 
-- - ----r ---- -~ - -- - --~-~-- ~- -+-- ~---------~--~~-~~-t--~~ --~ --~ --~--j------ -~ 
Inducer PB I PB i PB +' PB I --~----~~--I----~~- ~---~;~----- -~-----~-.--~--i --~- - -----~--~---___t- ---~--~~---~~-~ -- ----. -~'------j 
§.~bstrat~i S-meJ)l~enytoll1(I'i-deln_ethylatloQl _ j ~R-, _~~, te~~()stero~1e _ 1 BP~E~_ _ ___ !Qrz, diazapai!i __ 
f-:-- - 1- ---1- Bup-'"2Piofl,-BR.,_f>~_ ,- -- --- i ---- - ~- ----4 - - - -- ~~ --- --
• 2C _ I CYP ~! 2C8/9/18/19 ~ ~ ~ 2C II, CYP2C6 -----1 2c29 I 2C21 (minor CYP) 
c ____ pnduc;~--nII(2t9,2C-II1J>B_(2C=l~L-~-=: De~_-~_ -==-=-__ lYI,-eny_toin ____ -=_ -=---=ti~ _=---=-~-
I j Substrate. Paclitaxal(2C8), Tolbutamide, i : I 
:-----~- -T-- --~ --- ~--- -~~--- - ~--~ -- ~T-~ ----~- ~- --~-~ -- ~--j---- -- ~------- __ L -----~~ 
I
, Diclofenac (2C9), S-MP J I I -- ---- -- ~~-~ -~ ---~-- ~ -~~- -- -- ~~-- ---- .j ~-- ~---~- ~-- -- I --~~~ ----~ ~~------
(hydroxylation,2C19) I I , 
: 4A ICyp---j 4A9/Tl ----- -; ~fAI/2/3/8- ------ - ;-Abse~-------
1- - I -----+-~------ ~ -+-~---~~-- -----~---- ~~ --- ~~--~----j -------~-
! :Jn~~eI...L(;Iot'ilJ!a~_ I C lotThr~te_ (4A l) __ ___--'-_ _ _ 
_ ! S.tJ_bstrate_j'___ __ Lauric acid i Lauric acid , 
_2D T cyp ~ __ 2D6 __ 20112 _____ --=12cl9-13 -! 2.0-15 ___ _ 
Inducer No known inducer 
;- S l;bst;;;:te- tDextro~i:;-~thoipj,an 
! 2;\ t- CYP I 2A6 
-- -----
I lnducer PB, RIF 













: 2£ -Cyp 2El 21:1 2el 
Ch lorzoxazonc 
-----~- ------------
- --- - Et!l(\!W!. Acetone pyrazinc Ethanol _----- t-LI"l9~isoniazid) 
Chlorz(~x:,?O;1t:,2~£'P Chlorz()~a~()l~~g~~~ !p-~litropht::noL 
Inducer ! Isoniazid. PB, __ ~[f' 
-
RIF = rifampin, PB = phenobarbitone, Dex = dexamethasone, B~F = B-napthoflavone, 3-MC = 3-methylchloranthrene, ER = 
ethoxyresorufin, MR = methoxyresorufin, BR = benzyloxyrcsorufin, PR = pentoxyresorufin, OM = omeprazole, p-NP= p-nitrophenol, 
s- MP = S-Mephenytoin (Table adapted from Hewitt et al (2007) Drug Metabolism Reviews. 39:159-234). 
t--
Table 2 
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(lahk copied from Hewitt et al.. (2007). Drug Metabolism Rc\ie\vs. 30:] 5l)-2.~'-i). 
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reproduction and development (Robinson-Rechavi ct al., 2003; Olefsky. 2(01). 
Nuclear hormone receptors are receptors for which ligands have been identitied. 
They transduce signals from small molecules like glucocorticoids, mineralocorticoids. 
sex steroids (estrogen, progesterone, and androgen), thyroid hormones, and vital1liJ: D~ 
within the cell cytoplasm. Orphan receptors are receptors for which the ligands are 
unknown. Nuclear receptors have common structural features (Figure "1). The N-terminal 
region contains the activation function-l (AF-l) domain. The central region is the ])1\/\ 
binding domain (DBD) responsible for targeting the receptor to the DNA response 
element. The C-terminal region consists of the ligand-binding domain (LBD). responcibJc 
for binding hormonal and non-hormonalligancls and receptor activation and the 
activation function-2 (AF-2) domain. Nuclear receptors can exist as h01110- or 
heterodimers with each partner binding to specific response element SCc;1i'.?I1CCS thaL c\is~ 
as half-sites separated by variable length nucleotide spacers bet'vYeel1 direct or inverted 
half-site repeats (Olefsky, 200 1). There are four categories of nuclear receptors 
UvIangksdorf ct al. 1995). Class 1 receptors include the steroid hormone receptors_ ,,\'bcll 
("unction as homodimcrs binding to half-site response element inverted repeats. ('lass :? 
receptors exist as heterodimers with RXR and function in a ligand dependent manner. 
The class 3 receptors are the orphan receptors, which function as homodimers hinding to 
direct repeat response elements. Class 4 receptors function as monomers, binding to (l 
single half-site response clement. 
A key function of nuclear receptors is the regulation of gcne expression. Th:s is 
achieved through recruitment of coactivators and transcription factors to the target 
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Figure 4. Structure/function organization of nuclear receptors. (Copied from Olefsky 




promoter, as well as chromatin remodeling. Several transcription factors arc known to 
exist. For the purpose of this project, I will describe a group of transcription bctors 
known as oxidative-stress sensitive transcription factors. These include activator protcin-
1 (AP-l), nuclear factor kB (NF kB), and nuclear factor E2-related factor 2 (Nr!'2). 
OXIDATIVE STRESS-SENSITIVE TRANSCRIPTION FACTORS 
Oxidative stress in the cell occurs when there is a productioa of more rcacti vc 
oxygen or nitrogen species than antioxidants. These reactive oxygen species include 
hydrogen peroxide (H20 2) hydroxyl radical (OH), superoxide anion (02 ) and organic 
peroxides. Oxidative stress can damage cells by causing lipid peroxidation, proteill. and 
nucleic acid modification. In order to prevent damage, cells have developed an 
antioxidant defense system that includes non-protein antioxidants (Vitamin C, ]) and !':. 
glutathione) and protein antioxidants or enzymes; glutathione reductase, calala",,' ~lr:Li 
sliperoxide dismutase. Another class of enzymes known as xenohiotie metabolizing 
el~zymes such as glutathione S-transferase and quinone oxidoreductase can prevent 
oxidative stress by metabolizing chemicals that generate oxidative stress. The expression 
of many of these xenobiotic metabolizing enzymes is regulated by thc oxidative strcss-
sensitive transcription factors AP-l, NF-kB and Nrf2. 
AP-l is a redox-sensitive transcription factor and a member of the basic leucine 
zipper family of proteins. AP-l family members include Fos, Jun and activating 
transcription factor (ATF). AP-l exists as different dimeric combinations of basic leucine 
zipper proteins from the Jun (c-Jun, JunB, and JunD), and Fos (c-Fos. Foss' Fra-l. and 
Fra-2). and ATF (ATF2. ATF3, B-ATF) families. Jun proteins form homodimcrs that 
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bind to the AP-l DNA recognition clement known as TP A (12-0-tctradecal1oyl-p!Jorl luI 
13 acetate) response element or TRE. The TRE consensus sequence is 5 '-TelA( ;/('1'(,.\. 
3' (Angel et af., 1987). Unlike Jun, Fos family members do not form stable hOll1odill1ers. 
Instead, they function as heterodimers composed ofFos and Jun family member proteins. 
Fos and lun heterodimerize, forming an X-shaped structure that binds to the palindromic 
TRE (Glover and Harrison, 1995). A common feature of the AP-l transcription j~lctors is 
a basic DNA binding domain and a leucine zipper domain collectively known ,!S blIP 
domain (Figure 5). The leucine zipper domain is responsible for dimeri/a~iOl; ()i' th,' 
protein, a prerequisite for DNA binding. The basic domain is used for I )J\li\ bimlill!'. 
Whereas the bZ[P domain has been well characterized, less is known about the structural 
properties of the transactivation domain. The activity of AP-l transcription LlClors is 
regulated by many factors including cytokines, stress signals. growth t~let,)rs. alld 
lll:cogCllic stimuli. Posttranslational regulation ofAP-1 involves pl~!)sp!:oi') !<.l(1.11 h i~,!.' 
mitpgen-activated and stress-induced protein kinases (MAPKs). Three MAPK j'all1ilil'~; 
have been identified in vertebrates. These arc c-.Tun N-terminal kin,lse (.INK). tlh.~ 
e;-.;traeellular regulating kinase (ERK) and the p38 kinase (Robinson <lnd Cobb. ]l)lJ7). 
The c-Jun N-terminal kinascs (JNK) arc comprised of three iSOj'Ol"11S namely 
.TNK I. JNK2 and JNK3 (Davis, 2000) . .INK is activated by a series or events in the 
MArK cascade. The kinase cascade is activated by compounds like acrolein (Ranganna 
ef a/ .. 2(02), butylated hydroxylanisole (BI-IA) and its metabolite tertiary butylatcd 
hydroquinone (tBHQ) (Keum et aI., 2006) and 4-HNE (Uchida et 01.. 1 C)()l)Llh' \1\P:~ 
kinase kinase (MAPKK kinase) phosphorylates and activates the MAPK kinase 
(f\1APKK) (Hibi et of., 19(3). Activated MAPKK in turn phospborylaks and acti\ ~ltes 
Figure 5. Functional domains of the activator protcin-l transcription factor. Thl: 
bZrp domain of lun is shown in blue and the bZIP domain of Fos in red. The DN1\ 
backbone is shown in yellO\v. The Jun and Fos proteins exhibit several domains, 
including the bZIP domain (leucine zipper plus basic domain), transactivation domains 
and docking sites for several kinases, such as JNK or ERK. JNK phosphorylates serine 
residues within the transacti vation domain oOun at position 63 and 73 and thereby 
regulating its transactivation activity. Copied from Hess et of. (2004). Journal of Cell 
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DEF liomain: clocking s ile for ERK 
MAPK. which then phosphorylates .TNK. Upon activation by the MAPK cascade. thc 
JNKs translocate to the nucleus, where they phosphorylate Jun within its N-tcrmin,;] 
domain at serine residue 63 and 73. Activated JNK is also implicated in thc 
phosphorylation-dependent activation of transcription factor Nrf2. 
Nuclear factor KB (NF-KB) is also a redox-sensitive transcription ractor. NF-I\-f3 
I~lmily members include pSO/plOS, pS2/plOO, p6S/RclA, RelB, c-Rel. ])osal. OiL ,lml 
Relish (Karin. 1999). Under basal condition. NF-KB is sequestered in the cytoplasm as all 
inactive complex with its inhibitor IKB. Exposure to oxidative stimuli leads to the 
phosphorylation and proteasomal degradation ofIKI3. thereby reka~;ing \JF-d3. \J;"-k:3 
activation is also mediated by tumor necrosis factor a (TNFa), intcrleukin ! (IL-I), 
bacterial lipopolysaccharide (LPS), viral double stranded RNA and ionizing radiati,ll1. 
These cause the phosphorylation-induced dcgradatiun of h:B ar:d tbe di::rlptioiJ \),' '\,~! -J\: I, 
!i'om Id3. Free NF-tJ3 dimers tben translocatc to UK' nuclers 'vv:1l'r,'lhl:. :):'J, 1, :,~ 
promotcr of target gencs and regulate their transcription. (Karin., 1999: Schmidt el C/I.. 
I ()95). 
The transcription factor nuclear factor E2-related factor 2 (NrJ'2.) is a ke: rC!',ULlil)J 
ni J\EET':pRE -driven transactivation of antioxidant genes. The cis-acting ckn:Cl1l 
!.;nOWll as the antioxidant response clement (ARE) or cIcctrop11ilc rcs;)onsc -:lcn:c::t 
(FpRF) is located in the promoter region of many genes encoding <lI1tio::ic.:lanl ;ll1d 
detoxifying enzymcs. j'\rf2 is a basic region-leucine zipper (bZipHYrC transcripti()11 
!~lctor (Itoh cf of.. J (95). Under basal conditions, Nrf2 is sequestered in the CytOpl:1SIl: ')\ 
binding to Keap J protein, thereby repressing nuclear activatio); oflhe ;\I:F hy :\JJ.!',2 \ foil 
1'1 al .. i 9(9). Upon activation, Nrf2 dissociates from KeapJ, transioeatcs to the lillCicll, 
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and binds to the ARE as a heterodimer with the small Mafprotein ([toh ef (f/ .. 1 ()9!) It) 
induce gene expression. 
Several factors can cause the dissociation from Kea)) 1 and activation of;'\j rf1. 
Nrf2 can be activated by exogenous compounds, endogenous products of oxidative Sl!TSS 
or other stresses generated inside the body, such as 4-hydroxy-2-nonenal (N UIncl'v\aza c/ 
(fl.. 2003; Ishii el aI., 2004). Other compounds like BHA and tBHQ (Keul11 e/ ill.. :::O()(l) 
also activate Nrf2. tBHQ is the prototypical inducer of ARE driven genes and is a l11a:or 
metabolite of the phenolic antioxidant BHA. tBHQ functions to disrupt Nr111i'011l i(eapi 
by increasing the phosphorylation of JNK, which in turn. phospboryJaks Nrf2. Nrl2 is 
then released from Keap 1, and translocates to the nucleus (Keul11 et 01 .. 20(6). The 
phosphorylation ofNrf2 occurs on serine residue 40 (Chen and Kong. 20()4: l\. \\(\1\ ('/ ul., 
20(4). There is also compelling evidence that some strong elcctrophilic compounds call 
caLIse Nrf2 release by direct interaction with Keap 1. This oecurs throclgh lh-.: covalent 
1'f- . j' , 'd C2'i7 e?73 C288 d C797 K 1 (l)' J '/ moul IcatlOn 0 cysteme rCS1 ues " - , ' . an - on .cap \1 ir; '.J)\a-;',()~:t()V~1 
el a/., 2002), 
The ARE motif was originally identi lied by a mutagenesis study c,f the rat ( rSI-
Ya ARE (Rushmore and Pickett, 1990), The consensus sequencc is 5'-
(;\/G)TGACnnnGC-3': n represents any nucleotide, The ARF has be:.T cUc\.:ld i:' l::,' 
promoter region of the genes encoding GST-Ya (rat and mouse: Friling el (II.. 1990: 
Rushmore e/ 01., 1990), GST -P (rat; Okuda e{ al., 1999), and rat and human NQO-l 
(Favreau and Pickett, 1991; Li and JaiswaL 1992), mouse hcme oxygellase-1 (II O-J ) 
(Prestcra el aI., 1995), y-glutamylcysteine synthetase (yGCS) heavy S'JbUllit (Mldcah) 
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and Gipp, ]995), mouse GST-Ml and M3 (Reinhart and Pearson, 19(3), and mouse 
ferritin light chain (Wasserman and Fahl, 1997). 
Little is known about the regulation of cytochrome P450 gene expression b: lipid 
aldehydes acting through the oxidative stress-sensitive transcription factors. but late!) 
there is increasing evidence that these transcription factors may regulate P450 gene 
cxpn.:ssion. 
The purpose of my research project is two-fold. 1. To determine the rol~ of 
cytochromes P450 in the metabolism of 4-HNE; 2. To investigate the regulation of 
cytochrome P450 gene expression by lipid aldehydes. This is the first extensive study 
of the P450s involved in lipid metabolism. 
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CHAPTER II 
CYTOCIIROMES P450 CATALYZE TIlE METABOLISM OF fl,fJ-
lJNSATlJRATED ALDEHYDES 
(The oxidation reactions in this chapter were published in Archives of Biochcmistl'~' 
and Biophysics 464: 187-196(2007». 
INTRODlJCTION 
rx,0-Unsaturated aldehydes are highly reactive molecules formed by biological 
and chcmical processes. These aldehydes include propene-2-al (acrolein). Irans-2-
hexenal, and 4-hydroxy-2-nonenal (4-HNE). Acrolein is a toxic environmental aldehyde. 
formed by combustion processes or metabolism of drugs like cyclophosphamide (Boor. 
I ()83). It is among the most chemically reactive aldehydes known. Tra17s-2-hcxen~11 i~ a 
major plant natural product Conned from oxidation of linolenic acid that pro\'ides the 
odor of apples and its closely related Corm is cis-2-hexanal vvhieh accounts for the smell 
of Creshly cut grass. [/1 l'ifro, 4-HNE can be generated from the 9- and 13-hydroperoxides 
of the (0-6 polyunsaturated ratty acid. linoleic acid (Schneider el (fl.. 2001 ). The 
concentration of 4-HNE is significantly increased in plasma, various mgans. and cell 
types including liver cclls under conditions of oxidative stress (Esterbauer e/ (f/ .. I ()91 ; 
Poli and Schaur, 2000). Significant levels of 4-HNE (1-5 ~lM) generated during oxidative 
stress have been shown to be associated with onset and progression of cardiovascular and 
ncurodegenerative diseases (Awashthi ef al .. 2003; Srivastava et (fl.. 20(2). For example. 
modifIcation of low density lipoproteins by ct.-IlNE renders this lipoprotein 1110re 
atherogenic and results in foam cell 1'ormation. Moreover, 4-1 INI: l1lodilicd proteins han: 
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been detected in atherogenic lesions (Esterbauer ef 01 .. 1993). At low ~LM concentrations. 
4-H\JE affects cell proliferation and shows genotoxic cffects (Eckl ef ai., 19(3). u.[)-
Unsaturated aldehydes are also prevalent in thc environment and they display toxic 
effects in ~lM concentrations (Esterbauer i'I al., 1991; Awasthi ef ai., 2003: Srinlstanl ef 
uZ .. 2002). 
Because of their pathophysiological relevance, attention has been focused during 
the last dccade on the ability of mammals to metabolize aldehydes, including 4-HNE. 111 
vitro, metabolic studies carried out with rat liver subcellular fractions showed that 4-1 fNF 
,vas rcduced to 1,4-dihydroxy-2-nonene (DHN) by cytosolic alcohol dehydrogenase 
(Estcrbauer el al., 1985) and oxidized by aldehyde dehydrogenases to 4-hydroxynol1cnoie 
acid (I-INA). In addition to these products. the glutathione-IINE (GS-HNE) conjugates 
were rapidly formed during incubation of 4-BNE with hcpatoeytcs. entcrocytes. and 
tumor cells (Siems e/ 01., 1992; Ramana et al., 2(06). In a study carried out alkr 
intravenous injection of 4-I-INE into rats, four mercapturic conjugates were characterized 
in the urine, namely 1.4-dihydroxy-2-nonene mercapturic acid, 4-hydroxynollenal 
mercapturic acid, 4-hydroxynonenoic acid mercapturic acid. and the corresponding 
lactone mercapturic acid derivatives (Alary ct al., 1995); glutathione conjugates of 4-
HNF and 1 ,4-dihydroxy-2-nonene were also observed. These results were further 
confirmcd by De Zwart e/ al. (1996) demonstrating that conjugation of 4-flNE with GSH 
is a high capacity, first pass metabolic step in the elimination ofthis aldehyde. 
Cytochromes P450 (P450) arc enzymcs that mctabolize xenobiotics and 
endogenous and compounds. They arc integral mcmbrane-bound heme-containing 
proteins. localized in the endoplasmic reticulum of hepatocytes (Black. 1 <)92) and 
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extrahepatic tissues as a complex with NADPH:P450 oxidoreductase (CYPOR) (Nelsoll 
and StrobeL 1987). A number of reports have demonstrated that exposurc to high 
concentrations of aldehydes. e.g. 4-HNE; inactivak these hCl11oproteins in a dircct or 
mechanism-based reaction (Kuo et al., 1997). The sensitivity of P450s to 4-1 INE is 
varied, with CYP2B4 and CYP2B 1 being inactivated to the greatest extent and 2C3, 1/\2, 
2El, and 1A1 to a lesser extent. The KinaClivatioll for 4-IlNE is normally greater than 0., 
mM for these P450s. However, levels of lipid-derived aldehydes probably do not 
normally attain suiIiciently high levels in vivo to cause extensiw inactinltion of thc 
P450s. A rolc for cytochromes P450 in the metabolism of endogcnous and cxogcnous 
aJI-unsaturated aldehydes has not been fully established. In this study, \VC dcmonstratc 
thJt mammJlian cytochromes P450, namely, mouse Cyp2c29, humJIl CYP3A4 and 
CYP2B6, and rabbit CYP2B4, catalyze the facile oxidation of a,0-unsaturated aldehydes 
to their carboxylic acids at low 11M concentrations of aldehyde substrate, whilc some 
enzyme inactivation occurs at higher conccntrations. Using mouse livcr microsol11cs and 
primary hepatocytes in conjunction with selective P450 inhibitors, we show that. in 
Jddition to aldehyde dehydrogenase, some hepatic P450s, such as CYP2B6, CYP3A4, 
CYP2c29 and CYP2J2 participate signi ficantly in oxidative metabolism of these 
aldehydes and display low KM values for these reactions. Interestingly, in additioll to the 
oxidation rcaction, we observed that CYP3A4, CYP32B6, CYP31 A2, Cyp2c29 and 
CYP32J2 also participate in the reduction of 4-HNE to 1,4-dihydroxy-2-noncne. 
MATI,:RIALS AND METHODS 
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Chemicals and plasmids. The expression plasmid, pCW-Cyp2c29, with Cyp2c29 cDNA 
cloned into Nde I and Hind III restriction enzyme site was provided hy lA. Goldstein, 
National Institutes of Environmental Health Sciences, Research Triangle Park, NC 
(Luo el af., 1998). The CYPOR expression plasmid was provided hy Mark Doll and 
David Hein, Department of Pharmacology and Toxicology, University of I.ouisvillc 
School of Medicine. All plasmids were restriction enzyme digested to confirm the 
identity of the cDNA of interest. Preparations of Escherichia coli membranes containing 
recomhinant CYPOR and CYPIA2, 2B6, 2EI, or 3A4 were prepared as described 
(Guengl.::rich and Martin, 1999). In thesc preparations, the ratio of P450 to CYPOR \VdS 
noted to he between 0.8-2.0. Human CYP2J2 and CYPOR expressed in insect cells was 
generously provided by Darryl Zeldin, National Institutes of Environmental Ilealth 
Sciences, Research Triangle Park, NC. Anthracene-9-carboxaldehyde (()-AA), ()-
anthracene methanol (9-AMeOII) and anthracene-9-carboxylic acid (9-/\C/\) were 
purchased {i'om Sigma-Aldrich Chem. St. Louis, MO and dissolved in DMSO bet(.)re usc. 
3flIJ-4-ITNE was prepared as describcd previously (Srivastava £'1 a!.. 2(02). and 4-1 INI: 
was purchased from Calbiochem, San Diego, CA. The HNA standard \vas gencrated by 
incubating 4-HNE with yeast aldehyde dehydrogenase (Sigma Chemic~ll Co .. St. Louis, 
MO) and, after monitoring NAD+ reduction for completion of the reactioll. the products 
were extracted into ethyl acetate (Srivastava e/ af., 2002; Ramana el ul., 200()). 
Escherichia coli growth conditions. Glycerol stocks containing dual expression 
plasmids, pCW-Cyp2c29 and pACYC-l Duct CYPOR gene in E. coli BL21 (DL]) 
served as innoculum for the expression experiment. Cells vvere grown overnight \vith 
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vigorous shaking (250 rpm) at 37°C in Luria broth containing 54 mg/mL or ampicillin 
and 34 mg/mL chloramphenicol. A 111 000 dilution of E. coli cells was made into 500 1111, 
of Terrific Broth and grown at 37°C to an optical density of 0.6 at 600 nm. One hour prior 
to induction, the growth medium was supplemented with 0.5 mM 6-aminolevulinic acid. 
Enzyme expression was then induced with 1 mM isopropyl-~-D-thiogalactopyranoside 
and the culture incubated at 30°C with orbital shaking at 190 rpm. After 48 h. the cells 
werc harvested by centrifugation at 5.000 x g for 10 min. The cell pellet was suspended 
in 100 mM Tris buffer, pH 7.8, containing 20% glycerol (v/v), and 0.5 mM EDTA to 
achieve a volume equal to 15% of the original volume of culture. Membrane preparation 
was carried out at 4°C as described (Richardson ef aI., 1995) with some modifications. 
Lysozyme was added to a final concentration of 0.2 mg/mL, and an equal volume of ice-
cold water vvith gentle stirring. After an additional 30 min of stirring, the resulting 
spheroplasts were centrifuged at 8,000 x g for 10 min and resuspended in 0.05 volumc or 
TMK buffer (50 mM Tris-HCI, pH 7.3, 50 mM KCI and 10 mM MgCh). The cell i)cllct 
was frozen at -80°C and upon thawing, a protease cocktail for bacterial cells (Sigma. St. 
Louis Mo.) was added as recommended by the manufacturer. The spheroplasts were 
lyzcd by sonication using six 1 O-sec pulses at 40% power using a Branson 200 scries 
soni tier fitted with a micro tip. Cell debris was removed by centrifugation at 5,000 x g Cor 
10 min, and the supernatant was ultra-centrifuged at 143.000 x g for 60 min. The 
resulting membranes were suspended in 10 mM potassium phosph,!te buffer, pH 7..t 
containing 20% glycerol and 0.1 mM EDTA by homogenizing in a Potter-Elvehjcl11 
homogenizer to form spherosomes and stored at -80ne until used. 
Preparation of mouse liver microsomal fractions. Male C57BLl6J mice (22 g to 27 g: 
Jackson Laboratories, Bar Harbor, MA) were fed ad lihitum for 1 week with AIN-76A 
diet (Purina Test Diet, Richmond, IN) or AIN-76A diet supplemented v.ith 0.45% HIli\. 
All procedures for handling the mice were approved by the University of Louisville 
IACUC Committee and conformed to the Public Health Service Policy on Humane Care 
and Use of Laboratory Animals. Animals were anaesthetized with CO2 and euthenized by 
spinal dislocation prior to harvesting the liver into icc-cold 0.9% NaCI solution. The 
livers were cut into small pieces and homogenized in a Potter-Elvehjem homogenizer 
(Sears Drill Press Stand Model 25921, Chicago IL) with 4 volumes of 50 mM potassium 
phosphate buffer. pH 7.4, containing 0.25 M sucrose per gram of liver. Microsomal 
fractions were isolated by differential centrifugation as described by Remmer c( 01 
(1966). Microsomal fractions were resuspended in 0.1 M Tris-HCI buffer (pIT 7.4). 
containing 0.25 M sucrose and sedimented a second time. The final preparation was 
resuspended in Tris-HCI bufTer containing sucrose and 10°;() glycerol and stored at -80°C, 
Determination of protein and P450 content. Total protein concentrations were 
determined by measuring formation ofbicinchoninic acid-eu+ complex at 562 nm (Pierce 
Chemical Co., Rockville. IL). P450 content was determined by thc CO-differcnce 
spectra of dithionite reduced P450 (Omura and Sato, 1964) using a Varian Model 50 
spectrophotometer (Varian, Palo Alto, CA). Cytochrome P450 content was calculated by 
assuming a molar extinction coefficient of91 mM'lcm'l. The pct50 content of liver 
microsomal fractions from untreated C57BLl6J mice was 0.23 nmol/mg. The final 
homogenization of membranes to obtain spherosomes resulted in significant Joss of 
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Cyp2c29 activity. Volk et al. (1995) observed a remarkable tendency of this P450 to 
dissociate from membranes during homogenization. It is possible that this results in the 
loss of activity due to conversion to the inactive P420. The maximum amount of active 
Cyp2c29 obtained in spherosomes was 1.52 nmollmg of protein. 
NADPII:Cytochrome P450 oxidoreductase activity measurement. The co-expression 
of each P450 of interest and the CYPOR was performed using E. coli BL21 (DE3). The 
activity of CYPOR in spherosomes was determined by measuring the reduction of the 
artificial substrate cytochrome c. The reactions were carried out at 37°C in 0.05 M 
potassium phosphate buffer, pH 7.4 containing 40 ~lM cytochrome c. diluted aliquots of 
the spherosome (contain the P450 and CYPOR), and I 00 ~lM NADPH. The absorbance 
change was monitored at room temperature at 550 nm with a Cary 50 Bio UV-Visiblc 
spectrophotometer. The CYPOR activity was determined assuming a mobr extinction 
coefficient of 21 mM- l em- l (Masters et at., 1966). During the preparation of 
spherosomes several fractions were tested and that with the highest CYPOR activity 
(Figure 6) was then used in metabolism assays. Similar fractions were used for the 
reconstitution experiments. 
Primary hepatocyte culture. Male Sprague-Dawley rats (180 g-200 g: I-Isd:SD, I farlan 
Indianapolis, IN) were used for liver perfusion as described by the method of Bayliss and 
Skett (1996). Cell survival was determined by trypan blue exclusion (Berry et (II.. 1991) 
and hepatoeytes having viability greater than 80% were plated at a density of 4 x 10
6 
cells/dish onto 60-mm plastic dishes precoated with collagen in Williams E-Fl2 1: 1 
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mixed medium described by Ferrini et al. (1998) and 1som e/ al. (1984). After allowing 
the cells to attach for 4 h, the medium was changed and renewed every 24 h thereaHer in 
the absence of serum. The cells were treated with 50 ~lM 4-HNE and the reactions 
terminated at 0, 10, and 20 min with trichloroacetic acid (TCA) to achieve 7.5 TeA 
concentration. The resulting samples were frozen at -80nC prior to analysis by llPLC as 
described below. The inhibitors (0.5 mM miconazole, phenytoin, or cyanamide) were 
added just prior to 4-HNE. When 0.5 mM troleandomycin was added as an inhibitor to 
the hepatocytes, the cells were pre-incubated with trolcandomyein 10 min prior to adding 
4-HNE. 
Purification of rabbit liver cytochrome CYP2B4 and NADPH :cvtochrome P450 
oxidoreductase. CYP2B4 was purified from rabbit liver in the Prough Laboratory as 
described by Dean and Gray (Dean and Gray, 1982) to a purity of approximately 1 X nn101 
hemoprotein/mg protein. Rabbit liver CYPOR was purified by the method oj' Yasukochi 
and Masters (1976) to a specific activity of 3 8.2 ~lln()l cytochrome c reduced per 111 i n per 
mg flavoprotein. Both preparations displayed a single major protein band upon analysis 
by SDS-PAGE. 
Cvtochrome P450 activity assay. CYP3A activity was determined in mouse livcr 
microsomes by measuring O-dealkylation of the benzyl ether or resorulin to the 
fluorescent product, resorufin (Prough et al., 1978). Reactions were carried out at 37"e in 
2 mL volume with 1 mM NADPH, and 0.25 mg/mL (50 nM P450) microsomal protein in 
0.1 M potassium phosphate buffer, pH 7.4. The production ofresorufin was monitored at 
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Figure 6. Determination of cytochrome c reductase activity in membrane fractions. 
NADPH-cytochrome P450 oxidoreductase was expressed in E. coli and membrane 
fractions called spherosomes prepared by sonication, centrifugation and homogenization. 
CYPOR activity was then determined by measuring cytochrome c reduction using 
enzyme-containing spherosomes, spherosomes from mock-transformed plasmid or the 
pellet obtained from centrifugation. The reduction of cytochrome c was measured at 550 
nm. Oxidoreductase activity was used to calculate the concentration of CYPOR llsing the 
factor 1.360 ~lmol cytochrome c reduced per minute per ~lM of oxidoreductase protein 
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an excitation wavelength of 535 nm and emission wavclel1l'th of 586 nm with a 
~ ~' 
luminescence spectrometer (Model LS50B, Perkin-Flmer, ]3oston, MA), i\ standard 
curve for the product, resorufin, was constructed to calculate enzyme activity normalized 
to microsomal protein concentration. 
Anthraccnc-9-carboxaldehydc oxidation assay. The oxidation of anthracene-9-
carboxaldehyde (9-AA) by P450 enzymes was determined by measuring the formation of 
anthraccne-9-carboxylic acid (9-ACA) as described by Watanabc el o/.. 2002 and :Vlarini 
el al., 2003. In brief, the incubation mixture included recombinant 1>450s (50 nM) or 
mouse livcr microsomes (0.25 mg/mL, ~50 nM P450), an NADPH-rcgcncrating system 
consisting of I 00 ~lM NADPH, 4.25 mM isocitric acid, 50 mM MgCI 2, and 1.3 Units/mL 
isocitrate dchydrogenase, 25 ~M 9-AA, and 0.1 M potassium phosphatc butkr. I'll 7.4. 
The reaction was carried out at 30°C for 10-30 min and terminated with I Ill] oro.s N 
NaOH. Ethyl acetate (4 mL) was added to allow product separation between thc aqueous 
and thc organic phase. The formation of 9-AMeOH was determined in the alkaline 
organic phase at 255 nm excitation and 411 nm emission wavellength with a 
spectrofluorimeter (Model LS50B). Aqueous phase (1 mL) was subsequently acidified 
with 1 mL or 0.5 N HCl and 9-ACA extracted with 4 mL cthyl acetate. The Iluorescence 
of 9-ACA in the acidic organic phase was measured at 255 nm excitation and 4SX 11111 
emission wavelengths (Figure 7). The fluorescence excitation and emission spectra oj' the 
metabolites was nearly identical to authentic anthracene-9-carboxylic acid and 9-
anthracene methanol. The 9-AA metabolism assay was used as an initial indicatioll or 
aldehyde oxidation or reduction by P450s. 
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The 9-AA metabolism assay was also performed with reconstituted CYP2B~. 
CYP2B4 and CYPOR were separately expressed in E coli and spherosomes containing 
both enzymes used. The reconstitution was performed in 0.05 mM 
dilauroylphosphatidylcholine, 86 nM pig CYPOR and 50 nM CYP2B4. The incubation 
reaction was initiated by adding 1 00 ~lM NADPH and continued for 10 min at JO"( '. The 
reaction was terminated with 1 mL 01'0.5 N NaOH and products extracted using 4 l11L 
ethyl acetate as previously described. 
Metabolism of 4-I1NE by cytochrome P4S0s. 4-HNE metabolism was performed by 
incubating 50 ~M eHJ-4-HNE with either E. coli expressed P450 (50 nM) or mouse 
microsomal protein (0.25 mg/mL, ~>50 nM P450). Incubations were carried out in 0.1 M 
potassium phosphate buffer, pH 7.6, containing 0.5 mM NADPI-I in a 1 mL reaction 
volume for 20 min in a 37°C-water bath with orbital shaking at 200 rpm. The NADPTf 
regenerating system was not used with 4-HNE due to the formation of additional anaJytcs 
associated with the isocitratelisoeitrate dehydrogenase mixture. Recombinant P450s (50 
nM), purified rabbit CYP2B4 (200 nM P450 plus 600 nM CYPOR) or mouse liver 
microsomcs (0.25 mg protein/mL) were analyzed for aldehyde oxidation activity. The 
reaction was initiated by adding 50 ~M eH]-4-HNE. The reactions were terminated aner 
20 min incubation by flash freezing sample tubes in liquid nitrogen. The frozen samples 
were thawed upon adding TCA and the denatured protein sedimentcd at 13,000 x g for 5 
min at 4°C. The supernatant was injected into the HPLC column after an aliquot \vas 
removed to measure radioactivity in a Packard Tricarb 21 OOTR scintillation counter 
(PackcmJ Instrument Co., Dovvners Grove, II,) with Ultimagold (Packard Instrument Co .. 
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Figure 7. Procedure to measure 9-anthracene aldehyde metabolites. 9-Anthracene 
aldehyde (25 ~lM) was incubated with P450 as described under methods. 9-anthracene 
mcth:.Hlol was extracted into the organic phase of the basic incubation reaction and 
measured at )cexeitation 255 nm and Aemission 411 nm. Aqueous phase (1 mL) was 
acidi ficd with 0.5 N Hel, followed by extraction with 4 mL ethyl acetate, and 9-
anthracene carboxylic acid was measured in the organic phase at ),excitation 255 nm and 
)~cll1ission 458 nm. 
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Downers Grove, IL) as the scintillation cocktaiL prior to separation by high performance 
liquid chromatography. The recovery of eII] radioactivity from the reaction mixtures 
were >98°;() and the recoveries from I-IPLC were determined to be >95%. All ofthe P450s 
displayed linear reactions to 20 min with 4-HNE. 
Inhibition of aldehyde metabolism by cytochrome P450 inhibitors. Metabolic assays 
with either 9-AA or 4-HNE were performed with either membranes containing expressed 
P450 or mouse liver mierosomes as described above. except for the addition ofselcctiw 
inhibitors. Phenytoin and troleandomycin (0.5 mM) were used to inhibit Cyp2c29 and 
Cyp3a. while cyanamide (0.5 mM) was used as an inhibitor of aldehyde dehydrogenase. 
Miconazole (0.5 mM) was utilized as a general inhibitor of P450. Trolcandol11ycin vvas 
preincubated with microsomal or expressed P450 fractions and 0.5 mM NAOPl I for 10 
min before 9-1\1\ or eHJ-4-HNE was added. Miconazole, phenytoin, and cyanamide 
were added to the reaction immediately prior to the aldehyde substrate. 
Anaerobic metabolism of 9-AA and 4-HNE bv mouse liyer microsomes. The 
incubation reaction was prepared as described above for 9-anthraccne aldehydc and 4-
TI~F in an Erlenmeyer flask fitted with a serum stopper fitted with syringes. First thc 
bufTer was bubbled for 5 min with carbon monoxide or argon followed by addition of the 
P450. A mixture of glucose (74 mM). glucose oxidase (0.33 mg/mL) and catalase (1400 
U/mL) was also added. The headspace ofthc reaction mixture was i1ushed with cither 
carbon monoxide or argon for 3 min and the reaction initiated with I 00 ~lM NADPH. The 
reaction was conducted for 20 min and during this time, the headspace of the reaction 
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\vas continuously flushed with either argon of carbon monoxide. The reaction Vias 
terminated by adding NaOH (for the 9-AA incubation) or frozen in liquid nitrogen (the 4-
lINE incubation). Extraction of products was performed as described above. 
Kinetic analysis of 9-AA metabolism bv Cvp2c29. The reaction contained prcpared 
sonicated membranes (containing both 50 nM CYP2c29 and approximately 100 nJ\! 
CYPOR), 0.1 M potassium phosphate buifer pH 7.4. and the NADNI-regenerating 
system. The membranes were co-incubated with 25 ~lM or 50 ~M 4-1 INE and increasing 
concentrations of 9-anthracene aldeyde for 10 min at 30°C shakillg at 200 rpm. The 
reaction was terminated with 0.1 M NaOH and product extracted with ethyl acetate as 
describcd above. Fluorimetric measurements were performed as described above. 
Analysis of the data was performed using the Kinetin program (Clark and Carol. 19R()). 
High performance liquid chromatography (HPLC). The HPLC system consisted of a 
Waters automated gradient controller with dual model 510 pumps (Vlilford. MA). a 
Waters manual injector (2 mL loop) and a C 18 reversed phase column (5 pm, 250 111111 x 
4.6111111 Varian. Walnut Creek. CA) connected to a radioactivity detector (Radiometric 
Flo-one B model ;\-515 detector, Packard Instrument Co., Downers Grove, IL) or to a 
fraction collector (Biorad Modcl221 0 BiOl'ad. Hercules. CAl. The mobile phasc v. as a 
linear gradient ranging from 100% solvent A (0.1 % (v/v) TFA in water) to 1 OO?Ic) solvent 
13 (40% solvent A, 60% acetonitrile). Solvents were delivered at a 110w rate of I mL/min 
for 75 min as follows: linear gradients from 100<% to 7M"o solvent l\ (0-15 min). ii'om 
76(X) 1\ to 74°;() i\ (15-40 min). from 74(Yo to 40% A (40-45 min). from elm'i) to 0% j\ (45-
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GO min), and then eluted with 100% A (60-75 min). The conditions were changed to 
100(0) A over 10 minutes prior to starting the next run. The incubation and J TPLe analysis 
Were performed in triplicate. 
Gas chromatography-electrospray ionization/mass spectrometrY of 4-HNE 
metabolites. For GC- MS analyses, the samples were derivatized in 20 ilL of acetonitrile 
with 20 ~lL ofN,O-bis(trimethylsilyl)-trifluoroacetamide (BSTFA) for I hat 600 e as 
described previously (Srivastava et al., 2000). The mixture was cooled to room 
temperature and 1 ~lL aliquots were used for analysis. The GC-EUMS analysis was 
performed using an Agilent 6890/5973 GC/MS system (Agilet11 Technologies) under 70 
tV electron ionization conditions. The compounds were separated on a bonded phase 
capillary column (DB-5MS, 30 m x 0.25 mm IO x 0.25 ~m film thickness from nw 
Scienti tic Folsom, CA, US!\. The GC injection port and interface temperature were set (0 
280"C. with helium gas (carrier) maintained at 14 psi. Injections were made in the 
splitless mode with the inlet port purged for 1 min following injection. The GC oven 
temperature was held initially at 100llC [or 1 min, and then increased at a rate of looe 
min'l to 28(tC, which was held for 5 min. Under these conditions, the retention time ror 
I1NA derivative was 9.67 min. 
Statistical analysis. Experiments were conducted in triplicate and the means and 
standard deviations (SO) were determined. Where appropriate a Student's I-Test was 
used for statistical analysis with p:S 0.05 as the criterion for significance. Alternati\'c1y, 
analysis of variance (ANOY 1\) was performed when required. 
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RESULTS 
Flourescence spectra of the 9-anthracene aldehyde metabolites 9-anthracenc 
carboxvlic acid and 9-anthraccne methanol. The method for measuring 9-anthraccnc 
carboxylic acid, the oxidized product of 9-anthracene aldehyde. had been previously 
described (Marini et al., 2003). The excitation and emission wavelengths 01"25511111 and 
458 nm respectively were used to measure 9-anthracene carboxylic acid formation. 9-
anthracene methanol is a reduced product of9-anthracene aldehyde. Using the Perkin 
Elmer model 50B spectroiluorimeter we determined the excitation and emission 
wavelength of 9-anthracene methanol to be 255 nm and 411 nm respectively (Figure 8). 
The emission wavelengths for both 9-anthracene carboxylic acid and 9-anthracene 
mdhanol were strikingly different, thus enabling us to measure these products {"rom [>450 
incubation reactions using appropriate standard curves for the two florescent metaholites. 
9-Antbracene methanol was measured in the ethyl acetate of the organic phase after 
raising the pH with base. The f1uorescence intensity of9-anthraccnc methanol was high 
in this phase suggesting efficient extraction into the organic phase. 9-Anthraeene 
carhoxylic acid was extracted into ethyl acetate following acidification of the aqueous 
phase. 
Evaluation of P450s capable of oxidizing anthracene-9-carboxaldchvdc to 
anthracene-9-carboxylic acid. Watanabe et al. (1991) demonstrated that Cyp2c29 is an 
aldehyde oxygenase utilizing a cannabinoid aldehyde at low ~ll\f concentrations as a 
substrate. Therefore, we sought to evaluate the ability of a number of PLt50s ror their 
ability to oxidize a synthetic aldehyde substrate, 9-AA (Watanabe et 01 .. 2002~ Marini el 
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al., 2003). Several P450s rapidly metabolized the aldehyde compound, while others 
apparently did not oxidize this aldehyde to its carboxylic acid Cfable 3). For example. l)_ 
anthracene aldehyde oxidation activity for human CYP3A4. human CYP2B6. and mouse 
Cyp2c29 was appreciable. while the ability of CYP 1 A2, CYP2E 1 and CYP2.J2 to oxidize 
this model aldehyde was negligible. There were also significant levels of activity seen 
with liver microsomes from mice (1.5 nmollmin/nmol P450). We sought to determine the 
kinetics of 9-AA oxidative metabolism by murine CYP2c29, as well as the human 
CYP3A4 (Figure 9). The P450s were incubated with varying concentrations of 9-
anthracene aldehyde at 30°C and subsequently analyzed to determine the KM for 
oxidation to acid. Recombinant mouse Cyp2c29 expressed with CYPOR in F. coli 
membranes oxidized 9-AA to 9-ACA with a Kea! 01'7.4 min-! and a KM 01' 71- 0.9 ~lM 
with apparent normal Michaelis-Menten kinetics. We observed a slight deviation or 
CYP3A4 from simple Michac1is-Menten Kinetics toward cooperativity. CYP3,\4 
displaycd a Kea! of 7.6 min-! and an So.s of 15 ~lM. These rcactions wcre inhibited by 
more than 98% by addition of either 0.5 mM mieonazole or by omission ofNADPI r fi'olll 
the reaction mixture (results not shown). The KM values were in the pM r~l11ge. Therci'ore. 
we assayed all P450s at a concentration of25 ~lM. since this value was at least 3-1 O-fold 
higher than the Km for Cyp2c29 and CYP3i\4. 
CYP2B4 was used in a reconstitution experiment to measure 9-/\;\ metabolism 
(Figure 10). Reconstitution was performed in dilauroylphosphatidylcholine and pig 
CYPOR. The reductase concentration (1.75 fold ratio of reductase to P450) that gave 
highest activity for the P450 was used in the reconstitution. Maximum oxidation of 
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Figure 8. Structure and fluorescence spectra of 9-anthracene aldehyde metabolites. 
The spectra of (A) 9-anthracene aldehyde (9-AA), its oxidized form, 9-anthracene 
carboxylic acid (9-ACA) and its reduced form, 9-anthacene methanol (9-AMeOH). (B) 
Excitation and emission spectrum of9-ACA, excitation and emission spectra of9-


















Figure 9. Concentration dependence of oxidative mctabolism of 9-anthraccne 
aldchydc Cyp2c29 and CYP3A4. The concentration of 9-AA was varied and the initial 
ratcs of metabolism measured in the presencc of an NADPII regencrating system, 
NADPI L and either recombinant Cyp2c29 or CYP3A4. The P450 concentrations wcre 50 
11M and both P450s were expressed into E. coli spherosomes with their flavoprotein 
oxidoreductase, NADPH:CYPOR. The data were mean ± SD collected in triplicate and 
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9-AA was observed when CYP2B4, the reductase and dilauroylphosphatidylcholine \vere 
all present. Little reduction of 9-AA was observed for this P450. 
Analvsis of 4-IINE metabolites generated bv CYP2B4. I [PLC and gas 
chromatography-mass spectrometry were used to characterize the oxidative metabolites 
of 4-HNE Cormed by recombinant cytochromes P450. r3H]-4-HNE at concentration or 50 
pM was incubated with CYP2B4 and CYPOR for 20 min in the presence of NADP[ f. 
Preliminary experiments with the recombinant samples demonstrated that the rates of 4-
lINE metabolism were linear for this time period. A representative ~!lrol11atogram or "~­
ITNE and its metabolites separated by HPLC when oxidized in a reconstituted system 
containing 200 nM purified rabbit CYP2B4, 600 11M CYPOR, 50 ~lM 
dilauroylphosphatidylcholine, 0.5 mM NADPI-L and 50 ~lM 4-HNL is shown (Figure II). 
Spontaneous decomposition of 4-HNE during the extraction and resolution procedurl' 
was minimal, as shown by the limited formation of any analytes that Vvere retained 
slIghtly longer than 4-UNE at the zero time point (Figure II A). Moreover, v"hen 
NADPI-I-P450 oxidoreductase and dilauroylphosphatidyl choline were reconstituted in 
the absence of P450, little product was formed (Figure II B). Identical results wcrc 
obtained when the NADPI-I, the oxidoreductase, or P4502I34 was omitted (results not 
shown). When all three components were reconstituted over a 20 min incubation period, 
3% of the total 3rHJ-4-HNE was converted to a product with a retention time (1/1) or :'i() 
minutes (Figure IIC, Table 3), indicating that this rabbit P450 cfTeetivcly metabolized 4-
lINE to one major product. Based on the co·-migration orthe authentic 4-
hydroxynonenoie acid standard generated with yeast aldehyde dehydrogena:ic, we 
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Figure to .. Metabolism of 9-Anthracene by reconstituted CYP2B4. The reconstitution 
or CYP2B4 was conducted in 50 flM dilauroylphosphatidylcholine, 86 nM pig 
NA])PlI:CYPOR and 50 nM CYP2B4. Incubation with 9-AA (25 ~lM) was initiated by 
adding 100 flM NADPH and continued for 10 min at 30°C. Formation 01' 9-A(,A and 9-
AMeOI [ was determined by spectrof1uorometry. Data represent the mean ' S.D. or a 
triplicate incubation. Statistical significance was determined using the Student's I test. 
*** Significant increase in 9-AA oxidation in the presence ofCYP2B4, CYPOR and 
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tentatively assigned the identity o[the product with a retention time generated hy 
CYP2B4 to 4-hydroxy nonenoic acid. An unknown metabolite (3% conversion. putative 
lactone) eluted slightly more slowly than the substrate 4-HNE (IF: 60 min lor the unknown 
and If( 58 min for 4-HNE); this analyte was present at zero time with j)uri1icd. 
reconstituted CYP2B4 and did not increase with timc. Inclusioll or 0.5 mM mieOllll;:ole 
as a P450 inhibitor with the fully reconstituted CYP2B4 system completely inhibited 
I INA formation, but had little or no effect on the amount of unknown product gencrated 
(Figure 11 D), suggesting that it may not be generated enzymatically. NADPJ I ~md~­
lINE incubated alone for 20 min did not result in analytes other than the small amount () I' 
an unknown metabolite (data not shown). These results demonstrate that reconstitution or 
purified rabbit CYP2B4 with CYPOR and lipid results in metabolism or 4-I-INJ·: to 4-
hydroxynonenoic acid. Similar results were obtained with other P450s tested using 1'111-
·+·IINI~, except that several P450s displayed products eluting in the region near that seen 
with the unknown metabolite and several displayed products that \\ere more polar than 4-
hydroxynonenoic acid. These results demonstrate that CYP2B4 generates 4-
hydroxynonenoic acid from the oxidation or 4-HNE. 
Evaluation of P4S0s in oxidative mctabolism of 4-HNE to 4-hvdroxvnoncnoic acid. 
U sing a fixed concentration of 50 11M 4-HNE, we examined several P450s as catalysts 
for oxidation orthis aldehyde to its carboxylic acid. After metabolism, the products werc 
analyzed by HPLC with radiometric detection of product. The reactions with either 
CYP2c29 or CYP3A4 were shown to be linear to 20 min with SO 11M 4-HNE substrate. 
Using a flxcd concentration of 50 11M 4~HNE, we examined several P450s as catalysts 
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Figure t 1. The reconstitution of 4-HNE oxygenation activity catalyzed by rabbit 
CYP2B4. Purified rabbit CYP2B4 was used to catalyze the NADPH-dependcnt 
oxygenation of [ltll-4-HNE in the presence of purified CYPOR and 
dilaurylphosphatidylcholine at 37°C. The CYP2B4 concentration was 250 nM and the 
amount ofNADPl-l:cytochrome P450 oxidoreductase was the amount that caused 
maximal 7-benzyloxyresufin debenzylation in the prescnce of 
dilaurylphosphatidylcholine (data not shown). The reaction was linear to 20 minutes and 
after terminating the reaction with an equal volume of 1 % TF A in water, 4-l-INE and its 
products werc analyzed by HPLC with a radiochemical detector. A. Zero time sample. 
B. 20-Minute time point with reconstituted P450 and oxidoreductase \\ ithout 
dilaurylphosphatidylcholine. C. 20-minute incubation reaction with reconstituted 
CYP2B4. oxidoreductase and dilaurylphosphatidylcholine. The arrow points to the 
putati ve 4-hydroxynoncnoic acid peale D. 20-minute incubation reaction with 
reconstituted CYP2B4, oxidoreductase and dilaurylphosphatidylcholine in the presence 
of 0.5 mJ\1miconazolc. L is the tentative lactone peak, 1 L = reconstitution in lipid alone, 
R + L + E~' reconstitution in CYPOR, lipid and CYP. 
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for oxidation of this aldehyde to its carboxylic acid. After metabolism, the products \\crc 
analyzed by HPLC with radiometric detection of product. The reactions with either 
CYP2c29 or CYP3A4 were shown to be linear to 20 min with 50 pM 4-HN}: substrate. 
In addition to the reconstituted rabbit CYP2B4, some human and murine P450s also 
catalyzed 4-HNE metabolism. The rates of 4-HNE oxidation shown in Table 3 wcrc ill 
the order of CYP2B6>CYP3A4>Cyp2c29>CYP2J2>CYP2B4. CYP 1 A2 and CYP::E I 
were analyzed and did not appreciably oxidize 4-HNE. 
Mass spectral analysis of products of aldchvde oxidation hy J>450s. Based on thc 
iluorcscence spectra of the products formed from 9-anthracene aldehydc, the products in 
the aqueous phase of the reaction appear to be identical to that of 9-anthracenc carboxylic 
acid. J fowevcr, in order to validate that the major product formed hom 4-I-INE is 4-
:lydroxynonenoic acid, we used HPLC to analyzc thc ability of Cyp2c2(), CYP3A"f. 
CYP2B4, and CYP2BG to metabolize 4-HNE to its carboxylic acid. Thc product that co-
migrated on HPLC analysis with the ALDH-biosynthcsized carboxylic acid metabolite 
was collectcd and derivatized with N-methyl-N-(t-butylidimethylsilyl)-
lritluoroacctamide prior to analysis by GC-MS. The mass spectra ofthc AIDII-
hiosynthcsized product, !INA, was identical to that of the putative !-INA product formcd 
by Cyp2c29 (Figure 12). A faint parent peak was noted at miz 316. and major ions at mil: 
of 30 I (M-CH3 due to loss of a methyl group from the trimcthyl silyl group) and at m/z 
245 (M-CIIII due to loss of the 5 carbon alkyl side chain to cleavage betwcen C5 and C() 
of 4-HNE). The mass spectra of the products formed by CYP3A4 and CYP2BL+ vvere 
nearly identical to that observed in the presence of' Cyp2c29 (dnta not shown). 
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Table 3 
Catalytic activities of mouse and human CYPs expressed in I,,'. coli 
9-AA Oxidation 
4-HNE 





(nl1lol/lllin/nnlOl CYP) (nllloi/illini nillol CYP) (nlllol/illin i nll10 l ('YI') (nJlloi:lllillilll1loi ('YI') 
Cyp2c29 7.4 0.96 0.30 
------.- ... -~---f__--- --------+--------- ----------
CYP3A4 7.6 2.39 25.1 
CYP2B6 2.3 53.1 33.3 
CYP2J2 <0.1 0.95 1.72 
--- - -------------. ----- -f---------- ---
CYP2B4 ?? 0.36 <0.1 
1- - -. ----------------.--~----r____--- ------------
CYP1A2 <0.1 <0.1 7.39 
- . -_.-
CYP2EI <0.1 <0.1 <0.1 
- -I-
Microsomes 1.5 
0.37 --1- 1.02 












The enzyme activities are expressed as turnover number and were the average of 4 assays 
with a standard deviation of less than 5% of the average. Mouse liver microsoll1al 
(i'actions were prepared from animals fed AIN-76A diet containing 0.51% butylClled 
hydroxyanisole for 7 days. The concentration of 9-AA used was 25 ~d\1 and of 4-f1NE 
\vas 50 ~lM. 
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Figure 12. Mass spectra of authentic 4-hydroxynonenoic acid and product generated 
from Cyp2c29-dcpcndent oxidation of ,3111-4-HNK After metabolism. the samples 
were analyzed by HPLC and the fractions eluting with the same retention time as the 4-
hydroxynonenoic acid standard were collectcd and subjected to cleetrospray ioni;:ation-
mass spectral analysis. A. Authentic 4-hydroxynoncnoic acid. B. 4-hydroxynonenoic 































documenting that a primary oxidation product formed from 4-HNE by several P450s was 
identified as 4-hydroxynonenoic acid, the expected oxidation product. 
Kinctic analysis of 4-IINE-inhibition of 9-ACA metabolism catalyzcd bv Cvp2c29. 
The observation that Cyp2c29 catalyzed the oxidation of both 9-anthracel1c aldehyde amI 
4-I-INE to their carboxylic acids led us to measure the steady-state kinetic parameters for 
Cyp2c29 oxidation of 9-anthracene aldehyde in the presence of increasing concentrations 
of 4-HNE. Previous studies by Coon and coworkers (1995) established that (,YP2!': I is 
inactivated at high concentrations of 4-lINE (J 40-400 flM). providing (l direct tool Cor us 
to determine the mechanism of 4-HNE as an inhibitor of 9-anthracenc carboxylic acid 
formation by Cyp2c29 at low. Since (X,~-unsaturated aldehydes may inactivate these 
P450s, we incubated most of the P450s shown in Table 3 with 4-hydroxynonenaL 
acrolein, and trans-2-hexenal to assess whether they are irreversible inhibitors (dal~~ not 
shown). After 20 minutes incubation, the samples were diluted 1 O-f'old and the 9-AC/\ 
f'ormation or other enzyme assay measured. Acrolein and lruns-2-hexenal had little or no 
cirec! on any P450 tested (data not shown), but in the case of 4-HNE. there was some 
inhibition. However, this inhibition was dependent on the initial concentration of'4-TII\I' 
added. Enzyme kinetic parameters were determined hy fitting kinetic elate: llsing non-
linear regression analysis to various models using the enzyme kinetic analysis prog:'(lm 
Kincti 77 (Clark and Carol, 1989). The best fit for Cyp2c29 was a mixed competitive 
inhibition by of 9-AA metabolism by 4-HNE (Figures 13). The Villax for 9-AA oxidation 
in the absence of 4-HNE was 130 ± 7. The apparent K, of 4-I-lI\L for Cyp2c29 \vas 
approximately 32 J: 4 ~lM calculated from the double reciprocal plot ( l/V vs. 1 II SI ill the 
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presence of 4-HNE; see inset Figure 13A). In separate studies not shown, we detcrmined 
an apparent Kill for 4-HNE oxidation to HNA by Cyp2c29 of ~ 15 ~lM. These results 
suggest that at low concentrations, 4-HNE is a competitive substrate ror Cyp:~c29 \vith 9-
AA (Figure 13B). At 4-HNE concentrations above 300 )1M. significant inactivation oj' 
many P450s occurs (Kuo et aI., 1997). There was no cifect of 4-HNE (100 ,LlM) 011 
CYPOR activity with up to 30 min incubation in the presence of NADPI-J (data not 
shown). 
Oxidation of 9-anthracene aldehyde by mouse liver mierosomes. The oxidation of 9-
AA by liver microsomal protein (0.25 mg/mL) from mice fed with O.5(j;) 1311/\ in I\IN-
7(lA diet was also determined (Table 3). The rate of formation of 9-ACA was 1.5 
nmollmin/nmol P450. In order to deduce which P450s may be involved in this reaction in 
mouse liver microsomes. we used selective cytochrome P450 inhibitors previollsly 
established to be effective in primary hepatocytes. Miconazole (500 ~tl\f) eausd 
approximately 50% inhibition. as expected (Figure 14). Lower concentrations of 
miconazole (1 00 ~lM) caused 20-25% inhibition suggesting that Cyp3a enzymes may be 
partially involved in 9-AA oxidation (data not shown). Phenytoin (500 ~lM) is a 
ccmpetitive substrate for Cyp2c29 (Jackson c! al .. 2(04) and caused approximately 40 lYt, 
inhibition of 9-AA oxidation activity. On the other hand, trolealldomycin is a speci fic 
mechanism-based inhibitor for CYP3A enzymes (Chaurct c/ (fl., 1997) and incubatioll or 
500 ~lM troicandomyein, 0.5 mM NADPH, and liver mierosomes ror 10 min prior to l)-
AA oxidation assays. resulted in 40~;) inhibition of the reaction in mouse liver 
mmicrosomes. The aldehyde dehydrogenase inhibitor cyanamide did not signiJic(lntiy 
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Figure 13. Kinetic analysis of inhibition by 4-I1NE of anthracene-9-carhoxaldehyde 
oxygenation by Cyp2c29. The concentration dependence of 4-HNE inhibition of 9-I\A 
oxidation was performed by incubating increasing concentrations or 9-AA with O. SO or 
I 00 ~lM 4-HNE in the presence of 0.25 mg/mL Cyp2c29-containing spherosomes and 
1 00 ~lM NADPH at 300e for 10 min in a shaking water bath. A. 0, 0 ~lM 4-HNE; L\, SO 
~lM 4-HNL U, 100 IlM 4-I-INE. Data shows the mean activity±: SD ofa triplicate 
incubation. Inset: double reciprocal plot of lIrate of metabolism vs. lIanthracene-9-
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inhibit microsomal oxidation of9-AA, suggesting that there was litlle or 110 contribution 
or ALDH in the microsomal preparation (Table 4). These results demonstrate that l~oth 
murine Cyp2c29 and Cyp3all (or related P450s) likely catalyzed the oxidation of 9-1\/\ 
with liver microsomes from C57BLl6 mice. Further, the partial inhibition by the t\yO 
compounds suggests the participation of multiple P450s in the microsomal reaction. 
namely Cyp2c29 and Cyp3a Cfable 3). 
Metabolism of 4-IINE by mouse liver microsomes. The oxidation of4-lINE by mOLlSe 
liver microsomal protein was also determined by HPLC as described previously 
(Srivastava e/ al., 2002). The reaction was performed by incubating 50 flM r.llIl-4-11NL. 
NADPH. and microsomes. 4-HNE was oxidized at a rate of 0.37 nmol/min/nmol P450 
(Table 3). As with the E. coli-expressed Cyp2c29. the mouse liver microsomal fi'aetions 
generated an unknown metabolite (tR = 62 min). In addition, a polar mctabolitc (tR -~ 4 
min) was observed near the bcginning of the gradient, which has not been characterized 
to date. Miconazole, a general P450 inhibitor, caused approximately 40(X) inhibition of 4-
HNE oxidative metabolism to 4-hydroxynonenoic acid by mouse liver microsomal 
protein fractions (Figure 14). The Cyp2c29 inhibitor phenytoin caused 70% inhibition oj' 
total 4-HNE metabolism. while troleandomycin. a specific inhibitor or C:yp3,,- caused 
40% inhibition. These data demonstrate the importance of the two murine P450s. ill the 
oxidation of 4-HNE and suggest that multiple P450s are involved in the oxidati"e 
metabolism of 4-HNE. 
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Figure 14. The effect of specific inhibitors on mouse liver microsomal aldchyde 
oxygenase activity for 9-anthracene aldehyde and 4-hydroxynonenal. Liver 
l1licrosolTles from C57BLl6J mice fed AIN-76A diet supplemented with 0.45% BIlA was 
used to perform the 9-AA and 4-HNE oxygenase activities. SpeciJic P4)0 inhibitors (0.) 
111M miconazole or phenytoin) were added to the reaction mixtures or preineubated (0.5 
mM troleandomycin) with liver microsomes and NADPH prior to adding aldehyde 
substrate. The enzyme activities are the mean ± of a triplicate incubation. Statistical 
significance was determined using analysis of variance. * Significantly difrerent II·om the 
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Table 4 
Effect of alcohol dehydrogenase, aldehyde dehydrogenase, and P450 inhihitors on 
recombinant CVP3A4 activity. 




~ - ~----~~-~-~---- -- --~--- ~--~- -~---- -~~~--- ~~-----
cyanamide 92 
I -- --~-~---~--~~------~ - ~ ---- ------
benomyl 37 
4-methylpyrazole 2 
The activity of CYP3A4 was measured at 25°C using the 7-benzyl ether of resorufin as 
substratc in the presence of 0.5 mM NADPH and E. coli membranes expressing both 
CYP3i\4 and NADPII:cytochrome P450 oxidoreductase. The acti\'itics were all C\\Cr;lgc 
of three assays and the standard deviation was never more than 5-8% of thc avcrage 
vJiue. 
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Metabolism of 4-HNE in primary cultures of rat hcpatocytes. Studies by Peters'211 and 
coworkers (Hartley et af., 1995) demonstrated that primary cultures of rat hepatocytes 
metabolize 4-HNE to its carboxylic acids by oxidative reactions, its dihydroxy form 
through reductive reactions and its glutathione adduct through GSIl conjugation 
reactions. Based on thc use of inhibitors, they concluded that aldehyde debydrogenClses 
were the major catalysts of the oxidative reaction. However, om results suggest that some 
P450s are sensitive to the known inhibitors of aldehyde dehydrogenases For example. 
I 00 ~lM benomyl caused 65% inhibition of CYP3A4 and 1 flM 4 methylpyrazole. alcohol 
dehydrogenase inhibitor caused 98% inhibition of CYP3A4, Table 4. Miconazolc and 
trolcandomyein are known to be potent inhibitors of CYP3A (Chamel e{ aI., 19(7). On I: 
r:yanamide was shown to be a specific inhibitor of aldehyde dehydrogenase at SOO :d\1. 
cll~d did it not inhibit benzyloxyresorufin O-debenzylase activity of CYP3A4. Since two 
major classes of enzyme catalyze the oxidation of aldehydes to carhoxylic acids. namely 
aldehyde dehydrogenases and the P450s, we sought to test the relative participation 01' 
these two systems in aldehyde oxidation in a cellular model. Specific inhibitors of ALDlI 
(cyanamide) and P450s (miconazole and troleandomycin) ,vere utilized to determine 1he 
relative participation of these enzymes in the metabolism of [311]-4-H\lE in primary 
cultures of rat hepatocytes. Because CYP3A4 is inhibited by 4-methylpyr,l/ole and 
hcnornyl (Table 4), we did not utilize these inhibitors previously believed to he specific 
ror alcohol dehydrogenase and aldehyde dehydrogenase, respeetive!y. The HPLC profile 
for the 4-HNE metabolites formed in rat hepalOcytes (Figure 15A). polar metabolites (tl, 
5 min), GSH conjugates of 4-HNE (tR 4l.5, 45, and 49 min), DHN (tR 55 min), HNA (tR 
57 min) and the slower eluting metabolite (tR 62 min), similar to that rcposted by Petersen 
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Figure 15. Use of specific inhibitors of aldehyde dehydrogenase (cyanamide) and 
P450 (miconazolc and troleandomycin) on 4-HNE metabolism in primary 
hepatocytes from Sprague-Dawley rats. Primary rat hepatocytes were prepared as 
described in Methods with a viability 01'>95(;10 and immediately treated with 4-IINE. The 
reactions were quenched by adding 1 % TF A and frozen at -80°('. The products were 
measured by HPLC and radioactivity determined using a radiomatie detector. A. HPLC 
elution profile for 4-HNE metabolized by rat hepatocytes. B. Effect of inhibitors (0.5 
mM) of aldehyde dehydrogenase (cyanamide) or P450 (miconazole or trolcandomycin) 
on formation of lIN A. Four preparations of rat hepatocytes was used to obtain statistical 
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and coworkers (Hartley et aI., 1(95). We treated hepatocytes with an AL])II inhibitor 
(cyanamide), a general P450 inhibitor (miconazole), or the speciiic CYP3i\ inhibitor 
(troleandomycin) at 500 11M, concentrations shown to maximally inhibit aldehyde 
dehydrogenases or P450s in microsomes or expressed recombinant P450s, respectively 
(results not shown). The effect of these inhibitors on production of various ul1conj ugatecl 
hepatocyte metabolites are shown in Figure 1513. Addition of the ALDII inhibitor 
cyanamide caused a 55% inhibition of HNA production, while miconazole caused ~ .. 25<% 
inhibition of EN A formation. When cyanamide and miconazolc were added together. 
IlNA formation was inhibited by 85%. Troleandomycin, the inhibitor orCyp3a. 
stimulated JTNA formation by 175%. Mieonazole alone, or miconazole plus cyanamide 
decreased formation of the polar metabolite, but increased GSI-l cOI~ugate formation 
(data not shown). These results demonstrate that the increase in GSI-I conjugates whell 
P·150 and ALDH are inhibited is most likely the result of all three pathv.ays of 
metabolism being similar in their metabolic rate and affinity. ar,d that the glutathione ,r..,'-
transfcrases utilized the remaining free 4-HNE. 
R~ducti()n of 9-anthracenc aldehyde to 9-anthraccnc methanol by cvtochromcs 
P450. Cytochromes P450 are mostly known to catalyze substrate monooxygenation. [n 
studying aldehyde metabolism by cytochromes P450, we definitively observed oxidation 
to the carboxylic acid. Interestingly, in addition to the oxidation reaction, a limited 
number ofP450s reduced the aldehydes to their corresponding alcohols. Incubdtion 
experiments were performed vvith either 50 nM recombinant P450 or 0.25 mg/mL mOllse 
liver microsomes as described under materials and methods. Incubati@ with 1l101lSl: liver 
microsomes caused the reduction of 9-AA to 9-anthracene methanol at a rate of 0.25 
nmollmin/nmol enzyme. Likewise, the incubation of human CYP3A4 with 9-anthracCllC 
aldehyde caused reduction at a rate of 0.32 nmol/min/nmol CYP (Figure 1 ()). This is in 
comparison with 9-AA oxidation activity of ] .5 nmollmin/nmol CYP for microsoll1es and 
7.6 nmol/min/nmol CYP3A4 Crable 3). 
Reduction of 4-HNE by P450s and identification of metabolite by IIPLC-mass 
spcl'tromctry. To study the reduction of 4-HNE by cytochromes P450, 50 nM of each 
['450 was incubated with 50 ~lM [3Ifj-4-HNE and NADPH for 10 J1lin. The NADPI I 
regenerating system consisting of ID} I was omitted hecause we observl'd a reactiop 
between 4-HNE and components of the regenerating system. The incubation of 4-11011': 
with P450 generated a product that migrated at a tR of 55 min by HPLC. The profile 
shown in Figure 17 was obtained by incubating 4-HNE with CYP3A4-. The identity or 
this CJmpound was determined by gas chromatography electron impact-mass 
spectrometry to be the reduced form of 4-HNE, namely 1 ,4-dihydroxy-2-nonene (D1-I[\) 
(Figure] 8). The parent peak was not observed at mil: 3 J 8, but n:ajor ions were ohsened 
at m/z of287 (M-CI-h due to loss of a methyl group from the trimcthyl sily! gr(iup) and ~lt 
m/z 231 (M-CHII due to loss of the 5-carbon alkyl side chain by cleavage bctween C5 
and C6 of 4-HNE). In addition, incubation of 4-lfNE with rat prinury hcpatoeytes 
resulted in 4-HNE reduction to DHN. 
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Figure 16. Reduction of 9-anthracene aldehyde to 9-antracene methanol by CYP3A4 
and mouse liver microsomes. 9-AA (25 ~ll'v1) was incubated in 0.1 .'vI potassium 
phosphate burfer. pH 7.4 with 50 nM CYP3A4 or 0.25 mg/mL mOllse liver microsomal 
protein at 3011 C for 10 min in a tinal volume of 2 mL. The tTaction \vas terminated with I 
1111, or 0.5 N NaOI-f. Following extraction in 4 mL ethyl acetate, 9-AMeOI r was 
measured by fluorescence spectroscopy O~ excitation, 255 nm; Ie emission, 411 nm) in tbe 
organic phase. The results are expressed as the average oflriplieate experiments of three 
reactions in which the SO varied by .:s SCYo. 
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Figure 17. HPLe profile of metabolism of 4-HNE catalyzed by CYP3A4. The 
metabolic assay was performed in triplicate with 2 mL of reaction mixture containing F 
m/i expressed CYP3A4 (50 nM) and 50 11M [3 Hj-4-HNE and 100 ~lM at 37°C Cor 20 
minutes in a shaking water bath. The reaction was terminated by flash freezing in liquid 
nitrogen. The reaction was thawed upon adding TeA, centrifuged and the supernatant 
injected onto the HPLC column. 1 A-dihydroxy-2-noncne is duted at 56 minutes and 4-
hydroxynonenoic acid at 57 minutes. 
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Figure 17 
Retention time (min) 
Figure 18. Mass spectra of 1,4-dihydroxy-2-nonene (DHN) generated from 
CYP3A4-dependent metabolism of [3HI-4-HNE. After metabolism, the samples were 
analyzed by IIPLC and the fractions that eluted with the same retention time as the DI-IN 
standard at tN 56 min were collected and subjected to mass spectral analysis. A. 





\Ve have not been able to confirm the identity of the lactone. which may be due to its 
re;lrrangemcnt to a more complex molecular (.I. Cai and W.M. Pierce. Ph.D .. Universit) 
of Louisville School of Medicine. privileged communication). 
The formation of DEN in rat hepatocytes was inhibited by the P·~50 inhibitor 
miconazole (57%) and troleandomycin (83%), the ALDH inhibitor cyanamide inhibited 
DIIN formation (8°/c» (Figure 15). A combination of cyanamide and miconazo\c caused a 
further inhibition of 73% of inhibition of DJ-IN formation. Taken togcther. this data 
suggcsts that P450s participate in both the oxidativc and reductive mctabolism of4·JIi\'I':, 
There is also a competition for 4-J-INE metabolism as seen vvith the increase in DI IN 
('ormation following inhibition of the oxidation pathway by cyanamide, 
Anaerobic conditions inhibit P4S0-depcndcnt oxidation but not reduction of 
aldehvdes, To catalyze a monooxygenation reaction, cytochromes P450 require 
molecular oxygen, CYPOR and NADPIl We developed a methcd 10 validatc the 
oxidative and reductive metabolism of9-AA and 4-HNE by cytochrol11cs P450. This 
method involves anaerobic metabolism in the presence of either argon or carbon 
monoxide. The anaerobic environment was created by two differcnt mcthods In thc hst 
mcthod. \VC bubbled the hcadspace or the reaction with argon and then addcd to the 
incubation reaction glucose oxidase, glucose, and catalase. The glucose oxidase reaction 
consumed molecular oxygen to catalyze glucose oxidation to glucuronic acid. a reaction 
that generates hydrogen peroxide, The hydrogen peroxide \vas removed by its 
conversion to 11202 and water by added catalase, The residual oxygen in the systcm was 
mini mized hy continuous f1 ushing of thc headspacc of the i llcuhation rcaction ,yi th argon. 
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Figure 19. Lack of oxygen inhibits P450 dependent oxidation but not reduction of 
aldehydes. The incubation reaction was prepared in an Erlenmeyer nask fitted with a 
serum stopper fitted with syringes. Following initiation of the reaction, the headspace or 
the reaction was continuously nushed with argon (anaerobic) or carbon monoxide (CO). 
The reaction was terminated with 0.5 N NaOH (9-AA) or by flash freezing ill liquid 
nitrogen (4-1INE). 9-ACA and 9-AMeOH were extracted with ethyl acetate and 
measured by f1uoreseence spectroscopy while 4-hydroxynoncnoic acid and 1 A-
dihydroxy-2-nonene were measured by HPLC. 
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file second method was by flushing the hcadspace or the reaction with carbon monoxide. 
CO hinds to the sixth coordination position of heme in the P450 ])[cvl:nting the binding or 
oxygen. From these experiments, we observed that the oxidation of 9-;\;\ to 9-;\C/\ and 
4-HNE to 4-hydroxynonenoic acid by mouse liver microsomes was signilicantly 
inhibited by more than 90% (Figure 19). The P4S0-mediatcd reduction of 9-;\;\ to 9-
AMcOlI and 4-HNE to 1 ,4-dihydroxy-2-noncne vvas not affected by the anaerobic 
environment. The reduction of 4-HNE to 1,4-dihydroxy-2-nonene was slightly elevated 
by the presence of CO suggesting that while O2 is required for oxygenation. it is not 
required for the reduction reaction by the P450s. In addition. CO docs not inhibit tl~e 
cytochrome P450 dependent reduction. 
DISCUSSION 
A typical reaction catalyzed by P450s is the hydroxylation of an un Il1l1ctionali:;ed ,llkyl 
group. However, examples are also known in which P450s catalyze the oxidation nf 
aldehydes to acids with the incorporation of molecular oxygen into the products 
(CTuengerich, 2001). Several critical P450-catalyzcd reactions have been showll iO 
involve oxidation of aldehydes or hemiacetals. namely the aromatase and sterol 14u-
demethylase reactions. The formation of estrogen requires oxidation of the 19-111ethy1 
gruup of 4-androslenedione to a methyl alcohol derivative. followed by two consecutive 
oxidation steps to form an intermediate aldehyde and carboxylic acid derivative. The 
thermodynamics of dehydration drives this reaction to produce aromati;:ation of the A-
ring or 4-androstenedione. A similar reaction also occurs during the removal of'the 1+(1-
l1ldhyl group of sterols via this same reaction pathway to form the esse!ltial sterol 
ergosterol; inhibition of this P450 in microorganisms has been sh()\\ n tc, be an dTcctivc 
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method to inhibit the growth offungi. Human liver microsomes possess the ability to 
oxidize aromatic aldehydes such as 11-oxo-!\ 8 -tetrahydrocannabinol to acids by the P450 
system (Watanabe e/ of .. 2002). More recently, model substrates. 9-AA and 4-
biphenylaJdehyde, have been used to measure the activitv of several ]>450s (Marini el (/1.. 
2(03). These f1uorogenic substrates provide simpk methods to measure the acid products 
formed from the P450-dependent oxidation of aromatic aldehydes. 
Our studies addressed the possible role of various P450s in the metabolism of 
aromatic <x,r)-aldehydes (e.g., anthracene-9-carboxaldehyde) and the aliphatic <x.0-
aldehydes (e.g., 4-HNE). Our initial observation of murine Cyp2c29-catalyzed oxidation 
of4-HNE suggested that Cyp2c29 and other related P450s may also be involved ill 4-
fINE metabolism in the heart and liver in vivo, 'where it is reportedly expressed (Luo el 
(f/ .. 1(98). Cyp2c29 was initially identified as a microsomal aldehyde oxygenase (P450 
lv1 UT-2) by Yamamoto et al. (1991), who observed that Cyp2c29 was the primary 
microsomal P450 responsible for oxidation of a cannabinoid aldehyde. We observed that 
P450s of the 2B, 2J, and 3A subfamilies also catalyzed oxygenation of aromatic 
aldehydes to their carboxylic acids. These results collectively demonstrate that [>450s 
also contribute to aldehyde oxidation. as suggested by Marini e/ al. (2003). l-!O'v\l'\'CL t\\O 
other P450s. P4501;\2 and 2E 1 were analyzed and appear to be poor catalysts uf 4-1 INL 
oxidation Crable 3). Our studies suggest that some of the P450s pruduce products in 
addition to lINA. Furthermore. we provide data showing that 4-11NEis a competitive 
substra1c for 9-AA metabolism by Cyp2c29 and suggests that other short chain alck-hydes 
may he substrates for the P450. The Kill values were in the range or 1-20 ~lM. 
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To evaluate the relative participation of P450s and aldehyde dehydrogenases ill 
oxidation of aromatic and aliphatic (X,p-aldehydcs, we studied their activity in murine 
liver microsomes or with expressed recombinant P450s and its flavoprotein 
oxidoreductase. The oxygenase activity ofliver microsomes was found to be inhibited> 
50<% hy 0.5 111M miconazole, an inhibitor of most P450s. Using spccilic inhibitors, \\C 
also showed the participation of Cyp3a (troleandomycin) and Cyp2c29 (phenytoin) 
activity in mouse liver microsomes. We observed the presence of an apprcciahle 
NADP"-dependent oxidation of9-A/\ to 9-ACA in the cytosolie fi·actions of mouse liver 
microsomes that was inhibited by cyanamide (data not shown). 
Studies wcre performed to evaluate the specificity of known inhibitors of 
aldehyde metabolizing enzymes using cyanamide (ALDI-I), 4-methylpyrazole (alcohol 
dehydrogenase), and benomyl (ALDH). CYP3A4 was shown to hc potently inhibited by 
heth i~-methylpyrazone and benomyL suggesting that cyanamide was the ollly ALDII 
~)pecific inhihitor that can be used to distinguish ALDHs from P450s.These inhibitors 
were utilized in experiments with primary cultures of rat hepatocytcs to cvaluatl: the 
relative participation of ALDH and P450s in 4-HNE metabolism. Cyanamide illhibitcd 
HNA formation by > 55% and miconazole only inhibited HNA formatilln around 25-
30<Y;). Troleandomycin actually stimulated formation ofHNA, sLlggl~sting thal CypJa 
enzymes may be involved in formation of other products from 4-1 TN]:. As a result, 
inhibition of the Cyp3a reactions apparently increased the steady-state concentration oj" 4-
fINE and led to higher levels of formation ofl·INA through other P450s, as well as 
/\LDlI. The production of polar products derived hom 4-11NL in :1Cpatocyles was 
inhibited by miconazole, suggesting that these products arc formed bv P450s. I IO\\c\cr. 
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these polar metabolites may also be due to tritiated water released during oxidative 
metabolism. We observed a slight difference in the retension time of the mdabolites 
between the different HPLC profiles (Figure 15 and Figure 17). We believe that this \vas 
due to difTercnces in the room temperature arc the time of separation of the difTerellt 
mc~tabolite fractions by HPLC. 
The GSH-conjugates were increased by P450 inhibitors. suggesting that upon 
blocking the P450 reactions. more substrate is available for GSI-I conjugation of 4-1 INF 
(data not shown). These results demonstrate that in hepatocytes the three pathways 
involving glutathione S-transferases, aldehyde dehydrogenases and cytochrome P450s 
apparently function at similar rates. Cytochromes P450 account Cor a signilicant portion 
\)1' the oxidative metabolites of 4-HNE in hepatocytes at the concentration studied. 
I)etcrsen and coworkers (1995) may have underestimated the role of P450s in rat hepatic 
mclabolism due to the sensitivity ofP4503A to the ALDH and alcohol dehydrogcnase' 
inhibitors used. 
During the study of the mouse liver microsomes and the diCkrcnt P450s that 
metaholized 9-AA and 4-HNE, we found that some P450s are able to reduce these 
compounds to the corresponding alcohol. We developed a method lor screening P'4S()' 
involved in aldehyde reduction by using a fluorescence measurement of 9-AMcOII. 
DitTerential extraction sepal'ates the carboxylic acid and the alcohol, allowing us to 
measure the two metabolites in the two organic phases. Human CYPJAt dnd mouse liwr 
microsomes were able to reduce 9-AJ\ to 9-AMe01-1. CYP3A4 is the major adult human 
\i,er P450 and metabolizes the most xenobiotics. We also observed that this P450 
catalyzed the reduction of 4-HNE to DHN. The magnitude or 4-IlNE reduction by the 
individual P450s analyzed was CYP2B6 > CYP3A4 > CYPIA2 > CYP2.12> Cyp2c29. 
Mouse liver microsomes also catalyzed 4-HNl: reduction. The observation or reductioll 
of 4-IINE with the different P450 was further confirmed by using the P450-specilic 
inhibitors. 
Reductive catalysis by cytochromes P450 is uncommon cxc...:pl Cor a re\\ 
substrates at low oxygen tension. Some reduced products JTlay not be stable as i -ekctron-
and 2-elctron-reduced intermediates in the presence of molecular oxygen. Azo dyes arc 
,\idely used in cosmetics, food, textiles and drugs. The azo compound sulfollazo III and 
aral1lanth are reduced by rat hepatic microsomes (Peterson ef al., jl)gg). The 
hcpatocarcinogen dimethylaminoazobenzene is reduced by rat liver microsomes in an 
oxyg...:n- and CO-insensitive manner (Levine and Raza 1988). The bioreductive activation 
(lfthe quinine 2,3j,6-tetramethy-lA-benzoquinonc is catalyzed by CYP2B 1 (Cocptm ('/ 
(Ii., 1992). 
P450s require NADPH and oxygen for oxidative metabolism. Therefore, in tl1'-: 
absence of eitheL the P450-dependent l11011ooxygenation reaction is inhibited. )11 ~1ddi:i0i1 
to 1 he usc of chemical inhibitors, we were able to demonstrate that the lac k () t' oxygel1 
inhibited the P450-dependent oxidation of both 9-AA and 4-HNL but !lot the reduction 
or either compound. An anaerobic environment was created by bubbling the readiol1 
mixture with argon or CO, Argon lowers the p02 to zero thereby creating a relative 
anactObic environment residual oxygen is removed by the glucose oxidase/catalasl: 
reaction. CO binds to the sixth coordination position o1'hel1\e irol1. prc\'\.~l1tillg oxygen 
binding. By using chemical inhibitors, CO and argon, we successfuily demonstrated tile 
role of P450s in lipid aldehyde metabolism. 
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Figure 20. Proposed pathway for the metabolism of 4-HNE by P450s with the 
involvement of the oxyferryl (Fe(V)=O) and the ferrous (Fe-II) species of the P450. 
Fe depicts the iron in the heme of the P450. The Fe-O v, Fe-Olv and Fe3+ oxidation states 
contribute to 4-HNE oxidation to HNA. The Fe2+ oxidation state contributes of 4-HNE 
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The proposed pathway [or 4-HNE metabolism by CYPs iis shown (Figure 20). 
During the metabolism of substrate, P450s exist in different oxidation states. 
These oxidation states can influence the product generated by the: P450 (Figure 3). The 
oxidation state of the P450 that generates HNA is the perferryl (Fe-Ov) or oxyferryl (Fe-
OIV), requiring oxygen, electrons and NADPH. Hydrogen is abstracted from 4-HNF 
forming a carbonyl carbon radical, which can then react with the iron-bound hydroxyl 
radical generating 4-hydroxy-2-nonenoic acid. The HNA may then undergo further 
reactions involving electron rearrangement, protonation and oxidation to tcmll a lactone. 
The cytochrome P450-dependent reductions are catalyzed by the ferrolls (Fe (II)) state-
P450, the electrons being transferred from NADPH to the P450 by NADPIlCYPOR 
(Mansuy, 1994).This may be the oxidation state of the P450 that generates 1,4-
dihydroxy-2-nonene. It has been noted that the P450 Fe(IT) state can occur during 
conditions of low oxygen tension. 
in conclusion, our results demonstrate that several P450s are efficient catalysts ill 
the oxidative and reductive transformation oflipid-derived aldehydes to carboxylic acids; 
l·hydroAynonenoic acid, and alcohols; 1 ,4-dihydroxy-2-nonene, and add a 1\e\\ Llcd to 
the biological activity of these metabolites. P450s are expressed in hepatic and 
extrahepatic tissue. By metabolizing 4-HNE, CYPs convert this reactive lipid aldehyde 
to a less reactive product. which could either be excreted of sUbjc:ctcd to further 
metabolism. Our studies suggest that P450-mediated metabolism operates in paralkl \\ ith 
other metabolic transformations of aldehydes; hence, the P450s could serve as reserve nl" 
compensatory mechanisms when other high capacity pathways or aldehyde elimination 
are compromised due to disease or toxicity. Finally, hecause 4-HNE like unsdturated 
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aldehydes. such as acrolein. trans-2--hcxenaL and crotonaldchyde. are also food 
constituents or environmental pollutants. P450s may be significant regulators of toxicity 
due to xenobiotic aldehydes as welL 
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CIIAPTERIII 
INDUCTION OF G~=NE EXPRESSION IN MOUSE HEART AND UVI(R BY 
BUTYLATED HYDROXY ANISOLE AND ACROLEIN 
INTRODUCTION 
To determine the changes in gene expression related to chemical cxposure, 
disease, toxicant and hazard prediction, researchers have extensively used the technique 
o/' DNA microarray analysis. By analyzing global gene expression changes, it i:-; possible 
to prcdict rcgulatory pathways for action of specific chemical compounds, as \vell as, 
mcchanisms for environmental disease progression. In this study. we used C57f3L,o mice 
to imestigate the role of butylated hydroxyanisolc (BIIA) and Hcrolcin in the rcguLttiol1 
()(" gene expression. Based on the hypothesis of Paul Talalay (Prestera and Talalay, 19(5). 
there is a paradigm that phase I enzymes are not generally induced i)) electrophilic agents 
like HHA and tBHQ or even 4-HNE and acrolein. We therefore sought to identi fy 
changes, if any, of P450s expressed in the liver and the cardiovascular system. In 
addition, we veritied a number of phase I and phase II xcnobiotic metabolizing enzymes 
whose gene expression is altered after exposure to B1IA and acrolein. 
The detoxification of many chemicals proceeds through a three-step enzymatic 
process, commonly referred to as phase I, phase 1I and phase III metabolism. In the first 
step, phase I enzymes such as cytochromes ]>450, dehydrogenase's, reductlses aJ1d 
oxidases modify lipophilic compounds. This allows for subsequent moditieation by 
conjugation to water soluble compounds by phase II enzymes like glutathione S-
transferases (OSTs), NADPH quinone oxidoreductase 1 (NQORI), and UDP 
glucuronosyl transferases. Phase II reactions consist mainly of glucuronidation. sull~ltion. 
glutathionylation, methylation, or conjugation with amino acids. In addition, estcrascs, 
amidases, imidases. epoxide hydratase, or other hydrophilic processes increase the 
hydrophilic nature of these compounds. Lastly, transporter proteins, also known as phase 
III enzymes, localized in the sinusoidal and the apical membranes of hepatocytes, 
intestinal, and kidney cells, regulate the intracellular levels of these compounds by 
transport and excretion (Jakoby and Ziegler, 1994). The interaction of phase t phase II 
and phase 1lI enzymes and proteins ensures the metabolism and disposition of 
xcnobiotics, thereby regulating their levels in l'ivo. 
The aim of this study was to investigate the regulation of gene expression b)! lipid 
aldehydes, particularly, to determine the role of lipid aldehydes. in the regulation or gene 
expression of lipid aldehyde metabolizing enzymes, including cytochrornes P450. 
Humans are exposed to a number of aldehydes, two of which we have studied, L~-Il\JI': 
and acrolein. These aldehydes are generated in vivo predominantly generated during the 
process of oxidative stress. Exposure can also occur via ingestion of foods containing 
these carbonyl compounds. Acrolein. a key component of cigarette smoke. is associated 
with a variety of diseases. It has been determined that the amount of carbonyl compounds 
obtained during the combustion of a regular size cigarette ranges from 1.92 to 3.14 
mg/cigarette. Of these, acrolein represents 0.22 to 0.47 ~g/cigarette (Fujioka and 
Shibamoto 2006). 
By their chemical nature. acrolein and 4-HNE arc highly rcactiv\~ 
clectrophiles. Several studies have demonstrated that these lipid aldehydes regulate gene 
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expression through the activation of transcription factors. These transcription f~lctorS. 
generally referred to as oxidative stress-sensitive transcription factors. include \'hl'2. ;\P-1 
and 1\'F-KB. 
High acrolein concentrations cause GSH depletion. In addition, acrolein reacts 
with nucleophilic groups such as the amino group oflysine. the sullhydryl of cysteine 
and with the imidazole group of histidine (Uchida et al., 1993). These reactions modi 1\ 
the function of macromolecules. These actions of acrolein, especially the depletion of 
glutathione, result in oxidative stress. Cells respond to this stress by activating the 
mitogen-activated protein kinases (MAPKs) such as ERK 1 and the c-.Tun N-terminal 
kinase JNK I 12 (Yuan et al.. 2(06). The downstream cifects of JNK 1 activation on 
oxidative stress-sensitive transcription factor activation are two- fold. First, 
phosphorylation and activation of .Tun results in the induction of gene expression by the 
A P-1 transcription factor through binding to the 12-0-tetradecanoylphorbol 13·-acetatc-
response clement or TRE (Angel el al., 1987). Second, activated ERK and JNK can 
phosphorylate Nrf2 at serine residue 40, causing Nri2 release fr0111 Keap-l and 
subsequent translocation to the nucleus. In the nucleus. Nrf2 binds to the antioxidallt 
response clement as a heterodimer with other proteins, small Mafs, c/EBP and Jun, 
resulting in an increase in gene expression. 
BIlA is a phenolic antioxidant widely used to study the induction ol'Phase II 
xenobiotic metabolizing enzymes. In addition to its antioxidant property. BHA is used to 
study the induction of gene expression resulting ji'Ol11 oxidative stress (Pinkus ef aI., 
1996: Yuan et al .. 2006). In vivo, BlIA is O-demethylated to tertiary-butyl hydl'OC]ulnolle 
(tBI lQ: Figure 21) by phenobarbital-induced microsomal enzymes (Cummings e{ ul., 
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1985). Both BHA and tBHQ induce gene expression through the oxidative stress-
sensitive transcription factors. Since BI-IA. tBIlQ and acrolein all induce gene expression 
through similar set of transcription factors, we hypothesize that P450s of interest may he 
regulated by Nrf2. Therefore, we used BHA as a control for acrolein treatment of mice 
fo!' the analysis CYP P450 gene expression by reactive lipid aldehydes. 
In order to achieve our goal of identi fying genes regulated by acrolein, we 
submitted RNA samples from treated mice to the Bradfield Laboratory for microarray 
analysis of gene expression using the environment, drug and gene expression (LDCE) 
data base program. This program was developed by the Bradf~eld laboratory at the 
McArdle Laboratory for Cancer Research, University of Wisconsin Medical Schoo!. This 
resource is a public database that allows two modes of research.?r interaction. First. 
investigators can query a large and growing database of toxicant induced transcriptional 
profiles generated using a common microarray protocol and platform. Second, the EDCiE 
resource accepts RNA sample submissions from laboratories interested in developing 
novel toxicant-induced transcriptional profiles for inclusion in the open access database 
(Hayes el al., 2005). 
In addition to the mieroarray analysis, we performed quantitative real-time PCR 
(qRT-PCR) analysis to verify the results of the microarray analysis. From the same 
tissue, we prepared liver mierosomes and used these in metahol ism assays to investigate 
changes in microsomal P450 activity following treatment with BHA Finally, WcsL:m 
blotting was performed with the same microsomes for Cyp2c29, to verify changes in 
protein level following treatment of mice with BllA. 
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Figure 21. Chemical structure ofbutylated hydroxyanisolc (BHA: hutyl-4-
h~'dr()xyat1is()le) and tertiary-butylated hydroquinone (tBlJQ). In vivo, I3IIA is 




















MATERIALS AND METHODS 
Treatment of Animals. Mice (C57BL/6, 22 g to 27 g; Jackson Laboratories. Bar llarbor. 
MA) were divided into two groups based on the chemicallreatmcnt they received. (JrOLIp 
1 was fed ad libitum for 1 week with either AIN-76A diet (Purina lest Diet, Richmond. 
IN) alone (control) or AIN-76A diet supplemented with 0.45% I3l-IA. Group 2 was 
divided into two subgroups. Subgroup I received a daily dose of either saline or acrolein 
in saline (5 mg/kg acrolein, Sigma, St Louis MO) by gavage for 7 days. The animals 
were fed Purina mouse chow (Richmond, IN). The second subgroup was exposed for 6-
hrs daily to 5-ppm acrolein by inhalation for 5 days. Thc control group was exposed to 
normal air for the same amount of time. The entire trcatment and e:\pcriment scheme is 
summarized in Figure 22. Thc mice were sacrificed and the liver and heart harvested and 
stored at -SO°C until used. All proccdures were approved by the University 01" l.ouisville 
IACUC Committee and conformed to the USPHS Policy 011 Hummle Care and Usc or 
! .aboratory Animals. The exposurc of mice to acrolein by inhalation was per\emlled at the 
inhalation core facility of the Program Project Grant PO I ES directed by Aruni 
Bhatnagar, Ph.D. The duration of exposure was selected based on their toxicological data 
following exposure at different time intervals. 
Total RNA isolation and purification. For total RNA preparations. about 0.1 g 01' 
frozen liver tissue or an entire mouse heart was homogenized in I 111L of TRlzol@ 
(Invitrogen, Carlsbad, CA). The mouse heart is fibrous and required maceration in :l 
mortar and pestle containing liquid nitrogen prior to homogenization with a pellet 
pestlc@ motor (Fischer Scientific, Pittsburg, PA). The supernatant was transferred to a 
sterile tube and incubated for 5 min at room temperature to permit the dissociation 01" 
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Fi~un' 22. Schematic representation of experimental design fiJr analysis of gene 
,:':pr('.'ision in male C57BLl6 mice following treatment with either BlIA or acroleill, 
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nucleoprotein complexes. Chloroform (0.2 m1, per I mL TRIzcl reagent) was added to 
each tube. the sample shaken vigorously for 15 seconds. and then incubated at room 
temperature for 2 min. The samples wcre sedimented at 12.000 x g for 15 min at 4()C. 
Thc colorless aqueous phase containing the R"JA was furthcr extracted by mixing with 
O.S mL isopropyl alcohol followed by incubation at room temperature for 10 min and 
sedimentation at 12.000 x g for 10 min at 4°C. The RNA pellet was washed with 1 mL of 
75°;() ethanol, followed by centrifugation at 7,500 x g at 4°C. The R,\JA pellet vvas air 
dried for 5 min and dissolved in 60°C RNAse free water. The RNA was purified u.'-)ing 
silica membrane spin columns (RNeasy® reagent; Qiagen, Valencia. CA). RNA integrity 
\\as then assessed using the 600 LabChip(g) kit with a 2100 8ioanalY7er (Agilent 
Technologies. Palo Alto, CA) and quantified Llsing the Nano Drop spectrophotometer. 
The RNA was aliquotcd and stored at -80nC until used. 
Sample preparations for microarray analysis. RNA samples ror mieroarray analysis 
of gene expression were prepared according to the requirements oj"the j':nvironmenL 
Drugs and Gene Expression (EDGE) program. RNA quality (Figure 23) and quantity \\as 
determined as explained above. At least 60 ~lg of RNA per sample was provided I'll!· 
analysis to the Bradfield Laboratory. The samples were analyzed using the Ccnispherc 
3]) Array 50 kit protocol adapted from Genisphere, Inc (Hatfield, PA). The detailed 
protocol for microarray analysis can he found at the EDGE program website 
11.!.!g://edge.oncology.wisc.edu. 
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Figure 23. Verification of RNA quality used for microanay and quantitative real-
tim.e peR analysis of gene expression. Aliquots of independent RNA samples extracted 
('rom mice heart and liver were analyzed with the RNA 6000 Nano-Labchip on the 
/\[',ilenl 2 I 00 Bioanalyzer. (A) The gel picture shows the RNA ladder (lane 1) and four 
SCllllples (lane 2 -5). (B) Representative eleetrophorcgrams depict two peaks for the ns 
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Microaarray data analysis. The Bradfield Laboratory performed microarray 
construction, image and data analysis and the detailed protocol has been published 
(Thomas et at., 2001). Gene expression was measured using a microarray chip that 
contained approximately 1,200 minimally redundant cDNAs from an expressed sequence 
tag (EST) project executed by the Bradfield laboratory, as well as, a public EST effort. 
The results for the genes were first collapsed into a fully non-redundant set by averaging 
the results from multiple copies of the same gene. After collapsing, the data set was 
screened for genes that did not respond to the treatments used in the study. A threshold of 
2-fold change in gene expression was typically used as the cut-off value. Only genes that 
showed greater than a 2-fold change in response to treatment were selected for further 
analysis. Finally, the gene expression values were discretized such that mRNA induced 
greater than 2-fold were given a value of one, mRNA decreased greater than 2-fold were 
given a value of minus one, and mRNA expressed with less than a 2-fold change were 
given a value of zero. A How chart for the data reduction scheme adapted from a 
Bradfield Laboratory publication is shown (Figure 24). 
Principle Component Analysis of Microarray data. The data are plotted in a 3D PCA 
map with Principal Component 1 (PCI) the x-axis representing 100% of variation in the 
data, PC2 the y-axis representing 2.62··0.06% of the variation. Control housekeeping 
genes used to nommlize the data, center around coordinate 0,0. Gene sets predominantly 
affected by BHA treatment (blue) and those predominantly affected by acrolein (red), 
map to different coordinates suggesting they are differentially affected by the two 
treatments. We wish to thank Amir Singh and Thomas Knudsen, Ph.D., for their 
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assistance in the analysis of this data through the resources of Birth Defects Center in the 
Department of Molecular, Cellular and Craniofacial Biology, University of Louisville, 
School of Dentistry. 
Quantitative real-time PCR (gRT -PCR) for micro array data validation. To verify 
the results of the microarray analysis, qRT-PCR was performed on mRNAs from control 
or mice that were treated with either BHA or acrolein. Quantitative RT-PCR was also 
performed on 5-ppm acrolein heart and liver samples from mice that were exposed to by 
inhalation. We seilected eight genes for verification based on our interests in lipid 
aldehyde metabolism. cDNA was synthesized from total RNA using the Advantage RT-
for-PCR kit (Invitrogen, Carlsbad, CA). RNA (I Ilg), 20 pmol random hexamer, 5X 
reaction buffer (50 mM Tris-HCI, pH 8.3, 75 mM KCI, 3 mM MgCh), 0.5 mM dNTP, I 
unit/ilL RNase inhibitor and 200 units/Ilg MMLV reverse transcriptase were used in a 20 
ilL reaction. Residual RNA was digested with 1.5 U of RNase H at 37°C for 20 min. The 
cDNA was then diluted 5-fold with nuclease-free water and stored at -80°C until used. 
Quantitative real-time PCR was performed using the ABI 7900HT Sequence Detector 
System according to the manufacturer's instructions (Applied Biosystems, Foster City, 
CA). FAM dye-labeled primers for Cyp2c29, Cyp3all, Cyp2a5, GST mul, nQOR-I, 
CYPIA2., HO-I and ALDHIAI were designed by the Prough laboratory at 
wwwoinvitrogenllux and purchased from Invitrogen (Carlsbad, CA). The qRT-PCR 
reaction was prepared as follows: TaqMan® Universal PCR Master Mix No AmpErase® 
UNG (Applied Biosystems, Foster City, CA; half the reaction volume), 50 nM of each 
primer, 2 ng/IlL cDNA and water in a final volume of 15 ilL. All qRT -PCR experiments 
were performed in triplicate using cDNA samples from independent RNA sets. For each 
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Figure 24. Flow chart outlining the method for microalTay data reduction and 
classification analysis for gene expression. Copied II'OIll Thomas 1'1 (II.. (2002). 
i\,kliJods in b1Zymology. Vol. 357: Pages 19X-205. (Bradliclel lahoratory publication). 
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gcne. a serial dilution of eDNA was Jlerformed to establish a standard CllrVC. All gene 
e>.;pression kvels were normalized to ISS rRNA. Primer specificity fnr the dilTerelll 
genes was veri lied by melting temperature (Till) analysis and bv performing ;In agdrnsc 
gel electrophoresis. The curves obtai lied follO\ving "1m analysis sh()\\ cd a single peJk /"m 
e~leh t~el1e (Figure =~5i\). In addition. agarose gel electrophoresis or the qI<."I-P(·R j),'Ot!llC( 
Jc\'ealed a single band per gene per sample (Figure :)513). These ohsendti·.)ns indicltcj 
tInt the primers used for the qRT-PCR analysis \'vere highl) spl·ciJic. 
Gene expression was calculated by determining the cycle threshold (( 'I) obtailled 
li'olll the fluorescence emission recorded in the geometric phase of gene ~llllP 1 i licat i OJ,. 
The /\C1 value was then calculated by subtracting the ('lor the LUTet fr;)1ll thlt 01 :ts 
respective ISS rR1\A. After determining the 2 6C1 , the ('old changes in the level of gene 
e':pression of treated samples over cuntrol samples \\ere calculated by as:-;iglling a llnit 
value to the control samples. 
\Vestern hlot analysis of Cvp2e29 rxpr('ssion in mouse liver. Mierosoml's \\ere 
prepared ii'om the liver of mice that wcre ICd AIN-76i\ diet only or (H:,\<j,) Bl 1.'\-
supplemented AIN-76A diet. Total microsomal protein was dekrl1lin<.:d by the !W!\ 
assay as previously described. Liver microsomal proteins (20 ~lg) \\ere re,ul\nj on Ci 
sodium dodecyl sulfate-polyacrylamide gel electrophoresis gel (PAGE: !t)% 
]Jnlyacrylamide) and transferred to a polyvinylidene dil1uoridc 1l1~Il:b!·al1e. The 
memhranes were incubated with antibodies against ('yp2e2() (antibm:y I X4 7) or (': p2d\) 
(antibody 1549). After incubation wi,h the secondary antib(ldy. the :mmu!loreacti\l' bamb 
were \'isualized with enhanced chemiluminescence Westclli hlouin' SySll'lli (\IllC:':-;\1Wll 
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f;';gm·l: 25. Analysis of the specificity of quantitative real-time peR primers. (i\) The 
'",Jelling cune (Tm) analysis was performed for each gene and primer sp'.:cilicity \LT:lil:d 
[;\ :t :iingle amplified peak.. A representative melting curve is shcm n t(:r Cyp2c2(). 
)R 1. Cyp3all and ISS rRNA. (B) !\ 1% agarose gel electrophoresis of the prcllillcts 
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Biosciences). The Western blotting experiments wen: performed by the laboratory nj' \)1'. 
Joyce!\. Goldstein (Laboratory for Pharmacogenomies, NfEHS. Research Triangle Park. 
NC). 
Cytochrome P4S0 enzyme activity assay. Mouse liver microsomes were prepared hom 
mice !Cd with AIN-76A diet only or 0.45% BI lA in AIN-7()A diet and used to perl()]"Ill ()-
anthracene aldehyde metabolism assays. The P450 content orthe llJierosol11es ("rolll each 
mouse liver was determined by CO-difference spectra of dithionite reduced 1>450 (Omura 
and Sato. I (64). Microsomal protcin hactions containing 50 ntv1 were llsed to I1lcasure 9-
anthracene aldehyde oxidative and reductive metabolism as previously described. 
IU~SULTS 
Changes in gene expression following exposure to xenohiotics. An important objectivc 
nt' the EDGE program is to create a public-access database of gel1e expressiol1 in rl'SpO!1Sl' 
to different chemicals. Figure 26, adapted from the EDGE database. shows projjles 
obtained by feeding mice with 2,3.7,8-tetrachlorodibenzo-p-dioxin (TCDD. ,111 aryl 
hydrocarbon receptor ligand), pregnenolone 16a-carbonitrilc (peN. a pregnane X 
receptor ligand), phenobarbital (PHB. a constitutive androstane receptor activator). and 
our test compound, BIIA ( Nrf2 and AP-I activator). As observed. different gcnes vvele 
induced or repressed by the four compounds. However. some genes were regulated (up or 
down) in a similar fashion between the four compounds. suggesting t11at these genes 
maybe regulated by more than one signaling mechanism. These gene') include Cyp2e2() 
(PB, TCOD and BI-IA), Cypla2 (PB, TCDO, and BITA) and Cyp2a4, GSTml (PB. 
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BHA). These four compounds also individually regulated unique subsets of genes. thus 
resulting in a divergent response to exposure to these compounds: Hsd 17b2 (TCOD). 
Cyp3a25 (PCN) and Ugp2 (BHA). The genes that were uniquely regulated can serve as 
characteristic markers for TCDD, PCN, PHB and BI-IA, thereby assisting in the 
prediction of outcome of exposure and the receptor or transcription factor involved. 
Determination of the changes in gene expression following the exposure to acrolein 
or BHA. C57BLl6 mice were exposed to BHA or acrolein for 7 days prior to sacrifice, 
and RNA extracted from the heart and liver. The duration of exposure was chosen based 
on prior studies demonstrating that the maximum expression of genes for foreign 
compound metabolizing enzymes occurred in rats between 5 and 8 days following 
exposure to phenobarbital or dehydroepiandrosterone (Rem mer, 1958, 1972; Canney ef 
al., 1960; Prough et al., 1994). 
From the electronic data provided following microarray analysis, we generated a 
heat map for genes responding to our treatments. A condensed heat map (Figure 27) was 
generated by assuming a cutoff for minimum induction of2-fold and a minimum 
repression of minus 2-fold of gene expression in response to BHA or acrolein. A color 
scheme is used to show the expression pattern: red indicates induction; green indicates 
repression and black signifies no change in gene expression. From this analysis, we 
observed a difference in the absolute fold change in gene expression level in the liver 
between the two control groups of mice, acrolein vs. BHA, per as. 
Principal component analysis of gene expression between acrolein and BHA treated 
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Figure 26. Heat map of microanalysis obtained from treating mice with different 
chemical compounds. 2,3,7,8-tetrachlorodibenzo-p-dioxin CTCDD; an aryl hydrocarbon 
receptor ligand), pregnenolone 16a-carbonitrile (PCN; a pregnane X receptor ligand), 
phenobarbital (PHB; a constitutive androstane receptor activator), and BHA ( a Nrf2 
activator and AP-l activator and inducer of oxidative stress).The PHB, TCDD and PCN 




mice liver. Since our initial evaluation of the data from BHA exposure per as and 
acrolein exposure by gavage or inhalation demonstrated differences between the control 
mRNAs, we assumed that the two diets differentially affected expression of the control 
mRNAs used to normalize the results of the two data sets. Unfortunately, we could not 
control the differences in diet, since the samples for acrolein exposure pel' os and by 
inhalation required use of chow diet for the inhalation facility at the University of 
Alabama Birmingham (E. Postlewaithe, Ph.D., personal communication). Therefore, we 
consulted with Amir Singh, Birth Defects Systems Manager 
(http://systemsanalysis.louisville.edu) who recommended we compare the genes induced 
by either BHA or acrolein (increase by 2.0 or more) and normalize those two sets of data 
using the control mRNAs utilized by the EDGE system to scale the results. The data was 
then plotted in a principle component map. As shown in Figure 28, one can see that the 
control (housekeeping genes) map to position (0,0), and the two sets of genes induced by 
either BHA or acrolein are very different sets of gene products. In addition, the 
magnitude of change was much less for acrolein than BHA. We interpret these data as 
indicating that BHA and acrolein at the concentrations used regulate different sets of 
targets genes. In addition, the responses for acrolein administration by gavage were 
much lower in magnitude, raising the concern that the dosage of acrolein used (5 mg/kg 
body weight to avoid death of the mice) might not be sufficient to achieve dosages 
necessary for induction of the set of genes regulated by BHA. From results in the 
literature, acrolein is toxic to cells. When assessing target gene expression, cell death 
becomes a significant feature of the experiment, before significant induction of gene 
expression is seen (Winner et al., 1997). 
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Figure 27. Heat map showing changes in gene expression in male C57BLl6 mice 
liver following treatment with BHA or acrolein. The first column represents control 
AIN-7oA-fed mice, the second column represents mice fed diet containing 0.45% BHA 
od lihilum for 7 days, the third column corresponds with mice treated with saline by 
gavage while the fourth column represents mice administered 5 mg/kg acrolein in saline 
hy gavage while on chow diet. The hierarchical clustering of genes is a total of four 
arrays generated using a condense clustering assuming a minimal induction of 2-fold and 
a minimal repression of minus 2-fold. The color scheme is used to show the expression 
pattern: rcd indicates induction, green indicates repression and black represents no 
change in mRNA in response to BHA or acrolein treatment. Circle shows changes in 
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Changes in gene expression following exposure to BIIA. Lipid aldehydes produced 
during oxidative stress are metabolized through conjugation to GHS by the GSTs 
(Esterbauer et aI., 1975). BHA caused the induction ofmRNA expression ofGSTa3, 
GSTml and GSTtl. The aldehyde dehydrogenases catalyze NAD(P)H- dependent 
oxidation of aldehydes including 4-HNE to their respective acids. The aldehyde 
dehydrogenase ALDH1, ALDHla7, ALDH4 and ALDH5 were all induced by BIll\. The 
aldo-keto reductases (AKRs) are a family ofNADPH-dependent enzymes that catalyze 
the reduction of aldehydes to alcohols (Jin and Penning, 2007). BH/\. caused induction of' 
the mRNA level ofaldo-ketoreductases AKRlc6, AKRlcl3 and AKRlc19 Crable 5). 
Enzymes of the GST, ALDH and AKR (Ellis, 2007) family are known to be induced by 
compounds that activate Nrf2. Our data has demonstrated that BHA, aN rf2 activator 
induces the expression of these enzymes and therefore correlates with previous 
observations (Nair et al., 2006, Purdon-Dickinson et al., 2006) .. 
P450s are induced by a variety of compounds including substrates and non-
substrates of this superfamily of enzymes. From the microarray analysis data. some CYPs 
were induced in response to BHA. These include Cypla2, Cyp2a4, Cyp2c29. Cyp2c37. 
Cyp2c40, Cyp2c50 and Cyp51 (Table 5). The 5'-promoter sequence of the P450 genes 
do not contain an apparent antioxidant responsive element. Therefore the induction of the 
CYPs most likely is not directly mediated by Nrf2 binding to the ARE. This suggests the 
involvement of a different transcription factor, most likely AP-l, also known to be 
activated by BHA. 
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Figure 28. Principle component analysis of data from BIIA and acrolein controls 
and treatments. C57BLl6 mice were fed with AIN-76A diet only (control) or 
supplemented with 0.45% BHA in AIN76A diet for 7 days. A second group of mice was 
fed with chow diet only (control) or administered 5 mg/kg acrolein by gavage daily for 7 
days. RNA was extracted from the mice lever and changes in gene expression determined 
by microarray analysis. The two sets of data for the genes induced by either BHA or 
acrolein (increase by 2.0 or more) were normalized using the control mRNAs utilized by 
the EDGE system to scale the results. The control (housekeeping genes) map to position 
(OJ)). and the two sets of genes induced by either BHA or acrolein are different sets of 
gene products. 
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Acrolein treatment altered gene expression in mouse liver. Microarray analysis was 
was also conducted to verify ehanges in gene expression in C57BLl6 mice liver, to 
identify xenobiotic metabolizing genes induced by acrolein. Table CJ shows a set of genes 
of interest that were induced or repressed in response to acrolein treatment. Some 
aldehyde dehydrogenases, aldo-ketoreductases, as well as glutathione S-transt'erases were 
induced by acrolein (Table 6). Interestingly, like BIIA, some cytochromcs P~50 were 
induced in response to acrolein. These include Cyp2c29, Cyp2c44, Cyp2el. and Cyp2.i6 
Crable 6). The mechanism through which cytochromes P450s arc regulated by 
compounds known to activate Nrf2 like BHA and acrolein are still'JnknO\vn. 
For most of these genes of interest the fold-change in gene expression caused by 
acrolein was lower than that observed for BIlA. It should be noted that the mice ,vere 
treated by gavage with only 5 mg/kg of acrolein. Trcatment with a higher dose or acrolein 
resulted in the death of the mice. Therefore, the low level of change ofmR:',L\ :mluetiol1 
observed with acrolein could be because of insufficient levels of acrolein reaching the 
liver and therefore robust induction was not observed. Also, there arc several xenobiotic-
mc!abolizing enzymes expressed in the gastrointestinal tract and the liver thal could 
mc!abolize the acrolein before its induction effect is initiated. Most importantly, cells 
contain the non-protein peptide GSH. GSH can spontaneously or enzY111mically conjugate 
with acrolein, causing a further reduction in acrolein levels. Acrolein is a highly reacti\c 
elcctrophile. It may have reacted with proteins and other macromolecules in thc gastro 
intestinal tract, thereby reducing the amount of acrolein reaching the hcpatocytcs. 
Quantitative real-time peR confirmation of microarray results. To verify the 
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Table 5. BHA-regulatcd xenohiotic-mctabolizing enzyme genes in mouse liver 
Biological Responw/G"ne 
PI""" I :\."lIohiutic I\letahoHzing EIl1.~·IJ],,': (\ torhn.m", P4S0 
Ull'; II1II';C1Il\1, C\I,'c:!U'c'JlLe 1'·1"'1 [alllih - :i\ll,Lllllll', ,I. Ih,I\-Ill'l'lhle II' \1,-;,1) II1}(H.\ 
()(IlIT pha.", I \:enohiotic llH'taholising Enzymes: The ..\] .VHs allli .\l'(.Hs 
:- II" 1I11l,;,'"III'; :dl.k,-k,·I" lc,IIICI<hC fClllllh I lllcJJll'CI 1.'\, I .. \kll ,',,1. lI,]C~.-'\ 
Phasl' IT \:ellohiotic l\J.·tabolisillg Elll.yUH'S: Th .. CSTs 
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results from the microarray analysis, quantitative real-time PCR (qRT-PCR) was 
performed to examine the effects of acrolein and tBIlQ on gene expression. The genes 
selected for analyses were Cyp2c29, Cyp3aJ L Cyp2a5, Cyp 1 a2, GSTm L ALDII 1 Al 
and nQORl. RNA samples from individual mice were reverse-transcribed using random 
hexamer primers to eDNA and then used for the qRT-PCR experiments. The C, value for 
the expression of each gene was normalized to 18S rRNA and the fold induction \vas then 
calculated. The RNA samples were not pooled; the data represent mRNA expression 
levels of livers from an individual mouse. The results are presented as box and whiskers 
plots. The box plots extend from the 25 th to the 75th percentile. The line across the box 
shows the median distribution of samples (n = 5) for each gene. For each point. a single 
mRNA was analyzed in triplicate and the average is shown. 
The average fi:)ld change in gene expression was Cyp2e29. 6-fold; Cyp3a II. 1-
fold; ALDHIAI 16-fold; Cypla2, 3-fold; GSTml, 22-fold; Cyp2a4, 33-fold. and 
nQORI, 47-fold in the liver of mice fed AIN-76A diet supplemented with OAYY<l BIJA 
for 7 days relative to AIN-76A diet alone (Figure 29A). The average fold change in gene 
expression in the mice heart following BHA treatment was Cyp2e29, 2-fold; GSTm 1. 
1.4-fold; ALDHIAL 1.4-fold and. nQOR-I, 1.5-fold (Figure 29B).Quantitative RT-PCR 
was also performed on samples from mice liver and heart that had beell treated with 
saline or 5 mg/kg acrolein daily for 7 days in the mouse chow diet. Gene expression was 
verified for Cyp2e29., 1.6-fold; GSTmL 0.96-fold; ALDBI A L O.n-fold; Cyp2aS. O.9'~­
fold and Cypla2, 0.93-fold in the liver (Figure 30A). Genes verified in the heart were 
Cyp2c29, 0.94-fold; GSTml, O.78-fold; ALDE1 A 1. O.81-fold and nQOR 1. O.CJ6-J"old 
(Figure 30B). Like with the previous samples, RNA samples used in this study \\"CrC not 
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Table 6. Acrolein-regulated genes in C57BLl6 mouse lin" 
Pha~(' IIll~taholislll: The en's 







IIlIH,\ ;,:\[ I ~ II II I 'I, 
I ~ 
{I I ,~ 
Olhe" pha~e T mrta\Hllizinj! .'nz~'III€s: ,\Lnn and AJ-':R fami\~' 





Pbsl' II '\enuhiutif metabolisinj! Enz~ Illes: Tht GSTs 
~[I!' Jlw,c\llus ),:111\:)\111"1 Ie S-trallsterllSC 11111 I l.li,111I1 ,I II\~:>L\ ~ I I 
1:25 
pooled. We observed a lower level of induction ofCyp2c29 mRNA in the heart and liver 
samples from mice that were exposed of 5 mg/kg of acrolein by gavage; there was no 
change observed for Cyp3aIl in the same samples. Even though the expression of 
Cyp2c29 was lower in acrolein-fed mice heart and liver compared with HIlA. the 
experimental levels were higher than for GSTml and ALDIIl A 1. Since these compounds 
normally acting through Nfr2 typically regulate GSTml and ALDI [IA 1, it is likely that 
Cyp2c29 is regulated differently from the Nrf2 target genes. We speculate that Cyp2c29 
is regulated by the oxidative stress-sensitive transcription factor, AP-l. 
Analysis of gene expression following acrolein administration bv inhalation. 
Acrolein is a major environmental pollutant. The sources of acrolein include cigarette 
s11l0ke, smoke from car exhaust and wild fire (Beauchamp cl al.. 198R). We performed a 
preliminary study to determine if the exposure to acrolein hy inhalation (.5-ppm. 6 1m per 
day for 5 days) affects gene expression in the heart and liver of mice. We sc\eelcd :; 
genes based on our previous observation that the expression of these genes were changed 
following oral administration of acrolein or BHA. The average fold induction of gene 
Expression was Cyp2c29, no change: GSTml, 1.2-fold; ALD1-Ilal, l.S-fold: nC)ORL 
2A-fold and HO-I, 2.3-fold in mice liver (Figure 31A). In the heart. we observed no 
change in gene expression for Cyp2c29. ALOHlal, nQOR-l. A minimal fold change 
was observed for HO-I, lA-fold and GSTml, 1.3-fold; in mice heart (Figure 31 B). These 
low levels of induction of mRNA suggest that either the level of acrolein in the inhalation 
chamber was not high enough to cause induction through Nrf2 and AP-I or. the inhaled 
acrolein is not reaching the heart and liver at concentrations high enough to cau;-;c a 
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Figure 29. Quantitative real-time peR analysis of gene expression in C57BLl6 mice 
heart and liver following treatment acrolein. Mice were treated by gavage with saline 
(control) or 5 mg/kg acrolein by gavage daily for 7days. RNA was extracted II'om the 
heart and liver. reverse transcribed to cDNA and uscd for qRT-PCR analysis of genc 
expression. The fold induction is shown in a box and whiskers plot. The boxes cxtend 
. I 'l5 1h 1 75 th '1 I I' I i' i' '1' . I rom t lC ~ to t 1e percent! e, t 1e me aeross rcpresents t 1e me( Ian ( Istn ,utlOn 0 t 
sampks (n= 5) for each gene. For each point. mRNA sample fr0111 a single mouse liver 
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Figure 30. Quantitative real-time peR analysis of gene expression in C57BLI(, mice 
heart and liv~~r following treatment acrolein. Mice wen~ treated by gavage with saline 
(control) or 5 mg/kg acrolein by gavage daily for 7days. RNA was extracted fioom the 
:leilrt and liver. reverse transcribed to eDNA and used for qRT-PCR analysis of' gene 
expression. The fold induction is shown in a box and whiskers plot. The hoxes extend 
'rom tile 25 th to the 75th percentile, the line across represents the median distribution of' 
samples (n ccc 5) for each gene. For each point, mRNA sample from a single mouse liver 
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robust induction in gene expression. 
BIIA induces 9-anthracene aldehyde metabolism in mousc liver microsomes. We 
demonstrated by microarray and qRT-PCR that feeding of C57BU6 miee with 0.45°;() 
BIll\. or 5 mg/kg of acrolein for 7 days caused an induction of Cyp:~c29 I~y \lsi ng I i vcr 
mierosomes from BI-IA-fed mice liver, we performed metaholism studies using 9-J\/\ as 
substrate. We observed that BHA-f(xi mice liver microsomal oxidation of9-/\./\ was 
induced 3-fold compared with the control. This induction was statistically signilicant at p 
n.005., There was also a small but significant increase in the reduction or 9-/\;\ to 9-
anthracene methanol (p < 0.05. Figure 32). This suggests that BIl/\ induced the 
expression of microsomal P450s responsible for 9-AA metabolism. In our published 
study (Amunom et al., 2007), we demonstrated that mouse liver microsomes oxidi/,e hoth 
()-/\/\ and 4-HNE and that this oxidation activity was inhibited by several [>450 
inhibitors~ mieonazole (general P450 inhibitor), phenytoin (Cyp2e29 inhibitor) and 
troleandomycin (Cyp3a inhibitor). Taken together. these data suggest that the treatment 
of mice with BHA induced the expression of hepatic P450s like C:yp2e:~9 (6A-fold;, 
which we have shown to be capable of metabolizing 4-HNE. The expression ofCyp2c29 
\vas also induced 1.6-fold by acrolein indicating the possibility ,)1' substrate-dependent 
transcriptional regulation. It is possible that during oxidative stress, when acrolein ~l11d 4-
fINE levels increase, some P450s are induced and contribute to the further mctahol ism of 
these lipid aldehydes. 
BIIA induced Cyp2c29 protein levels in mouse liver. In addition to measuring the 
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Figure 31. Quantitative real-time peR analysis of gene expression in C57BLl6 mice 
following treaitment acrolein by inhalation. Mice fed chow diet \\'eIT treated with 
acrolein hy a 6·-hour daily dose of normal air (control) or air containing 5-ppm acrolein 
for 5 days. RNA was extracted from the heart and liver. reverse transcrihed to cDNA and 
lIsed for qRT-PCR analysis of gene expression. The fc)ld induction is shown in a box and 
\vhiskers plot. The boxes extend from the 25 th to the 75 th pereentile_ the line across 
rcprcsL'nts the median distribution of samples (n = 4) for each gene. For each point. 
mRNA sample from a single mouse liver was analyzed in triplicate and the average is 
:-;I1O\"In. Fold induction for Cyp2c29, GSTmL ALDHIA L nQORI and 110-1 ill A.l\licc 
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mRNA levels in mice liver (control vs. BHA), we measured Cyp2c29 (52 kDa) protein 
level in liver microsomes. A Western blot analysis of mierosomes from C57BU6 mice 
liver with antibodies generated against Cyp2c29 (Goldstein .lA., PhD, NIEI IS, Triangle 
Park, NC), revealed a 2.5-3.0-fold increase of this P450 in BHA-fcd mice (Figure 331\). 
The Cyp2c29 antibody cross-reacted with the Cyp2c39. However, Cyp2c29-specilic 
change could be distinguished from Cyp2c39, because the Cyp2c39 antibody did not 
cross .. react with Cyp2c29 (Figure 338). The Cyp2c29 antibody did not cross-react \\?ith 
othcr members o[the Cyp2c class ofP450s that included Cyp2c37, Cyp2c.38. Cyp2ccJO, 
Cyp2c44, Cyp2c50, Cyp2c54, Cyp2c55, Cyp2c65, Cyp2c6CJ and Cyp2c70. This is 
important because the mouse Cyp2c class has about 75 % identity the results conlirmcd 
the specificity of the Cyp2c29 antibody used (Figure 33C). I-Iaving previollsly 
demonstrated that Cyp2c29 metabolizes 4-HNE and that Bl fA induces this P!l50 by both 
microarray and qRT-PCR, taken together, the results suggest that BH/\ and acrolein 
induce Cyp2c29 expression. It is possible that the protein level or other P'~50s were 
induced in the microsomal samples; however, they were not individually determined. 
Discussion 
To identify genes that arc induced following exposure to Bl IA and acrolein. 
Jllicroarray analysis was performed on 1200 genes and the expression pattern compared 
between the control and acrolein- or BHA-fed C57BLl6 mice. Bascd on our analysis, 
several genes were induced by either acrolein or BlI/\ in mouse liver: v,,'e observed a 
higher induction of gene mRNA in the BHA-fed mice than acrolein-fed mice. 
Cytochromes P450 constitute a superfamily of enzymes that metabolizl.: lipophilic 
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Figure 32. Induction of cytochrome P450 activity in mouse liver microsomes by 
BIIA treatment. Mice were fed with AIN-76A (control) diet or AIN-76A diet containing 
OAY!';) BIlA (treated) for 7 days and microsomal fractions prepared frot1l the liver. 
Cytochrome P450 (50 nM) activity in the mierosomes were analyzed by measuring the 
oxidation of9-AA to 9-ACA and reduction to 9-AMeOH in the presence ofNADPIJ 
regenerating system at 37°C. ** Significantly different from controL p'-O.OOS; 




[I[~ AI N-76 Control 
~§a O.4S 1% B BA ** 
9-ACA 9-AMeOff 
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compounds. Some CYPs also function as biosynthetic enzymes. While humans have 57 
P450 genes, mice have 102. In this study, we observed that some P450s were induced in 
the BlIA- or acrolein-fed mouse liver samples. Most importantly Cyp2e29, Cyp I a:2. and 
Cyp2a4 were strikingly induced. Cyp2c29 is a murine P450, abundantly expressed in the 
liver and other extra hepatic tissue including the heart. lungs, brain and intestine (I ,uo el 
(II .. I (98). We have previously demonstrated that this P450 metabolizes 4-J INL. Cyp:2a'~ 
(C)g (Ytl sequence identity with Cyp2a5) is expressed in the liver and olt~lctory mucosa ~ILlt 
not in the heart (Su and Ding, 2005). BIIA induced this P450 in ll1uuse li\'Cl". \\hich we 
demonstrated was also able to metabolize 4-HNE. Induction of P450s hy HilA and 
acrolein were of interest to us since these compounds arc predomin:.mtly associated with 
the induction of the expression of genes that encode enzymes invoh'ed in phase II 
xcnobiotic metabolism. BHA and acrolein inducc gene expression by utilil'.ing a group or 
t!"(inscription factors referred to as oxidative stress-sensitive transcription f~letors as 
mediators. Acrolein activates the .INK signaling pathway (Ranganna e/ al., 20(2). [n 
vivo. RHA is O-demethylated to tBHQ and tBHQ can undergo redox cycling generating 
hydrogen peroxide (oxidative stress) causing the activation of JNK. The activation of 
.INK can either result in the phosphorylation and activation of c-JUI1 or the 
phosphorylation and activation ofNrf2. Activation of these transcription l~H.:t\)J"s result in 
the induction of expression of target genes. 
The involvement ofNrf2 in cytochrome P450 gene regulation has not been 
extensively documented. Some studies have suggested a possible wic orNrf2 in P:150 
gene expression. For example, Bu et al. (2004 and 20(6) performed microarray an~dysis 
of gene expression by sulforafane (SFN, a compound known to induce gene expression 
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Figure 33. HilA induces the expression of Cyp2c29 in mice live!". MOllse li\l~r 
lIlicrosomalfi-actions from AIN-76A controls and OAY% BHA supplemented AIN7()-fccL 
\'vcrc electrophoresed on a 10% SDS-polyaerylamide gel. Resolvecl proteins were 
transCcrred to nitrocellulose membrane and immunoblotted ror the presence of 
cytoehromes P450. A. The membrane was immunoblotted llsing antibodies against 
('\,p:2c:29 and immunoreactive bands detected by enhanced chemiluminescence: I ~al1es I 
~lIld 14. protein standard (2 ilL); lanes 2 and 13. E. coli expressed Cyp2c29; lanes 3 U 6. 
("y]12c29 in control microsomes; lanes 7 to 12, Cyp2c29 in HI lA-treated microsomes. 
HIIA-CL, BlIA-controlliver; BHA-TL, BHA-treated liver. B. The membrane was 
i!11il1Llt~ohlottcd with an antibody against Cyp2c29. C. Members of the mouse Cyp2c 
Lll1lily were immunoblotted with an antibody against Cyp2c29 to check for eross-






















through Nrf2). In these rat studies, several P450s were induced: CYP 1/\, CYP:lA. 
CYP28, CYP4A and CYP39A. This observation led these authors to suggest a possible 
role ofNrf2 in the regulation of expression of the above-mentioned P450s. [n addition. 
studies have shown that Nrt2 regulates the induction of Cyp2a5 in DBAI2 mice (J\bu-
Bakar et af., 2004; 2007). 
GSTs are a family of cytosolic enzymes that mainly function to detoxify by 
conjugation through Michael addition of GS} [ to electrophilic compounds. Bf-{;\ or 
acrolein induced GSTml. GSTn:, GSTr by at least 2-fold. ALDI-I was also induced at 
least 2-fold. GST and ALDH are known acrolein and 4-HNE mctabolizing el1zvmes. 
~ , 
Recently. we also demonstrated that some P450s (CYP2c29, CYP3A4. CYP2J2. 
CYP2B6) are good oxidativc and reductive catalysts for 4-IINF. It is possible that the 
induction of these genes by BHA and acrolein serves as a protective role against th,; toxi i': 
effects of these lipid aldehydes. 
In addition to treatment of mice with acrolcin by gavage, we analyzed RN!\ 
samples from the heart and liver of mice that had received acrolein by inhalation. The 
rcsults from this study suggested that 5-ppm acrolein failed to robustly induce gene 
expression in mice heart and liver. This may be due to insulfIcicnt amounts or acrolein in 
the smoke or insufficient amount of acrolein reaching the targct orgalls to inducc genc 
expression. 
As a follow up to the microarray analysis and qRT -PCR, we performcd 9-1\/\ 
metabolism assay with microsomes from BIIA-fed mice liver and observed a 3-/old 
induction of 9-AA oxidation activity compared with the control. Phenytoin. a high 
aflinity substrate for Cyp2c29 was a potent inhibitor of this enzyme reaction. This 
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confirmed the observation that BHA-induced P450 gene expression in mouse liver, 
specifically Cyp2c29. Additional verification of the induction of P450 expression was 
conducted by Western blot analysis of liver microsomes prepared from Bf-IA-treated 
mice liver. The results revealed a 2- to 3-fold average induction in the level of ('yp2c2() 
in HI lA-fed mouse liver compared with eontrolmicrosoma\ samples. Taken together. 
thcse results demonstrate that BHA and acrolein induce xenobiotic mdaho\i:;.ing 
cnzymes, including Cyp2c29, which metabolizes the lipid aldehydes. suggesting the 
occurrence of substrate-dependent transcriptional regulation of this gene. 
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CHAPTER IV 
TRANSCRIPTIONAL REGULATION OF THE MOUSE CYP2C29 GENE 
INTRODUCTION 
Alteration in the regulation ofP450 expression is a major sou:"CC orvariabil~ty II1 
the mdaholism of xenobiotics and endogenous compounds. Induction of P450 expression 
can lead to alterations in drug efficacy and create the potential for drug-drug interactiolls 
(Sucyoshi and Negishi, 2001). In our study using the microarray analysis or ~'.enc 
c);pression, we observed that Cyp2e29 was induced following treatment of l11iCI~ \\ ilh 
either BHA or acrolein for 7 days. This observation was further confirmed by qRT-PCi~ 
and Western blotting. This result is particularly interesting since we have prcy'ic;usly 
shown that this P450 is capable of metabolizing 4-HNE to 4-hydroxyno!1eno:c dcid ami 
to a lcsser extent l,4-dihydroxynonene. The induction of Cyp2c29 gene expres~~ion hy 
BJ Ii\ and acrolein suggests substrate-depcndent regulation of gene ':);pre~sioi1 lhn'ug 1l 
the participation of the oxidative stress-sensitive transcription factors such as AP-l and 
Nrf2. ('yp2c29 is the first mouse Cyp2c to be sequenced and characterized (Matsunaga 
e{ (If" 1994). Its complete coding region contains 490 amino acids. The deduced amino 
acid sequence ofCyp2c29 exhibits 83% identity with that of the rat CYP2C7, and it is a 
homolog of the human CYP2C9 (Guo et (fl., 2006). Cyp2c29 is expressed at high levels 
in mouse liver (Matsunaga ct al., 1994) and extra-hepatic tissue inclt:ding the heart. small 
intestine (Zhang et al., 2003) and mOLlse brain (Volk el oL 1995\. Cyp2:J9 cal,11Y/cs tl1l.: 
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metabolism of several structurally diverse compounds; the oxidation of /11- and /)-
tolualdehyde to toluic acids (Watanabe et af., 1994), the metabolism of the anti-epileptic 
drug, phenytoin (Volk et af., 1995) and the oxidative hydrolysis of the coumarin 
derivative scoparone (Meyer et af., 20(1). Reccntly we demonstrated that Cyp2c29 is 
capable of metabolizing aldehydes namely, 4-HNE and 9-anthraccne aldehyde (Aniunolll 
e{ aI., 20(7). 
The mechanisms governing the regulation of hepatic cytochrome P450 gene 
expression are diverse. The use of gene promoters in transfection studies has facil itatcd 
the understanding of these mechanisms of regulation. The study by Jackson e{ 01. (2004) 
has documented transcriptional regulation of Cyp2c29 by the constitutive active 
androstane receptor (CAR). In this study, it was determined that ph..;nytoin. acting 
through CAR, increased Cyp2c29 mRNA and protein levels in mouse liver. Cyp2c~~<) 
e:'-.pression in the liver is decreased in hepatocyte nuclear factor I -alpha (lINF I (f.) null 
mice (Cheung et ai., 2003) implicating HNF I a in Cyp2c29 basal expression. 
AP-l family members include Fos, lun and activating transcription factor (AlF). 
The AP-l transcription factors bind to the DNA sequence known as thc TP A (12-0-
tetradecanoylphorbol 13-acetate)-response elcment (TRE), as different dimcric 
combinations of basic leucine zipper proteins from the Jun (c-Jun, .TunB. and JunO) and 
Fos (c-Fos, FosB, Fra-l, and Fra-2).The TRE sequence was originally described in the 
human collagenase gene promoter and has the sequence 5'-TGA(CG)TCA-3' (Angel ct 
(//., 1987). The activity of the AP-l transcription factors is regulated by components 01' 
the mitogen-activated protein (MAP) kinase cascade. The MAPKs arc cvolutionari;y 
conserved proteins that allow cell-surface receptors to act upon several regulatory targets 
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within the cell. Three cascades composed of a MAPKK kinase or MEK kinase. a MAPK 
kinase (MEK) and a MAPK regulate the activity of MAPKs. Mammals express at least 
four groups ofMAPKs; ERK1I2, JNK1I2/3, p38 and ERK5. The targets of the stress-
activated kinase, lNK, include lunD, c-Jun, ATF and ELK-I. These proteins are 
activated following exposure to oxidative stress or other cell stresses. 
Transcription factor Nuclear factor erythoid-2 related factor 2 (Nrf'2) is a 
basic leucine zipper (bZip) protein. Nrt2 binds to is canonical antioxidant response 
clement (ARE) as a heterodimer with other bZip proteins notably small MaL Jun. and 
ATF. The ARE consensus sequence initially described by Rushmore e/ of (1991) is 5'-
GTGACNNNGC-3'. It was later observed that the bases flanking the core ARE sequence 
also influence the function of the ARE. The sequence was therefore expanded to 5'-
TMAnnRTGAYnnnGCRwww-3'; M represents A or C, R reprcser:ts A or G. Y 
represents C or T, W represents A or T, S represents Gore (Wasserman and FahL 19(7). 
By performing point mutation studies, it was determined that the "OC" in the ARF core 
sequence is an absolute requirement of a functional ARE (Rushmore e/ ill., 199 J). It l~as 
also heen demonstrated in the human c-Ha-ras gene that in addition to the nanking 
sequence, the trinucloetide "NNN" within the core ARE also intluenees the recruitment 
of proteins to the ARE (Miller and Ramos, 2005). 
Compounds that cause oxidative stress in the cell have heen shown to activate 
both AP-l and Nrfl. Treatment of cells with 4-HNE results in the depletion of GSl r, the 
production of peroxide and the activation of the JNK (Uchida et al.. 1998). Acrolein 
activates the MAP kinase signaling cascade resulting in the activation of JNK, p38 and 
ERK1I2 (Ranganna et al., 2002). Several studies have also shown that BHA alld its 
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metabolite tBHQ activate AP-l. BHA induced the rat glutamate-cysteine ligasc and 
glutathione synthetase, two enzymes involved in thc synthesis of GSIl through the 
activation of AP-l (Yang et al., 2002). 
In addition to activating AP-l. acrolein, 4-HNE and BHA also cause the release 
ofNrf2 from Keap-J and allow translocation ofNrf2 from the cytoplasm to the nucleus. 
BIIA is the prototypical Nrf2 activator and has been used by several groups to induce 
gene expression via Nrf2. A study by Yuan et al. (2006) demonstrated that BflA 
regulated the ARE-mediated induction of heme oxygenase-l gene expression through 
Nrf2 coupled with ERK and JNK signaling pathways in HepG2 cells. Upon activation . 
.INK phosphorylates Nrf2 at Serine-40 causing the release ofNrf2 from Kcap I. Thl~sc 
ohservations imply that in addition to AP-l activation, the MAP kinase cascade can also 
activate Nrt2. 
The core ARE sequence strikingly resembles the consenSLlS TRI·:. implying lh~lt 
sequcnces that resemble these response elements have to be tested lor their functioll b: 
determining which transcription t~lctorS are recruited to these cis-elements. As stated 
above. we observed that Cyp2c29 is induced by BIIA and to a lesser extent by acrolein. 
We also confirmed by Western blotting that Cyp2c29 protein levels were 2-fold higher in 
liver microsomal fractions prepared from mice treated with BEA compared with 
untreated mice. We therefore hypothesize that Cyp2c29 gene expression is regulated by 
HilA and acrolein through the oxidative stress-sensitive transcription Cactors. To test this 
hypothesis, we cloned and analyzed the 5'-flanking sequence ofthc ('yp2e29 gene for 
transcriptional regulation by the oxidative stress-sensitive transcription i~lctors. Using 
MatInspector (http://www.genomatix.d~) and TFSEARCH 
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(bttp:l/www.cbrc.jp/research/db/TFSEARCH.html). we scanned 3000 hases of the 
Cyp2c29 promoter for putative transcription factor binding sites. A putative TRE \\as 
observed at -1249 bp, upstream of the Cyp2c29 transcription start site. This sequence 
strikingly resembles the TRE and contains the consensus ARE described by Rushmore ef 
al in 1991. We subsequently analyzed the 3000 bp 5'-tlanking sequence, as well as the 
TRE for regulation ofCyp2c29 gene expression. We observed that induction oCCyp2c29 
is mediated by transcription factor AP-l. 
MATERIALS AND METHODS 
Chemicals. Tert-BHQ, SP60012S (JNK inhibitor), and okadaic acid (phosphatase 
inhibitor) were purchased from Sigma Chemical Co, Inc. (St. Louis, MO) anll dissol\ cd 
in dimethyl sulfoxide (DMSO). Acrolein was purchased from Sigma Chemical Co and 
diluted to the required concentrations in phosphate buffered saline. The luciferasc assay 
reagent and cell culture lysis reagent (SX) were purchased from Promega (Madison, WI). 
When reagents were prepared in DMSO, the maximum concentration orDMSO Pc!' 111101' 
media on treated cells was 0.4 % (v/v). 
Plasmids used for transfection. Plasmid GL-3 basic vector was purchased frolll 
Promega (Madison, WI). Cyp2c29 promoter constructs were prepared by a similar 
method as described by Jackson et al., 2004. Mouse genomic DNA was purchased from 
Promega (Madison, WI) and used in PCR experiments to generate :103 c t bp of the 
(~vp2c29 S'flanking sequence. This region contains 123 bp ofthc (yp2c2Y gene, as well 
as, 301 J base pairs of the Cyp2c29 S'-flanking sequence. The downstream primer: 5'-
T'GGATCTGGTCGTGTTCCTAGC- 3' introduced an Nco! site. \\hilc the upstream 
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primer: 5' --ACACAATTTGGTTTTGGTTA- 3' introduced a Kpn ! site to the upstream 
region of the 3034 bp PCR product. A 600 bp fragment ofthc Cyp2c29 5'-FS was also 
generated. The upstream primer, 5' -CCCGGGGATAGTGGTTATCACTGAATAG-3' 
introduced a Smal site and the down stream primer 5'-
CTCGAGCTGTACTGGGGCATATAAAG-3'introduced an Xhol restriction enzyme 
site. The amplicons were recovered into pCR;J<4Blunt-TOPOC,j; "ector 
(Invitrogen, Carlsbad CA). After sequence verification by comparison with genomic 
DNA sequence data, the Kpnl and Neal sites were used to remO\'e the Cyp2c29 -3043 bp 
promoter region and inserted it into the pGL3-Basic vector to generate the reporter 
plasmid pCyp2c29-3.0Luciferase reporter plasmid (pCyp2c29-3.0Lue). Dr. .IA. 
Goldstein (NIEHS, Triangle Park NC) provided the pOL3 luciferase rcporter plasmid 
containing 1500 bp of the Cyp2c29 promoter (pCyp2c29-1.5Luc). Plasmid O_lMGSTYa-
Luc (pO.164GSTYa-Luc) containing 164 bases of the rat GST Ya minimal prollloter 
cloned in front of the luciferase reporter gene was generated by Dr. K. C"meron Falkner 
(University of Louisville). This construct has been extensively used in the Prough 
Laboratory to drive the expression of genes by various enhancer clements. The plasmid 
pO.164-GSTYa Luc was used to generate the shorter Cyp2c29 fragments lacking the 
Cyp2c29 native promoter. The restriction enzymes SmCi I ancLU70 / \'/ere used to remove 
a 600 bp region of the Cyp2c29 5'flanking sequence and inserted into pi), 164-GSTYaLuc 
upstream of the rat GST Ya promoter to generate pCyp2c29-600Luc, Dr. ('B. Pickett 
and T. Nguyen (Schcring-Plough Research Institute, Kenilworth. New Jersey) provided 
the expression plasmids for c-Fos (pRSV-cFos) and c-.Tun (pRSV-c-.Tun). Dr. KS, Ramos 
(University of Louisville) provided the Nrf2 expression plasmid (pCI-Nrf2nco), Plasmid 
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O.I64GSTYa-ARELuc (O.I64Ya-ARELuc) containing 164 bases orthe rat GST Ya 
minimal promoter and the consensus antioxidant response clement cloned upstream of 
the luciferase reporter gene was used as a positive control for Nrf2-dependent regulation 
of gene expression. 
A luciferase reporter plasmid containing 30 bp fi'agment of the Cyp2e29 promoter 
region (pCyp2c29-TRELuc) or mutants of the TRE (pCyp2c29-AP I Mut L pC'yp2c2()-
GCMutJ) were generated by the technique of primer annealing. We also generated a 30 
bp fragment containing the human collagen TRE. The 30 bp oligonucleotides were 
obtaim:d from Integrated DNA Technologies. Inc. (Coralville. IA) and the scqucnces arc 
shown in Table 7. For each fragment a Kpnl restriction enzyme site was included at the 
5' -end and a Nhe 1 site at the 3' -end. The olignucleotides were re-suspended in 10 1l1l\1 
Tris-EDTA (pH 8) and phosphorylated using T4 polynucleotide kinase according to tll(: 
manufacturer's instructions (Promega, Madison WI). Phosphorylated oligonucleotides 
were cleaned with the QIAquick nucleotide removal protocol (Qiagell. (JermantO\vn MD) 
according to the manufacturer's instructions. The primers were annealed in bufler (1 mM 
Tris pH 8, 50 mM NaCl, 10 mM EDT A, Sigma Chemical Co, St Louis !'vIO) by heating 
at 95°C for 2 min and gradual cooling to 25 °c (room tempcraturc) for 45 min in the 
Amplitron@ II Thermolyne thermocycler. Each double-stranded DNA was ligated into 
Kpnl- and Nhel-digested p0.164Ya-Luc (Figure 34) using T4 DNA ligase. according tll 
the manufacturer's instructions (Prom ega, Madison WI). 
Transient transfection of HepG2 cells and measurement of luciferasc actiyity. The 
human hepatoblastoma cell line HepG2 (HB8065. American Type Culture CollectioJl, 
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Table 7 
Oligonucleotides showing the Cyp2c29 putative TPA (12-0-tetradecanoylphorhol 
13-acetate)-response clement (TRE), wild (vpe and mutant sequenccs, and th{~ 
human collagenase TRK 
Oligonucleotide Sequence 
Cyp2c29TRE 
Forward 5'-A TCACTGAATAGTGACCTAGCACATAC;TCi\-3' 
Reverse 5'-CTAGCTGACTATGTGCTAGGTCAC'TATrCAGTGGTAC'-]' 
Cyp2c29-Mut-TRE 
rorward 5'- ATCACTGAATAGGAGACTAGCACATAC;TCA-]' 
Cyp2c29-Mut-GC 
Forward 5'-ATCACTGAATAGTGACCTAAAACATAGTCA-] , 
Collagenase TRE 
Forward 5' -CAAAGCATGAQTCAGACACCTCG-3' 
Reverse 5' -CTAGCGAGGTGTCTGACTCATCiCrITCJGTAC'-] 
The underlined nucleotides in Cyp2c29 TRE were mutated to determine their rule in the 
induction of reporter plasmid in response to transfected Fos and Jlli1 expression pl'lsmids. 
The underlined sequence in the collagenase TRE is the core sequence. Thesc 
oligonucleotides were cloned in front of the lucifcrase gene in pO.164GSTYa-Luc to 
generate recombinant reporter plasmids. and used in transfection e:-: pcrimcnts. 
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Figure 34. The modified pO.164-GSTYa Luciferase plasmid showing the luciferase 
gene, the minimal rat GST Ya promoter (164 bases) and the Cyp2c29-TRE (-30 
bases). The Cyp2c29-IRE was replaced with mutants of the IRE (pCyp2c29-APIMut or 
pCyp2c29-GC-mut), 600 bases of the Cyp2c29 promoter (pCyp2c29-0.6Luc), or the 
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Transient transfection of HepG2 cells and measurement of luciferase activity. The 
human hepatoblastoma cell line HepG2 (HB806S, American Type Culture Collection. 
Rockville, MD) was maintained in Eagle's minimal essential media with 10% fetal 
bovine serum (HyClone, Logan UT), antibiotic-antimycotic solution (1 X, contains 
penicillin, streptomycin and fungizone; Invitrogen, Carlsbad CA) and nonessential amino 
acids (IX; Mediatech Inc. Herndon VA). For transfection experiments, cells were plated 
at a density of IS0,000 cells per well in 12-well plates. Twenty-four hours after plating, 
cells were transfected using 4 Ilg/mL LipofectAMINE (Invitrogen, Carlsbad, CA) with 
either the reporter plasmid pCyp2c29-3.0Luc, pCyp2c29-1.SLuc, pCyp2c29-0.6Luc and 
pCyp2c29-TRE and its mutants, p0.164GSTYa-ARELuc, or pCol- TRELuc (100 ngiI11L). 
The cells were also cotransfected with pRSV-cfos (3.S-S0 ng/mL), pRSV-cJun (3.5-50 
ng/mL), and a ~-galactosidase expression plasmid (pCMV-~Gal) in 1 mL of serum frec 
medium. After an overnight incubation at 37°C, the cells were overlaid with 1 mL media 
containing 10% FBS and then treated with 4 ilL of 12.S mt\l tBHQ in DMSO. The 
trcatment of cells with acrolein (0.2 nM and 0.4 nM) was performed in normal and serum 
li'ce media. Seventeen hours later (overnight) the cells were harvested with 1 00 ~lL of cell 
lysis buffer (Promega, Madison, WI). The ~-galactosidase and luciferase activities were 
determined as described by Falkner et at. (1998). The data are expressed as luciferasc 
activity relative to ~-galactosidase activity to correct for transfection efliciency. All 
transient transfection experiments were performed in triplicate, and experimcnts wcre 
repeated at least twice to confirm rcsults. 
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Statistical Analysis. Experiments were conducted in triplicate and means .1: standard 
deviations were determined. Statistical comparisons among treatment groups were 
determined using analysis of variance (ANOVA) or a Student's t test. 
RESULTS 
Cloning and sequencing of the 5'-flanking sequence of Cyp2c29. The sequence of the 
3.0 kb product of the Cyp2c29 5'-flanking sequence (5'-FS) is shown (Figure 35). This 
sequence was generated by PCR and analyzed for transcription factor binding sites using 
MatInspector Version 3.2 and TFSearch.html. The phenytoin-responsive module 
(PHREM), characterized by the Goldstein Laboratory (NIEHS, Triangle Park NC) is 
located at -l.3 71 Kb upstream of the Cyp2c29 translational start site. This module 
contains a CAAT enhancer binding protein (C/EBP) binding site. The PHREM is 
responsible for the constitutive androstane receptor-dependent induction of Cyp2c29 by 
the anti-epileptic phenytoin (Jackson et al., 2004). The 3.0 kb 5'-FS ofCyp2c29 also 
contains putative binding sites for AP-l, NF -kB, the coactivator p300, signal transducer 
and activator of transcription (STAT), specificity protein (SP-I), pregnane X receptor 
(PXR), myeloid zinc finger protein (MZF) and heat shock factor (HSF) (Figure 35). 
Functional analysis of the 5'-flanking sequence of Cyp2c29. Microarray analysis, 
qRT-PCR and Western blotting analysis demonstrated that treatment ofC57BLl6 mice 
with BHA or acrolein resulted in the induction of Cyp2c29, both at the mRNA and the 
protein level (Chapter III). To determine the oxidative stress-sensitive transcription 
factors responsible for Cyp2c29 induction, we co-transfected HepG2 cells with luciferase 
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Figure 35. The 3.43 Kb of the Cyp2c29 5'-flanking sequence. The sequence shown is 
the -t3 to -3043 bases of the Cyp2c29 5'-FS. The underlined nucleotides represent 
putative transcription factor binding sites identified by MatInspector and TFsearch 
software. The phenytoin responsive module (PHERM) is shown. The box shows 
nuclcotides that were cloned into the pO. 164Ya-Cyp2c29-TRE-Luc. The transcription 
~;tart site is italicized. 
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reporter plasmids containing different lengths of the Cyp2c29 5' -FS generated by 
deletion, and Fos and lun (AP-l) or Nrf2 expression plasmids. Luciferase activity from 
the pCyp2c29-3.0 reporter plasmid gradually increased with the increase in co-
transfected AP-l. However, the levels were lower than the basal activity seen in the 
absence of AP-l (Figure 36). There was a 2-fold increase in luciferase activity from the 
pCyp2c29-600 luc:iferase reporter plasmid in the presence of 50 ng and 100 ng of Fos and 
lun suggesting that this sequence is regulated by AP-l. The luciferase activity returned to 
control levels when the cells were transfected with 150 ng of AP-l expression plasmids. 
The reporter plasmid pCyp2c29-TRE contains a 30 base pair fragment of the 
Cyp2c29 promoter. The highest fold induction (6-fold) was obtained when HepG2 cells 
were transfected with this reporter plasmid in the presence of 50 ng ofthe Fos and lun 
expression plasmids. Luciferase activity then decreased with increased amounts ofFos 
and lun expression plasmids (Figure 36). The decrease in luciferase activity with 
increasing cotransfection of the Fos and lun expression plasmids was unexpected. This 
may have been caused by limiting coactivators or the formation of nonproductive protein 
complexes at higher AP-l concentration. Unlike Fos and lun, Nrf2 did not induce 
luciferase activity even when the cells were treated with tBHQ (data not shown). 
Transcription factor AP-l induced reporter activity through a Cyp2c29 TRE. As 
shown in Figure: 36, the pCyp2c29-TRE reporter plasmid showed maximum induction in 
the presence AP-l transcription factor. According to the results of MatInspector and 
TFSEARCH result, this fragment contains a putative AP-l binding site (TRE, 89 %). 
However, this site also closely resembles the consensus ARE (Table IV). We therefore 
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Figure 36. Deletion analysis of the 5'-flanking sequence of the Cyp2c29 gene. 
1.1Icikrase constructs were prepared \vith different length Il'agmcnts of the 5'-FS oCthe 
Cyp~c2c) gene. A. Schematic representation of the different deletion constructs of the 
(':p2c29 5' -nanking sequence. B. The constructs were tested by transient cotransfection 
\"illl Fos and .Tun expression plasmids in HepCr2 cells. The normalized lucifcrase activity, 
l'.,\pressed as relative light units divided by the i)-galactosidase activity. is the mean I Sf) 
\)f!!Jree wells. Data was analyzed by Anova followed by a Dunnett test. *** Signilicantly 











_1 ______________________________ ~r_7 
Fos+Jun 
pCyp2c29-3.0L uc 
pCyp2c2'J-3.0L l C 
_---------~- •... -•.•• _____.r___7 
pCyp2c2<J~1.61, uc 






pCyp2c29-T ;{F L IIC 
subjected this fragment (pCyp2c29-TRE) to further analysis in the presence of AP-I alld 
Nrf2. 
In the previous experiment, we observed the highest reportcr gelle expression 
when IIepG2 cells were co-transfected with the lowest combination of Fos and Jun 
expression plasmids (50 ng). We therefore decided to transfCct cclls with 10\\ cr alllounts 
or AP-l: Fos (3.5 -60 ng) and Jun (3.5 -60 ng) expression plasmids. Thc highcst 
induction of luciferase activity (8-fold) was observed when the cells were cotransfCcted 
with Fos (3.5 ng) and Jun (3.5 ng) expression plasmids (Figure 37). In addition to 
responding to AP-I, the Cy2c29 TRE sequence of interest resembles the consellSLlS /\I\Y. 
Therefore, to determine ifNrf2 contributes to Cyp2e29 induction. I Iep(J2 cells wcre 
transfected with the Cyp2c29-TRE Luc rcporter plasmid and the NrQ and AJ>-1 
cxpression plasmid, and luciferase activity measured (Figure 37). Surprisingly. Nrl2 did 
!wt alfect luciferase activity even in the presence ofFos or .Tun (data not shown). This 
obscrvation indicates that the induction orIucifcrase activity is in response to an /\J>-I-
:'I<.F and not an Nrf2-ARE interaction. 
A positive control for AP-l-mediated induction of gene expression was per!'onm:d 
by transfecting HepG2 cells with a Col-TRE lucifcrasc reporter plasmid. This plasmid 
contains the human collagenase TRE Crable 7). Luciferase activity incl'L'ased by J.5 to 2-
fold in the presence of 15 -- 60 ng the Fos or .Tun expression plasmid (Figure 38). j\ co-
transfection of the Fos and Jun expression plasmid caused an increase ill luciferase 
activity with the highest induction of2.75-fold observed in the presence of 3.5 ng Fos 
and 3.5 ng Jun expression plasmids. The collagenasc TRE thercf~m' interacts with a I'os 
.run heterodimer to mediate the induction of luciferase activity obscn cd. 
159 
Figure 37. Differential activation of the Cyp2c29-TRE Luciferasc reporter in 
HcpG2 cells by AP-l proteins. HepG2 cells were transfected with pCyp2c29-TRELuc 
reporter plasmid and the expression plasmid for Fos (3.5-60 ng) and .fun (3.5-60 ng). 
Twenty four hours after transfection, the cells were harvestcd and the lysate assayed for 
(I-galactosidase and luciferasc activity. The data represent the mean j SD of three wells. 
i~:'\pcrimcnts were repeated at least three times with similar results. Statistical 
signilicance was determined using Anova followed by the Dunnett post-test. * * * 
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Figure 38. Induction ofCollagenasc-TRE Luciferasc repol"ter activity folJowing 
cotransfcction of Fos and Jun in lIepG2 cells. HepG2 cells were trans1Cctcd with pCol-
!RU ,lIC reporter plasmid and the expression plasmid for 1"os (3.5-60 ng) . .lUll (J.5-60 
llg). and Nrf2. The eells were maintained for 24 hrs and harvested. The celllysates \\ere 
assayed for ~-galaetosidase and lueiferase activity. The data represent the mean:1 s]) or 
thn.T wells. Experiments were repeated at least three times with similar results. Statistical 
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In a similar experiment, IIcpC;2 cells were transfected with pCyp2c2-rl~E Luc 
and treated with 0.2 nM or 0.4 nM acrolein. There was no change in lucifcrase acti"ity at 
0.2 nM acrolein. However at 0.4 nM acrolein treatment. thcre was a modest but 
inconsistent increase in luciferase reporter activity (data not shown). The tn~atment of 
I kpG2 cells with higher concentrations of acrolein caused cell death as detl~rmined by a 
decrease in the p-galactosidase activity in the acrolein-treated cells. 
The core and proximal nuclcotides of the TRE contribute to AP-l-dcpcndcnt 
induction of Cyp2c29. To determine the contribution of the lluc]cotidcs in the Cyp2c29 
TRF sequence in the induction of luciferase acti\'ity. HepG2 ce:ls were transiccted 'v\itll 
the Cyp2c29-TRE (wild-type) or the AP-I mutant reporter plasmid Crable 7). 
In the presence of AP-I, we observed a 2.S-fold incrcase in luciferase activity 
from Cyp2c29-TRE (Figure 39). This activity was modestly increased when the cells 
were treated with 50 ~lM tBHQ. There was no effect of co-transfcction ofNr!,2 alol1e. 
e\en when the cells were treated with tBHQ. This suggests that Nrf2 may not interact 
with the Cyp2c29 TRE. The core TRE sequence within the Cyp2c29-TRE-Luc \vas 
mutated to generate the Cyp2c29AP-1 Mutl luciferasc plasmid. This lllutatioll obliterates 
the Fos/Jun binding site. The increase in luciferase activity as seen with the \\ild-type 
TRE in the presence of AP-I was lost when the cells were trans1Ceted with the 
Cyp2c29AP-IMutl reporter plasmid. As expected. there was no change in lucijcrase 
activity in the presence Nrf2, Fos/JunlNrt2, Jun alone or Jun/Nrf2 expressioll p!aslllids. 
In addition to the AP-I mutation. the "GC" dinucleotide which is proximal to the 
J '-end of the Cyp2c29 TRE was mutated to determine its elTecl on 1\[>-1 mediated 
164 
Figure 39. Mutation of the core TRE results in the ablation of AP-l-depcndent 
transcriptional induction of Cyp2c29. IlepG2 cells were transfected with pCy]12e:29-
11<1<: LLie (wild type), or pCypp2c29-AP I MUTl (mutant) n~porter plasmid ami the 
l'xpression plasmid for Fos, lun and NrC. The cells \vere trcated with DMSO or 50 pivl 
tlillQ In DMSO for 16 (overnight) hrs and then harvested. The eelllysates were assayed 
Cor lucifcrase and ~-galactosidase activity. The data shown is the mcan ± Sf) of three 
\\elk Lxperimcnts were repeated two times with similar results. Statistical significance 
was determined using the Students {-test. * * * significantly di tlerent from the A P- I 111 L1tant 
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induction of luciferase activity. This "GC" is an obligate requircment for :1 functional 
A RE (Rushmore et a!.. 1991). There was no si gnificant di fterence in basal I uci !Crase 
activity between the wild-type Cyp2c29 TRE and the GC-mutant (Figure 40). J\ co-
transfection of the AP-I expression plasmids caused an 8-fold increasc in luci fcrase 
activity from the Cyp2e29-GC-mut plasmid compared with 2.S-fold increase from the 
wild-type TRE plasmid. This suggests the presence of the "GC" cis-acting clement 
results in negative regulation of induction of the Cyp2e29-TRE luci ferase activity hy AP-
I. but mutation of the element results in even higher inducible expr'2ssion of the gene. 
Over-expression ofNrf2 had no effect on luciferase activit}. but these cells e:-.:press I\'rJ'2. 
Induction by BEA in Nrf2 null mice is actually increased significantly ovcr wild-type 
mice suggesting that Nrf2 may ameliorate AP-I signaling in the expression or this gene. 
In order to compare the response from the Cyp2e29 TRE to tha: or the:on.:CIlSLlS 
ARE. HepG2 cells were transfected with the pO.164-GSTYa-ARELuc reporter plasmid. 
This plasmid contains the antioxidant response clement of the rat G ST Ya promoter ane! 
has been extensively used in the Prough Laboratory as a positive c(lntrol ror the ARL·· 
~rf2-dependent induction of gene expression. Luciferase activity vvas measured 
t()llowing cotranst'ection orthe Fos, Jun or Nrf2 expression plasmid (Figure 41). First, 
there was a significant increase in basalluciCerasc activity following eo-transCcctioll of 
the .fun (p <0.05), Fos and Jun. Nrf2 or Nrf2 and .Tun (p <0.(1) and the Fos express:on 
plasm ids (p>O.OS). Second. following trcatmcnt with tBlIQ. wc ob~erved a Curther 
increase in luciferase activity; II-Cold (.lun; p <(J.O I). 21-fold, Fos and .fun (p <0.(1). 2S-
fold. Nrf2 (p <0.01) and 38-fold. Nrf2 and Jun (p <0.01) compared with tlK pO.l (l"j y~,-
J\ R E alone treated with tBH Q. These data confirm previous observati OllS that Fos or .I un 
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Fi~ure 40. Mutation of the "GC" dinucloctidc rcsults in the induction of AP-t-
dcpendcnt transcriptional induction of Cyp2c29. I-lepG2 cells were transfccted with 
pCyp2c29-TRELuc (wild type), or Peyp2c29-GCMlrn (mutant) reporter plasmid and 
the expression plasmid for Fos, Jun and Nrf2. The cells were treated with I )[v1S0 or 50 
~l\ltBI [Q in DMSO for 16 (overnight) hrs and then harvested. The eelllysates were 
a:;sayed for lueiferase and I~-galactosidasc activity. The data shown is the meal1 J Sf) or 
three vyells. Experiments were repeated two times with similar results. Statistical 
sit',l1iticance was determined using the Students I-test. *** Signiticantly dirferent h'oI1l the 
Cvp2e:29-TRE Lue activity in the absence oftBHQ treatment. p < 0.00 I. 
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Figu re 41. Effect of Nrf2 and AP-l on ARI~-dependent activation of pO.164GST Va-
A RE-Lucifcrase activity. HcpG2 cells were transfcctcd with pO. I M-CiST Ya-A RL Luc 
,cpul'ter plasmid, Nrf2 and AP-I expression plasmids. Lucifcrase activity in I IcpG:2 cells 
\v~IS measured after treatment with DMSO or 50 ~lM tBI IQ in DMSO. The data is the 
relative lucifcrase!~-gal activity for three wells. Experiments were repca~ed at least rnur 
times \\ith similar results and statistical analysis performed by Anova i'olloV\cd by the 
Dunl1elt post test.* (p<O.05) and *** (p<O.Ol) significantly different from basal "chicle 
treatmcnt. -i-t And ttt significantly different from the basal tBIIQ treatmellt. p<O.01. 
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can synergize with Nrf2 to potentiate the GSTA2 reporter gene expressil)l] undcr control 
of this ARE (Nguyen et al., 2003). 
The effect of MAP kinase inhihitors and phosphatase inhihitors on AP-l-dcpcndcnt 
~lctivation ofluciferase activity. AP-l (Yang el a/., 2(02) and Nrf2. (Yuan el a/" 19%) 
an: activated by components of the MAP kinase cascade. To determine which kinases arc 
involved in AP-l activation resulting in the induction ofluciferase activity, I TcpG2 cdls 
were transfected with pCol- TRE Luc, the Cyp2c29-TRE Luc or pO.164 Ya-J\RI~ I.ue. 
The transfected cells were then treatcd with the JNK inhibitor SP600 125 (Bennett el u/., 
2.(01), the protein phosphatase inhibitor okadaic acid (Takai et a/., 1(87) or the ERK 
inhibitor PD098059 (Dudley et al., 1995). SP600 12.5 functions to inhibit .INK-mcdiated 
phosphorylation of Jun, thereby inhibiting .Tun activation. Treatment of the tral1~Jeeted 
1 kpG2 cells with the JNK or the ERK inhibitor caused a 40-50(% inhibitinl1 of iuci fCr~uc 
activity ufthe Cyp2c29 TRE luciferase reporter plasmid and a 50-60% inilibitinn in the 
collagenase TRE reporter activity (Figure 42). The protein phosphatase inhibitor. oi<adai': 
acid caused an increase in luciferase activity, 4-fold for Cyp2c29-TRE and 3-fold for 
collagenase TRE. The GST Ya antioxidant response clement was also inhibited by 50 % 
by the JNK inhibitor SP600125 or the ERK inhibitor PB098059, and induced 1.4-fold by 
lhe protein phosphatase inhibitor okadaic acid. These data support the observation that 
Cyp2c29 induction is mediated by AP-l and that this transcription factor requires 
phosphorylation for activation. 
Regulation of the cyp2c29 5' flanking sequence in mouse primarY hepatocytcs. 
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Mouse primary hepatocytes were transfected with luciferase reporter plasm ids contJillin,U 
the different Cyp2c29 5'FS fragments, and the cells treated for 1 G hrs with tBI ro. We 
observed a 3-fold induction of luciferase activity with the reporter plasmid containing 
3.0 kb of the Cyp2c29 5' -FS (Figure 43). In addition, we observed a 5-fold increase in 
luciferase activity with pCyp2c29-0.6Luc compared with the basal pCyp2c29-3.0 lue 
activity. In a separate experiment, treatment with tBHQ also caused induction of the 
Cyp2c29-TRE in mouse primary hepatocytes (data not shown). We observed that 
induction of the luciferase activity was more robust in mouse primary hepawcytes than in 
llepG2 cells (Figure 39). Tert-BEQ is proposed to induce gene cxpn.:ssion by 
undergoing redox cycling in the presence of enzymes capable of one-electron reductioll 
ortBI IQ (Kahl et al., 1989). This reaction produces reactive oxygen species (oxidative 
stress) which activate the MAP kinase cascade subsequently activating Nrf2 and AP-l. It 
is possible that the enzyme system required for this process is absent in HepC;2 cells. 
thereby causing the reduced induction of AP-1-mediated reporter activity observed. 
Alternatively, there might be other transcription factors required to mediate the induction 
ofCyp2c29 by tBHQ and acrolein, which are absent in IIepG2 cells. 
Cvp2c29 is induced by RHA in Nrf2+/t and NdT/- mice liver. We have so I~ll' madc till' 
fpllowing observations for Cyp2c29: 1. Its expression is induced by HIlA an~1 acrolein in 
ll1iee liver. 2. The Cyp2c29-TRE is induced by Fos/Jun and not by Nri2. 3. There is a 
further induction of the Cyp2c29-TRe reporter activity following mutation ofthc "ne" 
dinucleotide at the 3 '-proximal region of the Cyp2e29-TRE. To further investigate till: 
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Figure 42. Effect of protein kinase and phosphatase inhibitors on Cyp2c2lJ-TRE 
lucifcrasc reporter activity. HepG2 cells were transfected with collagenase TRE, 
('vp7.c29-TRE or GST Ya ARE luciferasc reporter plasmids. Cells were treated for 16 h 
with 25 ~tM of JNK inhibitor SP600125, 40 nM protein phosphatase inhibitor okadaie 
acid dr 50 ~tM ERK inhibitor. PD098059. Cells \vere harvested and Iysates assayed for r)-
galactosidase and luciferase activities. The relative luciferase activity was calculated by 
normalizing the change in luciferase activity following treatment to the vehicle treated 
control:;. Data represent the mean ± S.D. of three wells and was analyzed by ANOVA 
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Figure 43. Lueiferase reporter activity in response to tBJlQ in mouse primary 
hcpatocytes. Mopse primary hepatocytes were transfected with pCyp2c29-3.0 Iuc. 
pCyp2c29-1.5 Lu¢ or pCyp2c29-604. After 24 hours. the cells were treated for 16 hours 
with vehicle or 50 ).lM tBHQ. Cells were then harvested and Iysates assayed l'or r)-
t'alact()sidase and luciferase activities. Data represent the mean ± S.D. of three \yells. 
Statistical analysis was performed by ANOYA followed by the Dunnett post test. *** 
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role of Nrf2, we conducted qRT-PCR with RNA from wild-type and Nrf2-'- mice liver red 
BlIA. 
C57BLl6 wild-type and Nrf2-'- mice were treated with BHA for 7days and RNA 
extracted from liver samples of the same animals. Following cDNA synthesis, the mouse 
liver sampiles were analyzed for changes in gene expression by quantitativc real-time 
PCR. The following observations were made (Figure 44): GSTml was induced on 
averagel0-fold; heme oxygenase 1, 3-fold: NAJ)PH:quinone oxidorcductase. 17-i'old and 
Cyp2c29. 6-fold. In the Nr12 -1- animals, GSTml and quinone oxidoreductase were 
induced only 2-fold and no induction was observed for heme oxygenasc 1. Interestingly. 
a further increase in induction was observed for Cyp2c29 (17-fold) in the Nd2 -I-mice 
liver. The Hayes laboratory has conducted studies looking at Nrf2-dependent regulation 
of gene expression. They have observed that administration of isothiocyanates which are 
activators ofNrf2, to nrj2+1+ and nrj2 1- mice produced a ~ I.S-fold inercase in 
NAD(P)H:quinone oxidoreductase 1 (NQO I) and glutathione 51-transferase (CST) 
activities in stomach, small intestine, and liver of wild-type mice but not in l11utantmice. 
The increase in transferase activity was associated with elevated levels of GSTA 1 /2, 
GSTA3, and GSTMl/2 subunits (McWalter ef al., 2004). This is in agreement with the 
induction ofGSTml and NQORI caused by BHA in wild-type mice. Unlike the other 
genes, Cyp2c29 was further induced in Nrf2-I-mouse liver supporting thal this enzyme is 
regulated by a different transcription factor, most likely AP-l. Taken together, \ve 
cOllcl ude that while N rf2 induces the expression of GS Tm 1, I 10-1 and nQO R -1 . 
Cyp?'c29 is induced by transcription factor AP-l. 
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Figure 44. Quantitative real-time peR analysis of gene expression in wild-type and 
:'1'12-/- miee liver following treatment with RHA. Wild-type mice WLrc fed with AIN-
7();\ diet only (control, n=c4), or supplemented with 0.45% HHA (treated, 11=7) Cld lihitum 
for 7days. Nrf2-I- mice were fed with chow diet only (control, n==3), Of supplemented with 
O.:l5% HI IA (treated, n=3) for 7 days. RNA was extracted from the liver, reverse 
lr~ll1scribed to cDNA and used for qRT-PCR analysis of gene expression. The fold 
induction is shown in a box and whiskers plot. The boxes extend from the 25 th to the 75 1h 
percentilc, the line across represents the median distribution of samples for each gene. 
For each point, a single mRNA was analyzed in triplicate and the average is shmvl1. The 
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Cytochromes P450 play an important role in the metabolism of xenohiotics as 
well as endogenous compounds. P450s also function in the synthesis of important 
endogenous biomolecules. Cytochromes P450 arc expressed in severed organs and tissllcs 
including the liver, heart, brain, lungs, and kidneys. The regulation of P450 expression is 
a major source of variability in the metabolism of xenobioties and endogenous 
compounds. Cyp2c29 is a major mouse P450, expressed in hepatic, as well as extra-
hepatic tissue. It is among the P450s recently demonstrated to be able to metabolize 4-
lINE. This P450 was also induced following the exposure of mice to HI IA or acrolein in 
liver. 
Analysis of the 5-t1anking sequence ofCyp2c29 revealed several putative 
tl,mscription factor binding sites including a putative TRE located at-1249 bp upstream 
df the Cyp2c29 transcription start site. This observation prompted us to examine 'v\bether 
the transcription factors Nrf2, Fos or .Tun are capablc of regulating Cyp2c29 induction in 
response to tBHQ and acrolein. 
We examined the induction of several Cyp2c29 5'-FS-derived lucifcrase reporter 
plasmids in the presence of exogenous Nrf2. Fos and Jun. Thc lueifcrase activity \\as 
induced in the presence of .Tun alone or to a higher extend by Fos and Jun expression 
pbsmids, suggesting that a Fos-Jun heterodimer and a .lun homodimcr may be 
responsible for Cyp2c29 induction. Even though the Cyp2c29 lRE resembled the 
consensus ARE, it did not respond to the presence of over-expressed Nrf2 or treatment 
with tBHQ. We therefore concluded that the induction of Cyp2c29 in response to BIL\ 
and acrolein is mediated by the oxidative stress-sensitive transcriptio111~lCtor AP-I. 
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We used a mutation strategy tn determine the role of the oligonucleotides within 
and close to the Cyp2c29-TRE in the induction of gene expression. We also mutated the 
core TRE from "GTGAC" to "GGAGA". This mutation resulted in the complete 
ablation of the FoslJun-mediated luciferase activity. By mutating this sequence. the 
binding of AP-l to the TRE is most likely inhibited. thus resulting in the jack of changl' 
in luciferase activity in the presence of Fos and Jun. Conversely. we ohser\ed that 
mutation of the dinucleotide "GC" to AA resulted in a higher inductiul1 or lucikrase 
activity by Fos and Jun. suggesting that the "GC" dinucleotide is not the optimal 
sequence for the AP-l mediated response. 
Analysis ofmRNA levels from wild type and NrfXI - miee liver demonstrated a 
further induction ofCyp2c29 in Nrf2-I- mice following treatment of mice with B1 IA. This 
:~l\ggests that Nrf2 might be acting indirectly to induce Cyp2c29 inductioll. III future 
:;ludies. an enzyme mobility shift assay (EMSJ\) will be conducted to \l~ril~v Fos anJ .iul1 
hinding to the Cyp2c29 TRE and the role of Nrf2 in protein-DNA complex formation. 
This is necessary in light of the study published by Ngueyn e{ al .. 1994. In the study 
lo()king at antioxidant response element-dependent regulation of GST /\ 1 gene 
expression, the authors observed that deletion of the "GC" in the ARJ~ found in 1 he OS!' 
Ya promoter resulted in a further induction ofluciferase activity by TPA. The authors did 
not comment on this observation. 
Substrate-dependent induction of cytochrome P450 gene expression is common. 
Phenytoin. a substrate for Cyp2c29, has been shown to be able to induce the expression 
of this P450 (Jackson et al .. 2004). \\'e have shown that acrolein is also able ~o induce 
Cyp2c29. It is likely that 4-IINE whieh is a lipid aldehyde as is acrolcill may also be able 
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to induce Cyp2c29 gene expression. Since we observed that acrolein induced tbe 
expression of several genes involved in lipid aldehyde metabolism (Figure 29, lO, 32;\), 
it is possible that acrolein could regulate its level in vivo by inducing the expression of 
enzymes responsible for its metabolism. This could hold true for 4-I{NI~: which is also a 
lipid aldehyde. 
Cytochromes P450 metabolize xenobiotics, endogenous compounds, as well as 
synthesize important metabolic and/or signaling molecules. making the regulation or 
('yp expression critical. Only a few P450s have been shown to be regulated by AP-I: for 
example CYP2J2, which is an arachidonic acid epoxygenase. is induced hy c-Jun and 
inhibited by Fos in HepG2 cells (Marden el ai., 2003). Cyp4a2 is all arachidonic acid (1)-
hydroxylase. More recently, the promoter of this P450 has heen determined to be up-
Frl;gulated by Jun in HepG2 cells (Fiala-Beer e{ 01., 2007). We have shown that Cyp2c29 
IS also regulated by AP-l. 
In our microarray analysis of gene expression (Chapter III). BIL\ and acrolein 
induced several P450s. These include Cyp2c29, Cyp2c40, Cyp=:c50 and Cyp3a23. fn 
addition, CYP39Al is induced 6-fold following 6 hours oftreatment of human colorectal 
cancer cells with 60 ~M 4-HNE (West and Marnett, 20(5). The l11echanism of inductioJ] 
nfthese P450s by these compounds is unknown. But. for Cyp2c29, we have at least 
ckmonstrated that this appears to be regulated by AP-l. 
In conclusion, by using cell-hased assays, we have determined that th~ inductil)!1 
of Cyp2c29 expression by compounds that activate oxidati\e stress-sensiti\e 
transcription factors is mediated by AP-l acting at a TRE located at -1249 bp upstream of 
the Cyp2c29 transcription start site. 
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CHAPTER V 
DISCUSSION AND CONCLUSIONS 
Prior to this study, the role ofP450s in the metabolism of lipid aldehydes 
had not been clearly defined. A study in PPARa knock out mice demonstrated that the 
Cyp4a class ofP450s is capable of metabolizing 4-HNE to 4,9-dihydroxy-2-nonenoic 
acid, the omega-hydroxylated metabolite of 4-hydroxynonenoic acid (Gueraud el ul., 
1999). No other reports have been published for P450s in lipid aldehyde mciabolism. We 
incubated 4-HNE with rat primary hepatocytes and observed rapid metabolism of ,1- I IN r:. 
Several different P450 inhibitors inhibited this metabolism. Based on this observati,m. \\ e 
hypothesized that P450s are lipid aldehyde metabolizing enzymes capable of 
metabolizing 4-HNE. Metabolic studies were then designed with individual P4.50s 
expressed in E. coli and 4-HNE or 9-anthracene aldehyde in the prl~senee ofN/dWIJ or 
an NADPH regenerating system. An NADPH regenerating system was not used in the cl-
lINE incubation reactions because we observed non-specific interactions or 4-1 INE \\ i:h 
components of the NADPH regenerating system. The use of! IPLe allowed for the 
separation of 4-HNE metabolites that wcre then identified by gas chromatography and 
ckctrospray ionization -mass spectrometry. In addition to residual 4-HNE. three major 
metabolites were generated by P450s. These metabolites were eluted "itb a retention 
time of 56 minutes, 58 minutes and 61 minutes hom the I1Pte column. J\ very polar 
metabolite was eluted from the column (tR =- 5 min). This metabolite is believed to be 
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eH]-H20. The metabolite peak corresponding to our authentic HNA standard (tR c 58 
minutes) was positively identified as 4-hydroxynonenoic based on common retcntion 
time in gas chromatography and mass spectrometry. CYP3A4. Cyp2c29. CYP2i~6 ami 
CYP2B4 generated the 4-hydroxynonenoic acid. Interestingly, the metabolite that eluted 
just prior to 4-hydroxynonenoic acid (tR c 56 minutes) was identified as 1 A-Llihyliro:xy-
2-noncne, a reduced product of 4-HNE. The 1 A-dihydroxy-2-nonene was gencrated b) 
CYP3A4, CYP2B6, CYP2J2 and Cyp2c29. While some P450s \\ere able to ge\lera~e both 
4-hydroxynonenoic acid and 1 A-dihydroxy-2-nonene, others such as CYP2B4 only 
generated 4-hydroxynonenoie acid. CYP2E 1 did not metabolize 4-1 INE. These reactions 
were confirmed by the inhibition of metabolite formation in the presence of 1>4:')0 
inhibitors (Amunom et af., 2007). Furthermore, we observed metabolism of4-IINl~ by 
mouse liver microsomes, a process inhibited by different chemical inhibitors oj' P450s. 
namely miconazole, phenytoin and troleandomycin. The metabolisll1 01'4-1 Il'\r in 
microsomes was not inhibited by cyanamide, an aldehyde dehydrogenase inhibitor 
(Figure 14). Aldehyde dehydrogenases are typically located in the cytosol or 
mitochondria (Vasiliou et uf .. 2000). Failure to inhibit microsomal ,+-HNI: metabolism 
with the aldehyde dehydrogenase inhibitor implies that the microsomes were not 
contaminated with the cytosol fraction. 
Primary cultures of rat hepatocytes also metabolized 4-IINL to 4-
hydroxynonenoic acid by oxidative reactions. 1,4-dihydroxy-2-noncne through reducti \e 
reactions and glutathione-conjugated 4-HNE through GSH conjugation reactiolls (Ilartley 
e{ al., 1995). Based on the usc of inhibitors, the authors concluded that aldehyde 
dchydrogenases were the major catalysts of the oxidative reactioll, hut OUi' results suggest 
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that some P450s are sensitive to the known inhibitors 0 f aldebyde dehydrogenascs ( 1 ()O 
~lM benomyl caused 65 % inhibition of P4503A4) and alcohol dehydrogenase (I ~l:v1 4--
mcthylpyrazole caused 98 o;() inhibition ofP4503A4, Table 2). Previous researchcrs may 
have under-estimated the role that P450s play in 4-IINE metabolism in past studies. 
Mercapturic acid conjugates oflINA and DlIN have been identified in rat urinc 
(Alary et af., 2003) indicating that these are detoxitication metabolites of 4-IINE. P450s 
therefore contribute to the metabolism and disposition of 4-HNE. to less reactivc 
intermediates which can then be subjected to further metabolism. On the other ham!. 
acrolein is metabolized in rats to several metabolites including oxalic acid. malonic acid. 
3-hydropropionic acid and other N-acetyl-conjugatcd species (Parent el 01.. 1998). In 
addition, acrylic acid, glycidol and glyceraldehydes have been ohserved in rat liver 
microsomal fractions (Patel et al., 1980). These are phase lmetabolie products of 
acrolein. It is possible that P450s contribute to acrolein metabolism by generating these 
products. However, we have not investigated this possibility. 
In addition to 4-HNE, we determined that the (x,r)-unsaturated aldehYlk. l)-
anthracene aldehyde, is also metabolized by cytochromes P450 to generate 9-anthracene 
carboxylic acid and 9-anthracene methanol. the oxidized and reduced metabolites of 9-
anthracene aldehyde, respectively. In metabolic studies, Cyp2c:29 nletaholizcc\ hotb 9-
anthracene aldehyde and 4-HNE with a pattern of mixed competitive inhibition indicating 
that 4-HNE and 9-anthracene aldehyde are alternate or competitive substrates of 
Cyp2c29. Cyp2c29 is a mouse P450 expressed in hcpatic and extra hepatic tissuc that 
\\<\s previously reported to oxidize a cannabinoid aldehydc to its acid ('r'amal11()to c{ ul.. 
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\995). In my dissertation research, we showed that this P450 can also metaho\i/e h<)th ~­
lINE and 9-anthraeene aldehyde. 
Cardiovascular tissues including heart. smooth muscle and endothelium express d 
variety of P450 enzymes that in humans include two gene famil ies of epoxygenases 
(CYP 2C8, 2C9, 2C 1 0, 2J2) which generate the regio- and stereo-spccillc 
cpoxyeieosatrienoie acids (EETs) and co-hydroxylascs belonging to the CYIl-fA t~\I11il) 
v;hieh form subterminal and co-terminal hydroxycicosatetraenoic acids (lIFTh). 
Together the products of these enzymes play an important role in regulating \'ascuiar tOIll' 
and homeostasis (Fleming, 2001). In these functions, the role 0 r l1Ul11an C Y P2Cl) appears 
to be particularly critical since sulfaphanazole, a selective inhibitor of CYP2C9. inhibits 
responses attributed to the endothelium-derived hyperpolarizing factor (EDIlF) and 
potentiates nitric oxide mediated relaxation (Fleming, 2001). On the basis of these 
',)hservations it has been suggested that CYP2C9 is the EDHF generating (,YP. I kl:CC. 
our observation that mouse Cyp2c29 metabolizes 4-HNE suggests that in addition to 
mediating or regulating NO/PGl2-indcpendent vasodilation, CYP2C9 and related forms 
of P450 may have an important role in preventing oxidative injury. Altcn;ali\'ely. 
competitive inhibition ofCyp2c29 by 4-HNE suggest that conditions associated wilh 
high levels of oxidative stress and the gencration of lipid peroxidation products could 
prevent or attenuate EDHF generation and thus compromise endothelium-depcndent 
relaxation in coronary. mesenteric, and renal arteries. where ED! [}<'-mediakd responses 
arc particularly critical. I-Ience, 4-HNE-dependent inhibition of CYP2C Corms could link 
the development ofhypcrtcllsion with oxidative stress such as that associated with 
atherosclerotic lesions formation. Clearly further physiological stu(Jics arc vvarrantcd to 
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understand fully the role of this and related CYP isolorms in the mctabolislll or reacti ve 
carbony Is. 
In addition to the metabolism of 4-HNF, we investigated the rok of lipid 
aldehydes in regulating the expression ofxenobiotic metabolizing enzymes ill mouse 
heart and liver by microarray and quantitative real-time PCR. Acrolein lS generated ill 
vivo from lipid peroxidation and is a prevalent environmental pollutant. C57BI./6 mice 
were treated with acrolein by gavage or inhalation to mimic the natural routes or acrolein 
exposure in humans. A separate group of mice was also treated with HIlA for comparison 
with the: acrolein exposure. In our micro array analysis of gene expression. we obserVl'd 
differences in the magnitude of basal gene expression between control animals Crom ti1~ 
acrolein-treated group (chow diet) and the: BlIA-treated group (AIN-76/\ diet). It i~ 
possible that the diets caused the differences observed. To address this ambiguity. \Ve 
conducted a principle component analysis ofthe two control groups. The control data 
ii'om both sets of controls were normalized to a coml11on group of diagnostic genes and 
then compared with the chronic acrolein and BH/\ treatments (Figure n). The genes ill 
the BHA and acrolein treated groups separated into two difCerellt groups suggesting that 
different genes were affected by the HIlA and acrolein treatment. 
Several P450s were induced by 13HA in mouse livcr: Cyp I a2. ('yp7acl. ('yp2c2() 
Cyp2c37. Cyp2c44, Cyp2c50 and Cyp5 L and acrolein: Cyp2c29, Cyp2c44. Cyp2c I and 
Cyp2j6. Other studies have also shown that compounds that induce Nrf2 induce the 
expression of some P450s. For example, in the study ofGST induction in CD-1 micc. P 1 -
450 and P3-450 mRNA were induced 3-5-fold in the liver and intestine after 1311/\ 
treatment (Pearson et ai., 1(88). In addition. the cxpression o/" ('YP I :\. CYP3!\, CYP2B. 
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CYP4A and CYP39A was induced by the Nrf2 activator sulforafanc: (JIll e/ a/., 2004L 
and Cypla2, Cyp2a4, Cyp2a12, Cyp3a13, and Cyp4aJO by 3H-L2-dithiole-3-thi(1I1e in 
Nrf2- wild type, but not Nrf2 knock out mice (Kwak et 01.,2003). More recently. 4-1 INt·: 
caused a 6-fold induction of CYP39Al in human colorectal carcinoma cells (West and 
Marnctt, 2005). Even though these P450s are induced, it is widely known that the 
promoter sequence of P450s does not contain an antioxidant element. the cis clement that 
binds Nrf2 to induce gene expression. It is therefore evident that a ~eparate mechanism 
exists for P450 induction by these compounds. 
The glutathione S-transferases catalyze the conjugation of (~SI-I to elcctrophilic 
compounds. BHA induced GSTa3. GSTmJ and GSTtL while GSTmi was induced by 
acrolein. This corresponds with other studies that have determined this family of enzyme 
to be induced by Nrf2-activating compounds (Thimll1ulappa et ClI., 20(2). 
NADPH:quinone oxidoreductase L Heme oxygenase J and some members oCthe 
aldehydle dehydrogenase and aldoketoreductasc f~lmily \\'ere also induced by both HI IA 
and acrolein. Just like GSTs, these enzymes arc believed to be regulated by NrC? (Kvvak 
et al., 2003: Thimmulappa et al., 2002). 
My studies have provided the following observations related to Cyp2c29. (i) It 
metabolizes 4-HNE; (2) Cyp2c29 mRNA is induced in mice liver by BHA and acrolein; 
(3) Cyp2c29 protein is induced in mouse liver microsomes after 7 days of' HI !/\ 
treatment, and (4) BHA induced expression ofCyp2c29 in Nrf2 null mice. TransfCction 
experiments with Cyp2c29-promoter luciferase reporter constructs indicated that 
Cyp2c29 transcription was regulated by AP-l and not by the Nrfl tt'anscriptic)Jl j~lct()r. 
Through a computer-based search of putative response elements and deletion analysis. 
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the AP-l-dependent regulation of Cyp2c29 was mapped to a 30-hase pair region of the 
Cyp2c20 promoter containing an AP-l response clement (TRE) li'om -1.23 8 to -1.2~~(J. 
This TRE responded to the expression of exogenous Fos and Jun as indicated by an 
induction ofluciferase activity. Mutation of the core nucleotides of thc TRI~ resulted in 
the loss of luciferase activity. Surprisingly. when we mutated the '"OC" dinucleotide 
which is immediately 5' of the Cyp2c29 TRE, we observed a 3-fold increase in lucifcrase 
activity. This implies that the "GC" dinucleotide is not required f()r optimal induction of 
Cyp2c29 by the AP-l transcription factors; in lact, they serve to negatively regulak 
Cyp2c29 gene expression. Furthermore, qRT-PCR analysis was performed on samples 
obtained from wild-type and Nrf2 ./. mouse liver. NADPH quinoJle oxidoreductase. hellle 
oxygenase 1, and glutathione S-transferase were induced in the liver Ii'om B1IA-ICd llild· 
fype mice liver and not in the liver from Nrf2'/' mouse liver. Conversely. Cyp2c.29 was 
induced in the liver of wild-type BI-Jl\-fcd mice liver and further induced in BIIA·jed 
Nrf2'/' mice liver. We conclude that while NAOPII quinine oxidoreductase. i1ellle 
oxygenase 1, and glutathione S-transfCrase are predominantly regulated by the NrC-/\R!': 
system. Cyp2c29 is most like regulated by AP-I. accounting for the further induction of 
Cyp2c29 observed in Nrf2'/' mouse liver. As we have demonstrated. the cxpr.?ssioll or 
P450s in the liver is altered in response to compounds that cause the ac~ivati()11 dr 
transcription factor AP-l. During oxidative stress. when the levels of lipid aldehydes are 
reported to be increased. this may also alter the levels or P450s being expressed. by 
activating AP-l. Consequently, there could be differences in P450 acli\'ities in dilTcrent 
organs resulting in alterations in the biosynthesis of biomolecules by the same P450s or 
dit1erences in xenobiotie metabolism. 
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In conclusion, P450s are lipid aldehyde metaholizing enzymes capable of 
oxidative and/or reductive metabolism of 4-HNE and 9-antlm:lcl~ne aldehyde. HilA am! 
acrolein induce the expression of some P450s. For Cyp2c29, this induclion is t1lediated 
by AP-I transcription factors, a mechanism not yet reported for any other P450s. 
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LIST OF ABBREVIATIONS 
4-HNE: 4-hydroxy-2-nonenal 
5' -FS: 5' -flanking sequence 
9-AA: 9-anthracene aldehyde 
9-ACA: 9-anthracenc carboxylic acid 
l)-AMeOH: 9-anthracene methanol 
A1"-1: activation function-1 
AF-2: activation function-2 
AIN76A: American institute of nutrition diet 76A 
AP-1: activator portien 1 
ALDH: aldehyde dehydrogenase 
AR: aldose reductase 
ARE: antioxidant response element 
HI IA: butylated hydroxy anisole 
CAR: constitutive androstane receptor 
CPM: counts per minute 
CYP: cytochrome P450 
DHN: 1,4-dihydroxy nonene 
D PLe: dilauroylphosphatidylcholine 
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(iC/MS: gas chromatography-mass spectrometry 
CiST: glutathione S-transferasc 
CiS-fINE: glutathione conjugate of 4-HNE 
HNA: 4-hydroxynonenoic acid 
I IPte: high performance liquid chromatography 
Kcap I: Kelch-like ECH-associated protein I 
NA])PH: nicotinamide adenine dinucleotide phosphate, reduced Corm 
NADPH:CYPOR: NADPH/cytochromc P450 oxidoreductase 
NFkH: nuclear factor kB 
P450: cytochrome P450 
RNA: ribunucleic acid 
SD: standard deviation 
tf?: retention time 
PXR: pregnane X receptor 
peR: polymerase chain reaction 
PPAR: peroxisome proliferator activated receptor 
QRT-PCR: quantitative real-timc peR 
RXR: retinoic acid receptor 
TBHQ: tcrtiary butylated hydroquinone 
TeA: trichloroacetic acid 
TRE: TPA (l2-0-tetradecanoyl-phorbol-13 acetate) response e1cnll'lll 
202 
CURRICULUM VITAE 
Name: Immaculate Amunom 
Education 
B.S., Life Sciences 
University of Buea- Cameroon (1998) 
M. S., Biochemistry 
University of Buea Cameroon (2000) 
Ph.D., University of Louisville School of Medicine (2008) 
Louisville KY 
Awards 
Graduate Student Travel Award, The American Society for Pharmacology ~lI1d 
Experimental Therapeutics (ASPET), 2006. 
Integrated Program in Biomedical Sciences (fPIBS) Fellowship 2002-2004. 
The Annual James Graham Brown Cancer Center Retreat, Condict Moore Studcnt 
Research Prize, U. of Louisville 2004. 
Professional Societies 
International Society for the Study of Xenobiotics (ISSX). 
American Society for Pharmacology and Experimental Therapcutics (ASPI-:,!,). 
Ohio Valley Society of Toxicology (OVSOT) 
Publications 
"The Role of Metabolism in Protection Against Cardiotoxic Compounds". R.J\. 
Prough, I. Amunom, and D..T. Conklin, Sustain 13:6-11 (2006). Review. 
"Several Cytochromes P450 are Aldehyde Monooxygenases"'. I. Amunom. 1..1. 
Stephens, D.J. Conklin, S. Srivastava. A. Bhatnagar. and R.A .. Prough. 
Enzymology and Molecular Biology a/Carhonyl Metabolism (cd .. I I. WcimT). 
12:118-123, U. Purdue Press. Lafayette. IN (2005). Review. 
2m 
"Cytochromes P450 Catalyze the Oxidation of a.B-unsaturated Aldehydes" I. 
Amunom, L.l. Stephens. V. Tamasi, J. Cai, DJ. Conklin. A. 8hatnagar. S. 
Srivastava, M.V. Martin, F. P. Guengerich, and R.A. Prough, A,.chh'es oj 
Biochemistry and Biophysics 464(2): 187-96 (2007). 
rv1anuscripts In Preparation 
"P450 3A4 Reduces a,B-unsaturated Aldehydes to Alcohols" I. Amunom. LI. 
Stephens, J. Cai, S. Srivastava, F. P. Guengerich and R.A. Prough. 
Abstracts 
"P4502c29 is Regulated Through thc Action oC AP-l transcription factor" L 
Amunom, J. A. Goldstein and R. A. Prough. 
"Murine P4502c29 is an Aldehyde Dehydrogenase" R.A. Prough. D..J. Conk I :11, 
LJ., Stephens and I. Amunom, (2004) lih International Meeting on the 
Enzymology, and Molecular Biology of Carbonyl Metabolism. I~urlingt()n. Vi". 
July 7-11. 
"Murine P4502c29 Metabolizes Endogenous Lipid Aldehydes" l. Amunoll1. L..1. 
Stephens and R.A. Prough, (2004) i h International ISSX Meeting, f),.u,l.', 
Metabolsim Revie'ws 36, Abstract No. 151. 
"Induction of Cytochromes P450 by Nrf2 activators: Impliutions for aldelwck 
metabolism" 1. Amunom. LJ. Stephens, D.l Conklin. and R.A Prough. (2CO()) 
Experimental Biology, Abstract No 176.11, April 1-5. 
"Aldehyde Metabolsim is Regulated by Nuclear Factor E2-reiated Factor:?" I. 
Amunom, L..T. Stephens, DJ. Conklin, A. Bhatnagar. and R.A. Prough. (20061 
13 th International Meeting on the Enzymology and Molecular Biology or 
Carbonyl Metabolism, Abstract AL-1, Nashville. TN, July 11- 15. 
"Cis-Regulatory Elements of Sexual Stage Gene Expression: Laboratory ~llld 
Field Characterization ofPfs25" Mbacham W.F .. Amunol11 L Colightly L.M ... 
Daily J.. Sullivan T..T., Harris OS., Ruel K., Lasersol1 K .. Dechering K., Yong S .. 
Enyong P., Titanji V.P.K., and Wirth D.F. (2000) University of Yaounde L 
Cameroon. 
204 
